[
  {
    "username": "GSK",
    "tweet_id": "1983069757482901994",
    "url": "https://x.com/GSK/status/1983069757482901994",
    "created_at": "Tue Oct 28 07:14:08 +0000 2025",
    "text": "#News for #investors and #media: Today we announced an agreement with Empirico to add to our pipeline in COPD and potentially other inflammatory respiratory diseases. \n\nFind out more: https://t.co/RPdN5Xono0 https://t.co/z6xTiZ19lj",
    "likes": 11,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1983067870511648813",
    "url": "https://x.com/GSK/status/1983067870511648813",
    "created_at": "Tue Oct 28 07:06:38 +0000 2025",
    "text": "#News for #Investors and #Media: Today we announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to an investigational antibody-drug conjugate in our oncology pipeline. \n\nLearn more here: https://t.co/ojUP5ZS7Hi https://t.co/cBXhmdCyKH",
    "likes": 8,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1983000289788547499",
    "url": "https://x.com/GSK/status/1983000289788547499",
    "created_at": "Tue Oct 28 02:38:06 +0000 2025",
    "text": "@Somchai55475884 Hi, in the interest of patient safety, we have forwarded your comment to our safety team. Please get in touch with us at 888-825-5249 or https://t.co/I4cIyo92ul so we can learn more about the experience you reported. Thank you.",
    "likes": 0,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1982705100997959946",
    "url": "https://x.com/GSK/status/1982705100997959946",
    "created_at": "Mon Oct 27 07:05:07 +0000 2025",
    "text": "#News for #investors and #media: Today we announced an agreement with Syndivia to add to our growing oncology pipeline in prostate cancer. \n \nFind out more: https://t.co/e31JAIiurL https://t.co/gBj6jZf1v2",
    "likes": 5,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1981638616200675396",
    "url": "https://x.com/GSK/status/1981638616200675396",
    "created_at": "Fri Oct 24 08:27:17 +0000 2025",
    "text": "Our Chief Digital & Technology Officer, Shobie Ramakrishnan,¬†spoke at #BloombergTech this week about how an integrated use of tech across everything we do is helping us get ahead of disease. Here, Shobie shares why it's so critical to drive innovation - bringing science, tech and talent together to innovate in R&D üëá",
    "likes": 5,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1981454830775181757",
    "url": "https://x.com/GSK/status/1981454830775181757",
    "created_at": "Thu Oct 23 20:16:59 +0000 2025",
    "text": "#News for #Investors and #Media\n\nThe US Food and Drug Administration (FDA) has approved our therapy to treat an incurable and challenging blood cancer. \n\nFor more information, visit: https://t.co/iq6ccrYH5Q https://t.co/OKNRPUur1c",
    "likes": 6,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1981299565232845200",
    "url": "https://x.com/GSK/status/1981299565232845200",
    "created_at": "Thu Oct 23 10:00:01 +0000 2025",
    "text": "At GSK, we're driven by the hope of a future where people don't just survive cancer but thrive long after.\n\nüîó Read more about this potential future and how we're working to get there: https://t.co/WhDWVfMmV7 https://t.co/ijshOX7mme",
    "likes": 7,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1980884858898403628",
    "url": "https://x.com/GSK/status/1980884858898403628",
    "created_at": "Wed Oct 22 06:32:08 +0000 2025",
    "text": "#News for #investors and #media: We‚Äôve just announced data from our pivotal phase III clinical programme for a metered dose inhaler (MDI).\n\nLearn more: https://t.co/ja3WXg8Tov https://t.co/lHF3gUrvg5",
    "likes": 7,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1980545845251506193",
    "url": "https://x.com/GSK/status/1980545845251506193",
    "created_at": "Tue Oct 21 08:05:00 +0000 2025",
    "text": "#News for #investors and #media: @GlobalFund welcomes renewed commitment from GSK and @ViiVHC to expand community-led health solutions with ¬£6 million joint pledge ahead of 8th replenishment: https://t.co/B4q3tkRMui https://t.co/bLsR63KNp0",
    "likes": 7,
    "retweets": 3,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1980529486404735411",
    "url": "https://x.com/GSK/status/1980529486404735411",
    "created_at": "Tue Oct 21 07:00:00 +0000 2025",
    "text": "#News for #Investors and #Media: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion for a new prefilled syringe presentation of one of our vaccines. \n\nLearn more: https://t.co/Tpd2mqJMQe https://t.co/FYuV9qsQ29",
    "likes": 6,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1980519294250225756",
    "url": "https://x.com/GSK/status/1980519294250225756",
    "created_at": "Tue Oct 21 06:19:30 +0000 2025",
    "text": "#News for #Media and #Investors: Today, with @Spero_Tx, we are sharing an update on the Phase III trial results of one of our investigational oral anti-infectives, presented during #IDWeek2025 in Atlanta. \n \nLearn more: https://t.co/8nBSnRL3ZD https://t.co/ERCHCVzsvF",
    "likes": 8,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1979865109787746411",
    "url": "https://x.com/GSK/status/1979865109787746411",
    "created_at": "Sun Oct 19 11:00:00 +0000 2025",
    "text": "‚ÄúIt‚Äôs hard to explain the pain of a UTI to people who‚Äôve never had one.‚Äù \n  \nüîó Read LeAnn‚Äôs story and why she thinks personalised care is so important: https://t.co/epuWrsYQ7u\n  \n#IDWeek2025 https://t.co/7uumcFB3Pj",
    "likes": 6,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1979502720026341585",
    "url": "https://x.com/GSK/status/1979502720026341585",
    "created_at": "Sat Oct 18 11:00:00 +0000 2025",
    "text": "Modern medicine has revolutionised the way we live, but the challenges to our health are evolving. We need to shift our health systems from reactive to proactive care. \n\nFind out why preventing disease is the best investment not just for people, but for the world‚Äôs health systems, societies and economies üëá \n\n #IDWeek2025  https://t.co/LFEbbqGHMR",
    "likes": 7,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1978417469686489535",
    "url": "https://x.com/GSK/status/1978417469686489535",
    "created_at": "Wed Oct 15 11:07:36 +0000 2025",
    "text": "#News for #Investors and #Media: Data presented at #EACS2025 by our specialist HIV company - @ViiVHC - offer a deeper understanding of therapy options and could help individuals and their healthcare providers make more fully informed choices about their HIV care.  \n \nFind out more: https://t.co/MIBReDRewz",
    "likes": 8,
    "retweets": 2,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1978116842632732850",
    "url": "https://x.com/GSK/status/1978116842632732850",
    "created_at": "Tue Oct 14 15:13:01 +0000 2025",
    "text": "Inspiring to see our CEO Emma Walmsley alongside so many trailblazing women at today‚Äôs #FortuneMPW summit. From discoveries in cancer treatments to leveraging AI, Emma shared her vision for the future of healthcare and reflected on the significant transformation she has led as a change agent for GSK over the past nine years.",
    "likes": 14,
    "retweets": 4,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1977982477265150205",
    "url": "https://x.com/GSK/status/1977982477265150205",
    "created_at": "Tue Oct 14 06:19:06 +0000 2025",
    "text": "#News for #Investors and #Media: The China National Medical Products Administration has approved a new indication for one of our vaccines.\n\nLearn more: https://t.co/0aFhIvvpbx https://t.co/3s8Jzoa6sS",
    "likes": 4,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1975953793058545980",
    "url": "https://x.com/GSK/status/1975953793058545980",
    "created_at": "Wed Oct 08 15:57:50 +0000 2025",
    "text": "@EliCVidales Hi Elizabeth, in the interest of patient safety, we have forwarded your comment to our safety team. Please get in touch with us at 888-825-5249 or https://t.co/I4cIyo92ul so we can learn more about the experience you reported. Thank you.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1974791678499201039",
    "url": "https://x.com/GSK/status/1974791678499201039",
    "created_at": "Sun Oct 05 11:00:00 +0000 2025",
    "text": "Invasive meningococcal disease (IMD) is uncommon but can strike fast with serious consequences. Together with the wider community, this #WorldMeningitisDay we‚Äôre raising awareness of IMD and highlighting the need for continued action to #DefeatMeningitis. \n\nüîó Learn more here: https://t.co/wU4czXurD7",
    "likes": 13,
    "retweets": 4,
    "replies": 8,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1973955103636766856",
    "url": "https://x.com/GSK/status/1973955103636766856",
    "created_at": "Fri Oct 03 03:35:45 +0000 2025",
    "text": "@bobybob2015 Hello. We'd love to help but industry regulations mean we're not able to discuss our medicines with you here. Your doctor or healthcare professional will be best placed to support. We hope this helps.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1973681866247946385",
    "url": "https://x.com/GSK/status/1973681866247946385",
    "created_at": "Thu Oct 02 09:30:00 +0000 2025",
    "text": "#ERSCongress 2025 has closed, but every day we apply our expertise and take on the complex challenges in respiratory health to help more people breathe with ease. Our aim, to improve the lives of half a billion people around the world living with chronic respiratory disease.  \n\nhttps://t.co/D5IaqxlBF7",
    "likes": 6,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1973439668373856344",
    "url": "https://x.com/GSK/status/1973439668373856344",
    "created_at": "Wed Oct 01 17:27:36 +0000 2025",
    "text": "@karthik_vk1 Hello, thanks for getting in touch. ENO antacid is now made by Haleon, not GSK. We encourage you to reach out with further feedback or questions via their channel  @Haleon_health or their website, https://t.co/nVW29kMR2D. Sorry we couldn't be of help this time.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1973402777171665071",
    "url": "https://x.com/GSK/status/1973402777171665071",
    "created_at": "Wed Oct 01 15:01:00 +0000 2025",
    "text": "As #ERSCongress 2025 comes to a close, Katharina Wolff, VP, Global Medical Affairs, Specialty Care, reflects on why our data line-up is testament to our focus on targeting the underlying drivers of respiratory disease to improve patients‚Äô future health and long-term outcomes. https://t.co/Kx1ernxVA6",
    "likes": 5,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1973056821846773810",
    "url": "https://x.com/GSK/status/1973056821846773810",
    "created_at": "Tue Sep 30 16:06:18 +0000 2025",
    "text": "@DKDRAAJAANI Hi, in the interest of patient safety, we have forwarded your comment to our safety team. Please get in touch with us at 888-825-5249 or https://t.co/I4cIyo92ul so we can learn more about the experience you reported. Thank you.",
    "likes": 0,
    "retweets": 0,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1972949543315558646",
    "url": "https://x.com/GSK/status/1972949543315558646",
    "created_at": "Tue Sep 30 09:00:01 +0000 2025",
    "text": "Kaivan Khavandi, SVP and Global Head Respiratory, Immunology and Inflammation R&amp;D at GSK, explains why getting ahead of COPD exacerbations is so important and why different patients need personalised treatment approaches. https://t.co/7h3yfPTnyF https://t.co/mKygC2pGd2",
    "likes": 8,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1972194637105291729",
    "url": "https://x.com/GSK/status/1972194637105291729",
    "created_at": "Sun Sep 28 07:00:17 +0000 2025",
    "text": "Rav Seeruthun and Barbara Cygler share their excitement about #ERSCongress 2025 and what they feel are the key data from more than 60 abstracts including research from our portfolio of inhaled therapies, biologics, vaccines and pipeline assets. https://t.co/sBoKzgkRGJ",
    "likes": 12,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1971854825609474084",
    "url": "https://x.com/GSK/status/1971854825609474084",
    "created_at": "Sat Sep 27 08:30:00 +0000 2025",
    "text": "We are preparing to share our latest research at  #ERSCongress2025 starting this weekend and we want to hear from you - what aspect of respiratory disease are you interested in knowing more about? üëá",
    "likes": 4,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1971491098536100112",
    "url": "https://x.com/GSK/status/1971491098536100112",
    "created_at": "Fri Sep 26 08:24:41 +0000 2025",
    "text": "As we prepare for #ERSCongress 2025, watch this thought-provoking conversation between GSK‚Äôs CEO, Emma Walmsley, Tonya Winders, CEO of the Global Allergy and Airways Patient Platform, and Jean Wright, CEO of the COPD foundation https://t.co/6z5PgetKm3 https://t.co/fh8QyRSQjk",
    "likes": 10,
    "retweets": 2,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1971216120234340626",
    "url": "https://x.com/GSK/status/1971216120234340626",
    "created_at": "Thu Sep 25 14:12:01 +0000 2025",
    "text": "On #WorldLungDay, as we aim to get ahead of respiratory disease, we are supporting FIRS Lungs First and the global respiratory community to raise awareness of the importance of vaccinations in protecting the future health of our lungs. \n\nRead more here https://t.co/fTPiTJ4hqD https://t.co/HyhUsO6yb5",
    "likes": 4,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1971137600367870159",
    "url": "https://x.com/GSK/status/1971137600367870159",
    "created_at": "Thu Sep 25 09:00:00 +0000 2025",
    "text": "On #WorldLungDay and as we prepare to share our latest research at #ERSCongress, GSK‚Äôs Chief Scientific Officer, Tony Wood explains why getting ahead of respiratory disease demands a preventative approach and breathtaking innovation.",
    "likes": 7,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1970177290613969264",
    "url": "https://x.com/GSK/status/1970177290613969264",
    "created_at": "Mon Sep 22 17:24:04 +0000 2025",
    "text": "@DrCSSeshadri Hello. In the interest of patient safety, we have forwarded your comment to our safety team. Please get in touch with us at 888-825-5249 or https://t.co/I4cIyo92ul so we can learn more about the experience you reported. Thank you.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1967622980076179905",
    "url": "https://x.com/GSK/status/1967622980076179905",
    "created_at": "Mon Sep 15 16:14:09 +0000 2025",
    "text": "#News for #investors and #media: At #ERSCongress 2025 we‚Äôll be sharing our latest research across more than 60 abstracts including 3 late breakers. \n\nWe‚Äôre redefining respiratory care for millions of people living with respiratory diseases. \n\nLearn more: https://t.co/xjh7S3ToRj https://t.co/V3YK7N9yCo",
    "likes": 10,
    "retweets": 5,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1965732055540510789",
    "url": "https://x.com/GSK/status/1965732055540510789",
    "created_at": "Wed Sep 10 11:00:18 +0000 2025",
    "text": "Healthy ageing is not just about living longer, it‚Äôs about living well for longer. We are currently at #ESCMIDVaccines 2025 congress sharing the latest data on how our vaccines can help individuals and societies do just this. Hear from experts about why this is important https://t.co/w0Fl78QSiR",
    "likes": 10,
    "retweets": 2,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1963622688435388895",
    "url": "https://x.com/GSK/status/1963622688435388895",
    "created_at": "Thu Sep 04 15:18:25 +0000 2025",
    "text": "@77mohitarora Hello Mohit. Thanks for your question. In India, we work with our partners to deliver medicines and vaccines to patients. Find out more: https://t.co/YsyrLV9q2e. Thank you.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1963538784160514241",
    "url": "https://x.com/GSK/status/1963538784160514241",
    "created_at": "Thu Sep 04 09:45:01 +0000 2025",
    "text": "GSK's Katie Ewer takes us on a journey inside the lab to explore the innovative research behind the second generation of malaria vaccine: https://t.co/3s6ONZzQDk https://t.co/6AE7gE4XNu",
    "likes": 10,
    "retweets": 3,
    "replies": 4,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1960990744736387075",
    "url": "https://x.com/GSK/status/1960990744736387075",
    "created_at": "Thu Aug 28 09:00:01 +0000 2025",
    "text": "üîç AI is changing the way we understand disease.\n\nNot just by helping us analyse data at speed ‚Äî but identify how diseases progress and which patients respond best to treatments.\n\nRead our article to find out more: https://t.co/oyvkC8I3gA https://t.co/iwS3vuVjbI",
    "likes": 12,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1960296170758037655",
    "url": "https://x.com/GSK/status/1960296170758037655",
    "created_at": "Tue Aug 26 11:00:02 +0000 2025",
    "text": "Imagine a future where cancer is managed like any other long-term condition, allowing people to live fuller lives. \n\nAt GSK, we‚Äôre working to turn that vision into a reality. \n\nüîó Read more about this potential future and how we're working to get there: https://t.co/MCKCyVmQtG https://t.co/S1bzRZnMoS",
    "likes": 11,
    "retweets": 3,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1958091639840293074",
    "url": "https://x.com/GSK/status/1958091639840293074",
    "created_at": "Wed Aug 20 09:00:01 +0000 2025",
    "text": "ü¶† ‚ÄúI was resistant to nine antibiotics,‚Äù says AMR survivor, Vanessa Carter. \n\n‚ÄúI had to learn how to walk again. It took me years to recover.‚Äù\n\nThe human impact of antimicrobial resistance is real ‚Äì but it is preventable.\n\nüîó Read our article to find out how we‚Äôre fighting back: https://t.co/n4U5yuoLmq\n\n #AMR",
    "likes": 13,
    "retweets": 1,
    "replies": 4,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1955917317998510366",
    "url": "https://x.com/GSK/status/1955917317998510366",
    "created_at": "Thu Aug 14 09:00:02 +0000 2025",
    "text": "The global population is ageing, and with it, the burden of infectious disease is set to grow.\n\nInnovative health policies are needed to help strengthen economies, bolster health services, and ensure people are able to live healthy lives.\n\nüîóRead more: https://t.co/pfi9cZ8A8A https://t.co/sMttnv3G43",
    "likes": 14,
    "retweets": 5,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1955570025302991260",
    "url": "https://x.com/GSK/status/1955570025302991260",
    "created_at": "Wed Aug 13 10:00:01 +0000 2025",
    "text": "It‚Äôs a time of life when many may feel invincible, but adolescents are at risk of invasive meningococcal disease (IMD), a bacterial infection that can be life-threatening. \n\nRead our article to hear from IMD survivor Kate ‚Äì and mother Michelle, who lost her son Ryan within 24 hours: https://t.co/ModtJcYiOM",
    "likes": 11,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1955301234660811207",
    "url": "https://x.com/GSK/status/1955301234660811207",
    "created_at": "Tue Aug 12 16:11:56 +0000 2025",
    "text": "@SumanDutta1609 Hi Suman, thanks for your feedback. We're not able to discuss our medicines with you here. Find out how to contact your local GSK team at https://t.co/DALX3q4Osh, or speak to your healthcare provider for further support.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1954787230993600855",
    "url": "https://x.com/GSK/status/1954787230993600855",
    "created_at": "Mon Aug 11 06:09:28 +0000 2025",
    "text": "#News for #Investors and #Media: Today we announced that one of our investigational oral anti-infectives has been accepted for priority review by US FDA.\n\nLearn more: https://t.co/FSB5pdh4FT https://t.co/qUb68yivUs",
    "likes": 11,
    "retweets": 1,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1953645055291314226",
    "url": "https://x.com/GSK/status/1953645055291314226",
    "created_at": "Fri Aug 08 02:30:52 +0000 2025",
    "text": "@DivyamS94222317 Thanks for contacting us. In the interest of patient safety, we have forwarded your comment to the relevant team in India and our local team have contacted you directly with the correct information. For any additional information contact GSK India office at https://t.co/w3sPqjpoFG.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1950204215009161666",
    "url": "https://x.com/GSK/status/1950204215009161666",
    "created_at": "Tue Jul 29 14:38:12 +0000 2025",
    "text": "@reubentech Hi Reuben, in the interest of patient safety, we have forwarded your comment to the relevant team. Please get in touch with us at: https://t.co/I4cIyo92ul or https://t.co/YsyrLV9q2e so we can learn more about the experience you reported. Thanks.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1950180447922622509",
    "url": "https://x.com/GSK/status/1950180447922622509",
    "created_at": "Tue Jul 29 13:03:46 +0000 2025",
    "text": "#News for #Investors and #Media: \n\nToday we are sharing new findings on Dementia and Alzheimer‚Äôs Disease at #AAIC2025, building on our leadership in immunology and inflammation. \n\nüîó Find out more: https://t.co/gXRjQHu3n6 https://t.co/DpXefm90nq",
    "likes": 14,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1949866512266776941",
    "url": "https://x.com/GSK/status/1949866512266776941",
    "created_at": "Mon Jul 28 16:16:17 +0000 2025",
    "text": "It‚Äôs #WorldHepatitisDay and we are proud to sponsor @Hep_Alliance in raising awareness of chronic hepatitis B (CHB)",
    "likes": 6,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1949713695736512656",
    "url": "https://x.com/GSK/status/1949713695736512656",
    "created_at": "Mon Jul 28 06:09:03 +0000 2025",
    "text": "#News for #investors and #media: We‚Äôve announced a collaboration with Hengrui Pharma to develop up to 12 innovative medicines across respiratory, immunology and oncology. Find out more: https://t.co/66InYqt8Ie https://t.co/B7c5rQF2A1",
    "likes": 17,
    "retweets": 8,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1948415227004866611",
    "url": "https://x.com/GSK/status/1948415227004866611",
    "created_at": "Thu Jul 24 16:09:24 +0000 2025",
    "text": "#News for #Investors and #Media \n\nThe European Commission has granted marketing authorisation for one of our blood cancer therapies. For more information, visit: https://t.co/ZuCjvOwJAK https://t.co/hITqrs41gB",
    "likes": 6,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1945726885381501096",
    "url": "https://x.com/GSK/status/1945726885381501096",
    "created_at": "Thu Jul 17 06:06:53 +0000 2025",
    "text": "#News for #Investors and #Media: The US FDA has approved a new presentation of one of our vaccines. \n\nLearn more: https://t.co/P18GUwjelp https://t.co/AJSWFnD8Jt",
    "likes": 11,
    "retweets": 3,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1945438263096869060",
    "url": "https://x.com/GSK/status/1945438263096869060",
    "created_at": "Wed Jul 16 11:00:01 +0000 2025",
    "text": "üöÄ At GSK, R&D is central to our purpose: to get ahead of disease together. Much of our cutting-edge innovation happens in the UK, where we invested ¬£1.5bn in 2024 alone. That‚Äôs why we welcome the UK Government‚Äôs new Life Sciences Sector Plan. \n \nüîó Read the plan here: https://t.co/DjsQzkrtYI",
    "likes": 8,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1945121176369390063",
    "url": "https://x.com/GSK/status/1945121176369390063",
    "created_at": "Tue Jul 15 14:00:01 +0000 2025",
    "text": "Many blood cancer patients face lifelong treatment challenges, but thankfully scientists are working hard to give them the quality of life they deserve. \n\nüîó Find out why patients living with incurable blood cancers need more treatment options in our latest Behind the Science article: https://t.co/9cHFSBy6Rs",
    "likes": 7,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1944789005792326064",
    "url": "https://x.com/GSK/status/1944789005792326064",
    "created_at": "Mon Jul 14 16:00:06 +0000 2025",
    "text": "#News for #Investors and #Media: Data presented at #IAS2025 by @ViiVHC (our specialist HIV company) reinforce the importance of providing people living with #HIV with innovative treatment options that best suit their individual needs and preferences. \n\nüîó Find out more: https://t.co/eqlMk3GttI",
    "likes": 9,
    "retweets": 3,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1944747618682212622",
    "url": "https://x.com/GSK/status/1944747618682212622",
    "created_at": "Mon Jul 14 13:15:38 +0000 2025",
    "text": "#News for #Investors and #Media: @ViiVHC (our specialist HIV company) has expanded its voluntary license with the Medicines Patent Pool to include further innovative treatments alongside prevention to enable increased access and reach those most impacted by #HIV. \n\nüîó Find out more: https://t.co/9CstSCRwt1",
    "likes": 9,
    "retweets": 1,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1944639879217869057",
    "url": "https://x.com/GSK/status/1944639879217869057",
    "created_at": "Mon Jul 14 06:07:31 +0000 2025",
    "text": "#News for #investors and #media: The United States Food and Drug Administration has accepted a regulatory application to expand the population indication for one of our vaccines.\n\nAccess our website here. https://t.co/clXF5AvMdR https://t.co/jddiXzIWxS",
    "likes": 8,
    "retweets": 2,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1944351097121906776",
    "url": "https://x.com/GSK/status/1944351097121906776",
    "created_at": "Sun Jul 13 11:00:00 +0000 2025",
    "text": "Long-acting medicines are helping people living with HIV transform their disease to a manageable condition by improving access to, and uptake of, essential treatment. \n\nHere, @ViiVHC's Dr. Kim Smith explains why this innovation is so important üëá \n\n#IAS2025 https://t.co/zAh2qzTUSt",
    "likes": 11,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1942578449584947509",
    "url": "https://x.com/GSK/status/1942578449584947509",
    "created_at": "Tue Jul 08 13:36:08 +0000 2025",
    "text": "#News for #Investors and #Media: at #IAS2025, @ViiVHC (our specialist HIV company) is presenting new data that highlight how its industry leading portfolio is continuing to transform HIV innovation for both treatment and prevention.  \n\nüîó Find out more: https://t.co/IkrKT5IB8z https://t.co/9vNkt3viwu",
    "likes": 9,
    "retweets": 6,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1942238719659885017",
    "url": "https://x.com/GSK/status/1942238719659885017",
    "created_at": "Mon Jul 07 15:06:10 +0000 2025",
    "text": "#News for #investors and #media: We‚Äôve announced the completion of our agreement to acquire a promising hepatology asset from Boston Pharmaceuticals. \n\nLearn more here: https://t.co/TCL9s7bTbe https://t.co/sccaBGexIu",
    "likes": 11,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1938615605457744139",
    "url": "https://x.com/GSK/status/1938615605457744139",
    "created_at": "Fri Jun 27 15:09:12 +0000 2025",
    "text": "This week at 'The Global Summit‚Äô, world leaders gathered to pledge support for @gavi, the Vaccine Alliance.\n\nLearn about GSK‚Äôs commitments, including our partnership that‚Äôs led to Bharat Biotech halving the price of the world's first malaria vaccine for children in endemic countries by 2028: https://t.co/43rc6reva4",
    "likes": 6,
    "retweets": 2,
    "replies": 4,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1937770238302466543",
    "url": "https://x.com/GSK/status/1937770238302466543",
    "created_at": "Wed Jun 25 07:10:01 +0000 2025",
    "text": "#News for #investors and #media: Bharat Biotech and GSK announce partnership impact and ambition ahead of Gavi, the Vaccine Alliance‚Äôs ‚ÄòGlobal Summit: Health &amp; Prosperity through Immunisation.‚Äô Learn more: https://t.co/kG7Mp9fgP8 https://t.co/D1Bp72KtyW",
    "likes": 13,
    "retweets": 1,
    "replies": 6,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1937052039940317522",
    "url": "https://x.com/GSK/status/1937052039940317522",
    "created_at": "Mon Jun 23 07:36:09 +0000 2025",
    "text": "#News for #investors and #media: We're pleased to share the EMA has accepted for review the use of one of our investigational assets to treat cholestatic pruritus in patients with primary biliary cholangitis (PBC). \n\nLearn more here https://t.co/eR2ufLE0ep https://t.co/MApBvi0sCU",
    "likes": 12,
    "retweets": 2,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1935943777387954206",
    "url": "https://x.com/GSK/status/1935943777387954206",
    "created_at": "Fri Jun 20 06:12:19 +0000 2025",
    "text": "#News for #investors and #media: Japan‚Äôs Ministry of Health, Labour and Welfare has accepted a regulatory application to expand the population indication for one of our vaccines.\n\nAccess our website here https://t.co/8z9eFhfDRj https://t.co/8VI7DuOFoN",
    "likes": 11,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1934851093546066266",
    "url": "https://x.com/GSK/status/1934851093546066266",
    "created_at": "Tue Jun 17 05:50:23 +0000 2025",
    "text": "@SatishHumbad1 Hello Satish. In the interest of patient safety, we have forwarded your comment to the relevant team. Please get in touch with us at: https://t.co/I4cIyo92ul or https://t.co/YsyrLV9q2e so we can learn more about the experience you reported.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1933796587492217116",
    "url": "https://x.com/GSK/status/1933796587492217116",
    "created_at": "Sat Jun 14 08:00:09 +0000 2025",
    "text": "At GSK, we empower our team with data tech, including AI, to enhance skills and integrate innovation into every aspect of our work.  \n\nOur focus on the complete patient journey ensures that we use technology to develop and deliver medicines and vaccines more efficiently than ever before, supporting health systems and enhancing patient care.\n\nDiscover how we're shaping the future of healthcare through technology: https://t.co/NAufSnz2QY",
    "likes": 9,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1933409239612960861",
    "url": "https://x.com/GSK/status/1933409239612960861",
    "created_at": "Fri Jun 13 06:20:58 +0000 2025",
    "text": "#News for #investors and #media: Today we have announced that the European Medicines Agency (EMA) have accepted a regulatory submission to expand the population for one of our vaccines. \n\nAccess our website here: https://t.co/QLka833sb1 https://t.co/0Pi7k7qivq",
    "likes": 10,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1933165428404048226",
    "url": "https://x.com/GSK/status/1933165428404048226",
    "created_at": "Thu Jun 12 14:12:09 +0000 2025",
    "text": "#News for #investors and #media: GSK out-licenses to Bharat Biotech for further vaccine development in diarrhoeal disease. Learn more: https://t.co/uTGF75Sihu https://t.co/gbqJwoEBp1",
    "likes": 8,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1933162435457806457",
    "url": "https://x.com/GSK/status/1933162435457806457",
    "created_at": "Thu Jun 12 14:00:15 +0000 2025",
    "text": "We are at #EHA2025 in Milan presenting our research in challenging blood cancers, such as multiple myeloma and myelofibrosis.  \n\n üîó Hear from people impacted by blood cancer and find out what scientists are doing to improve patient care: https://t.co/2UzO8akCzA https://t.co/QBJMfO6Bvo",
    "likes": 4,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1932758462896750955",
    "url": "https://x.com/GSK/status/1932758462896750955",
    "created_at": "Wed Jun 11 11:15:01 +0000 2025",
    "text": "Scientists at GSK are using digital biological twins and organoids ‚Äì miniature living replicas of tumours grown in a lab ‚Äì to create personalised solutions for patients with cancer: https://t.co/mKg330YysT\n#LTW25",
    "likes": 9,
    "retweets": 5,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1931925126896849141",
    "url": "https://x.com/GSK/status/1931925126896849141",
    "created_at": "Mon Jun 09 04:03:38 +0000 2025",
    "text": "@eckerusla Hello Hannah. Due to industry regulations, we are unable to provide our medicines and vaccines directly to you. Our products can only be prescribed or administered by licensed healthcare providers. We recommend reaching out to your local doctor or healthcare provider for further support. Thank you.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1931637359314907357",
    "url": "https://x.com/GSK/status/1931637359314907357",
    "created_at": "Sun Jun 08 09:00:09 +0000 2025",
    "text": "Using the power of technology, we're revolutionising the development and delivery of medicines and vaccines to make a real difference to people's health on a global scale.\n\nThrough cutting-edge data tech and platform technologies, we delve deeper into patient care, human biology, and disease mechanisms. This allows us to work with unprecedented speed, scale, and precision, empowering our teams to drive innovation like never before. \n\nDiscover how we are transforming healthcare for the better, one breakthrough at a time: https://t.co/NtiQErPggw",
    "likes": 7,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1931305133406593054",
    "url": "https://x.com/GSK/status/1931305133406593054",
    "created_at": "Sat Jun 07 11:00:00 +0000 2025",
    "text": "Heading to #LondonTechWeek? Join our leaders discussing everything from driving growth and transforming the future of healthcare, to exploring the impact of generative AI on drug discovery and the world of digital twins in drug development. \n\nüîó Can't make it? Learn how we are using tech to reach patients better and faster than ever before: https://t.co/NwAZlrjnRt\n \n#LTW25",
    "likes": 9,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1931003219200663954",
    "url": "https://x.com/GSK/status/1931003219200663954",
    "created_at": "Fri Jun 06 15:00:18 +0000 2025",
    "text": "#ASCO25 may be over for another year but our drive to push the boundaries of innovation by combining science, technology and partnership to get head of cancer never stops.\n\nHear from our oncology leaders as they reflect on this year‚Äôs conference. \n\nüîó https://t.co/OllgTxhoza https://t.co/lujRKKnOwF",
    "likes": 9,
    "retweets": 7,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1930981034876649475",
    "url": "https://x.com/GSK/status/1930981034876649475",
    "created_at": "Fri Jun 06 13:32:09 +0000 2025",
    "text": "At this year‚Äôs @ERAkidney congress, we‚Äôre focused on preventative measures in managing lupus nephritis to preserve kidney function. Early conversations between patients and doctors can facilitate a treatment plan to help reduce the risks of irreversible organ damage. https://t.co/Xq1nXueBD0",
    "likes": 6,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1929916036393951467",
    "url": "https://x.com/GSK/status/1929916036393951467",
    "created_at": "Tue Jun 03 15:00:13 +0000 2025",
    "text": "We're at #ASCO25, where we caught up with our oncology leaders Hesham and Nina. Curious to know what sets GSK Oncology apart? Let's hear what they had to say üëá\n\nüîó https://t.co/26nTKr8fSG https://t.co/IsQkMcLOen",
    "likes": 12,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1929568693366804802",
    "url": "https://x.com/GSK/status/1929568693366804802",
    "created_at": "Mon Jun 02 16:00:00 +0000 2025",
    "text": "Cancer is unrelenting, but so are we.\n\nWe believe that getting ahead of disease is the best investment ‚Äì for patients, communities, health systems, and economies.\n\nLearn more: https://t.co/I0Lcd9m40U",
    "likes": 10,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1929420188060909924",
    "url": "https://x.com/GSK/status/1929420188060909924",
    "created_at": "Mon Jun 02 06:09:54 +0000 2025",
    "text": "News for #investors and #media:\n\nToday, we announced that the FDA has accepted a new drug application for a medicine to treat cholestatic pruritus in patients with primary biliary cholangitis (PBC). \n\nLearn more here: https://t.co/IED1OPCj07 https://t.co/6VcA7vvr5P",
    "likes": 13,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1929388171751514408",
    "url": "https://x.com/GSK/status/1929388171751514408",
    "created_at": "Mon Jun 02 04:02:41 +0000 2025",
    "text": "@Bi11smith1 Hello Bill. In the interest of patient safety, we have forwarded your comment to our safety team. The team may be in touch to learn more about your experience. You can also contact us at: https://t.co/ZhqYlPBN5n or https://t.co/io1duI4hM8. As you've shared personal information, we'd recommend deleting your comment. Thank you.",
    "likes": 0,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1928988528777523660",
    "url": "https://x.com/GSK/status/1928988528777523660",
    "created_at": "Sun Jun 01 01:34:38 +0000 2025",
    "text": "We‚Äôre at #ASCO25 - showcasing groundbreaking cancer research at the world's largest oncology gathering. \n\nHear from our CEO Emma Walmsley & SVP, Global Head Oncology R&D, Hesham Abdullah, as they share how we're tackling complex oncology challenges for patients. \n\nüîó https://t.co/vlkhIoXGbQ",
    "likes": 12,
    "retweets": 5,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1928451794318905714",
    "url": "https://x.com/GSK/status/1928451794318905714",
    "created_at": "Fri May 30 14:01:51 +0000 2025",
    "text": "Many blood cancer patients face lifelong treatment challenges, but thankfully scientists are working hard to give them the quality of life they deserve. \n\nWe're sharing our progress in reshaping the landscape of cancer care at #ASCO25 \nüîó https://t.co/8RphIZSdxD https://t.co/EBglExs8FC",
    "likes": 6,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1928078224879231000",
    "url": "https://x.com/GSK/status/1928078224879231000",
    "created_at": "Thu May 29 13:17:25 +0000 2025",
    "text": "#News for #investors and #media: We‚Äôre pleased to present new data from our oncology portfolio at ASCO25 and EHA25. Read more: https://t.co/KyR6lHP0lE https://t.co/ceYGIxqllC",
    "likes": 8,
    "retweets": 5,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1927752060390322366",
    "url": "https://x.com/GSK/status/1927752060390322366",
    "created_at": "Wed May 28 15:41:21 +0000 2025",
    "text": "At the @WSJ's \"The Future of Everything\", our CEO Emma Walmsley joined leaders across business, tech, sports, and style to tackle tomorrow's challenges, including the future of drug discovery using cutting-edge tech and the impact of prevention on disease.\n#TheFutureOfEverything https://t.co/soVeGgnOBU",
    "likes": 7,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1927686741235802584",
    "url": "https://x.com/GSK/status/1927686741235802584",
    "created_at": "Wed May 28 11:21:48 +0000 2025",
    "text": "#News for #Media and #Investors: Today we are announcing with @Spero_Tx an update on the Phase III trial of one of our investigational oral anti-infectives, following a recommendation by an Independent Data Monitoring Committee.\n\nLearn more: https://t.co/WHifqwBy7B https://t.co/vXVMyNuE9L",
    "likes": 5,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1926146654702334092",
    "url": "https://x.com/GSK/status/1926146654702334092",
    "created_at": "Sat May 24 05:22:03 +0000 2025",
    "text": "@brad_hyer Hi Brad. We are unable to give medical advice. Please talk to your local doctor or healthcare professional for support. Thank you.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1925877383078322559",
    "url": "https://x.com/GSK/status/1925877383078322559",
    "created_at": "Fri May 23 11:32:03 +0000 2025",
    "text": "#News for #Investors and #Media\n\nThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending approval of our blood cancer therapy.\n\nFor more information: https://t.co/8z9eFhfDRj https://t.co/66gMKImewb",
    "likes": 5,
    "retweets": 1,
    "replies": 12,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1925612568724361658",
    "url": "https://x.com/GSK/status/1925612568724361658",
    "created_at": "Thu May 22 17:59:47 +0000 2025",
    "text": "#News for #investors and #media: Today we announced that one of our biologic treatments has been approved by the US Food and Drug Administration (FDA) as an add-on treatment for people living with COPD. Learn more: https://t.co/8z9eFhfDRj https://t.co/5Cz4kSIq7U",
    "likes": 8,
    "retweets": 5,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1925405396937658610",
    "url": "https://x.com/GSK/status/1925405396937658610",
    "created_at": "Thu May 22 04:16:33 +0000 2025",
    "text": "@ruirob2 In the interest of patient safety, we have forwarded your comment to the relevant team. Please get in touch with us at: https://t.co/I4cIyo92ul",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1925280495379648822",
    "url": "https://x.com/GSK/status/1925280495379648822",
    "created_at": "Wed May 21 20:00:14 +0000 2025",
    "text": "We are leaving #ATS2025 inspired to continue our work to redefine respiratory care. \n\nHear more from GSK‚Äôs own Kaivan Khavandi as he shares his key insights and takeaways from ATS. https://t.co/IOziBkdqMU",
    "likes": 8,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1925144568959226249",
    "url": "https://x.com/GSK/status/1925144568959226249",
    "created_at": "Wed May 21 11:00:07 +0000 2025",
    "text": "We‚Äôre in Toronto at the biannual @LupusCongress reinforcing our commitment to the global lupus community and sharing research about the importance of early intervention and disease management. \n\n#LUPUS2025 https://t.co/AYFvydVqKu",
    "likes": 7,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1924512880084333034",
    "url": "https://x.com/GSK/status/1924512880084333034",
    "created_at": "Mon May 19 17:10:00 +0000 2025",
    "text": "At #ATS2025 we‚Äôre sharing our latest research as we continue in our work reduce the impact that exacerbations can have on the future lung health of patients with conditions like #asthma and #COPD.  \n\nRead more on why it‚Äôs important to prevent exacerbations.  üëâhttps://t.co/8VAIF2357i",
    "likes": 7,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1924346665168748723",
    "url": "https://x.com/GSK/status/1924346665168748723",
    "created_at": "Mon May 19 06:09:32 +0000 2025",
    "text": "#News for #Investors and #Media \n\nThe Japan Ministry of Health, Labour and Welfare (MHLW) has approved one of our blood cancer therapies. \n\n Find more information here: https://t.co/qwGmlrZXNQ https://t.co/JM4nu1rmSJ",
    "likes": 3,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1924154731275989207",
    "url": "https://x.com/GSK/status/1924154731275989207",
    "created_at": "Sun May 18 17:26:51 +0000 2025",
    "text": "We‚Äôre at #ATS2025 to share our latest research from across 40 abstracts from our respiratory portfolio.\n\nCourt Horncastle, SVP, US Specialty Business Unit head, shares his thoughts on why ATS is so important to getting ahead of respiratory disease.  \n\nhttps://t.co/FKWRE7X1ZW https://t.co/lDJ62WNckY",
    "likes": 6,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1923740295360827729",
    "url": "https://x.com/GSK/status/1923740295360827729",
    "created_at": "Sat May 17 14:00:02 +0000 2025",
    "text": "In advance of #ATS2025 Kaivan Khavandi shares his thoughts on how we are applying our expertise to deliver the next generation standard of care and help millions of patients with respiratory conditions. üëâ https://t.co/Pb4h8npETp https://t.co/dS4yhEIgcf",
    "likes": 9,
    "retweets": 1,
    "replies": 4,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1922536477025591532",
    "url": "https://x.com/GSK/status/1922536477025591532",
    "created_at": "Wed May 14 06:16:29 +0000 2025",
    "text": "#News for #investors and #media: Today we announced an agreement with Boston Pharmaceuticals to further strengthen our hepatology pipeline in steatotic liver disease.  \n\nhttps://t.co/8z9eFhfDRj https://t.co/7pSPAtF9F1",
    "likes": 4,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1920465972294488441",
    "url": "https://x.com/GSK/status/1920465972294488441",
    "created_at": "Thu May 08 13:09:02 +0000 2025",
    "text": "Congratulations to our CEO Emma Walmsley on being named in the 2025 #TIME100HEALTH list, which recognises the most influential leaders in health each year.\n\nSee the full list here: https://t.co/BuWVSMDNFS\n\n#Time100 https://t.co/SrmjSddGuz",
    "likes": 25,
    "retweets": 7,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1920425688336572667",
    "url": "https://x.com/GSK/status/1920425688336572667",
    "created_at": "Thu May 08 10:28:58 +0000 2025",
    "text": "#News for #investors and #media: New data has been presented at #EASL2025 on our research into cholestatic pruritus (relentless itch) associated with primary biliary cholangitis (PBC), a rare autoimmune liver disease. \n\nMore information: https://t.co/vONuXjlZMl https://t.co/CsELbrcekj",
    "likes": 5,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1920039272825942099",
    "url": "https://x.com/GSK/status/1920039272825942099",
    "created_at": "Wed May 07 08:53:29 +0000 2025",
    "text": "Years of innovation have expanded the menu of preventative medicines available but science alone isn‚Äôt enough to make sure people have access to them. \n\nHere, @ProfHeidiLarson, anthropologist and co-founder of the Global Listening Project, explains why üëá https://t.co/5pMJzXokOk",
    "likes": 14,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1918591364524105918",
    "url": "https://x.com/GSK/status/1918591364524105918",
    "created_at": "Sat May 03 09:00:01 +0000 2025",
    "text": "The race against malaria is on ‚Äì find out why, and how, we‚Äôre accelerating research to help #ChangeTheTrajectory of the disease, here üëá\n\nhttps://t.co/93L7ktS9aG https://t.co/UV6wtBjBv8",
    "likes": 5,
    "retweets": 2,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1918357321740062826",
    "url": "https://x.com/GSK/status/1918357321740062826",
    "created_at": "Fri May 02 17:30:01 +0000 2025",
    "text": "‚ÄúIt took 35 years to even get to the point where malaria vaccines are available. And now we‚Äôre excited to be researching a second-generation vaccine‚Äù. \n\nKatie Ewer, GSK Malaria Vaccine Project Leader explains to The Telegraph that our research aims to work at a different stage of the life cycle of the malaria parasite  \n\nhttps://t.co/2whw7n72RZ",
    "likes": 6,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1918279689648349515",
    "url": "https://x.com/GSK/status/1918279689648349515",
    "created_at": "Fri May 02 12:21:32 +0000 2025",
    "text": "#News for #investors and #media: At #ATS2025, we‚Äôll be presenting data from 40+ abstracts on our work to redefine the future of respiratory care. \n\nLearn more: https://t.co/GGgHR6ngLG https://t.co/vy2q18OzTX",
    "likes": 10,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1917686381444288559",
    "url": "https://x.com/GSK/status/1917686381444288559",
    "created_at": "Wed Apr 30 21:03:56 +0000 2025",
    "text": "#News for #investors and #media:\n\nToday we have announced the full results of a phase III trial of one of our biologics in patients with chronic obstructive pulmonary disease (COPD) have been published in the New England Journal of Medicine. Learn more at: https://t.co/bgHgZ5Yelk https://t.co/74Q0FJqOVs",
    "likes": 11,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1914700939971150148",
    "url": "https://x.com/GSK/status/1914700939971150148",
    "created_at": "Tue Apr 22 15:20:52 +0000 2025",
    "text": "@reallovelyjane In the interest of patient safety, we have forwarded your comment to the relevant team. Please get in touch with us at: https://t.co/I4cIyo92ul so we can learn more about the experience you reported.",
    "likes": 0,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1914666670221643888",
    "url": "https://x.com/GSK/status/1914666670221643888",
    "created_at": "Tue Apr 22 13:04:41 +0000 2025",
    "text": "@nw_jan Hi Jan, our UK Medical Information team is best placed to support with your enquiry. You can contact them on 0800 221 441 or customercontactuk@gsk.com. We hope this helps.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1914609974434505070",
    "url": "https://x.com/GSK/status/1914609974434505070",
    "created_at": "Tue Apr 22 09:19:24 +0000 2025",
    "text": "#News for #investors and #media:  \n\nTwo of our vaccines have received new recommendations from the US Advisory Committee on Immunization Practices (ACIP). These recommendations will be reviewed for official adoption.  \n\nLearn more: https://t.co/8z9eFhfDRj https://t.co/1o3mJVg9No",
    "likes": 5,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1912890410537537830",
    "url": "https://x.com/GSK/status/1912890410537537830",
    "created_at": "Thu Apr 17 15:26:28 +0000 2025",
    "text": "#News for #Investors and #Media\n\nThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has licensed one of our blood cancer therapies.\n\nMore information for media and investors: https://t.co/8z9eFhfDRj https://t.co/uCu7pHY3Q0",
    "likes": 5,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1909908708089274714",
    "url": "https://x.com/GSK/status/1909908708089274714",
    "created_at": "Wed Apr 09 09:58:15 +0000 2025",
    "text": "COPD exacerbations can cause changes to lung tissue which can accumulate over time leading to irreversible lung damage. \n\nWe are ambitious for people living with COPD and have developed the COPD Exacerbation Recognition Tool to support them. \n\nRead more: https://t.co/8B5l4A8srg https://t.co/paf33HF2uc",
    "likes": 8,
    "retweets": 4,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1909591105340834228",
    "url": "https://x.com/GSK/status/1909591105340834228",
    "created_at": "Tue Apr 08 12:56:12 +0000 2025",
    "text": "GSK welcomes the ambition and urgency of yesterday‚Äôs announcement by the UK Government on health data and clinical trials.\n\nFind out more: https://t.co/IvOiFvDHzq https://t.co/ItDNy4gglT",
    "likes": 13,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1907357350878478625",
    "url": "https://x.com/GSK/status/1907357350878478625",
    "created_at": "Wed Apr 02 09:00:04 +0000 2025",
    "text": "Advances in technology are transforming cancer treatments ‚Äì and the lives of patients with cancer. Here, Hesham Abdullah, GSK‚Äôs Global Head of Oncology R&amp;D, discusses the leaps forward his team has made, and their ambitions for the future: https://t.co/4ZoWpoGzBC https://t.co/wlytQXpWiD",
    "likes": 11,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1906708261312536969",
    "url": "https://x.com/GSK/status/1906708261312536969",
    "created_at": "Mon Mar 31 14:00:49 +0000 2025",
    "text": "@Dick_Castle We'd love to help but unfortunately we're not able to discuss our medicines with you here. Find out how to contact your local GSK team at https://t.co/DALX3q4Osh, or speak to your healthcare provider for further support.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1905602673719603306",
    "url": "https://x.com/GSK/status/1905602673719603306",
    "created_at": "Fri Mar 28 12:47:36 +0000 2025",
    "text": "We understand the critical need for innovation and effective treatments in #COPD. \n\nLearn more about our progress and commitment to help patients breathe easier: https://t.co/z6LvZPMlVY https://t.co/h4hE4MvfMY",
    "likes": 23,
    "retweets": 2,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1905243121518018749",
    "url": "https://x.com/GSK/status/1905243121518018749",
    "created_at": "Thu Mar 27 12:58:52 +0000 2025",
    "text": "@Dick_Castle Hi, thanks for getting in touch. Due to local regulations, we are unable to provide medical advice. We suggest speaking to your local doctor or healthcare provider for support.",
    "likes": 0,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1904865919773384892",
    "url": "https://x.com/GSK/status/1904865919773384892",
    "created_at": "Wed Mar 26 12:00:00 +0000 2025",
    "text": "As adults over 60 outnumber children under five for the first time in human history, the burden of vaccine-preventable disease among adults is increasing.\n \nFind out why vaccinations are not just for children üëá \n \nhttps://t.co/b0RXTxgf2u",
    "likes": 9,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1904577866441908572",
    "url": "https://x.com/GSK/status/1904577866441908572",
    "created_at": "Tue Mar 25 16:55:23 +0000 2025",
    "text": "#News for #Media and #Investors: Today we announced that our oral antibiotic for uncomplicated urinary tract infections has been approved by US Food and Drug Administration (FDA).\n\nüîó Learn more: https://t.co/VqG87V2geS https://t.co/5ENFMiKnBN",
    "likes": 12,
    "retweets": 4,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1904501763182375058",
    "url": "https://x.com/GSK/status/1904501763182375058",
    "created_at": "Tue Mar 25 11:52:58 +0000 2025",
    "text": "#News for #Investors and #Media:\n\nWe are announcing a major new research collaboration with @UKDRI and @HDR_UK to advance our understanding of neurodegeneration.\n\nüîó Find out more: https://t.co/aIidc3OCnd https://t.co/FT1zL4d8TO",
    "likes": 16,
    "retweets": 10,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1904155652668494177",
    "url": "https://x.com/GSK/status/1904155652668494177",
    "created_at": "Mon Mar 24 12:57:39 +0000 2025",
    "text": "@L_88K Thanks for contacting us. GSK does not manufacture the product you referenced. Please contact your local doctor or healthcare provider for support.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1904069368792637494",
    "url": "https://x.com/GSK/status/1904069368792637494",
    "created_at": "Mon Mar 24 07:14:48 +0000 2025",
    "text": "#News for #investors and #media: We're pleased to share the EMA has accepted for review the use of one of our biologics for chronic obstructive pulmonary disease (#COPD). \n\nLearn more: https://t.co/1TYYIIat6J https://t.co/lJtHZ0f3uV",
    "likes": 8,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1901702265456755145",
    "url": "https://x.com/GSK/status/1901702265456755145",
    "created_at": "Mon Mar 17 18:28:46 +0000 2025",
    "text": "@TheSilverFox_ In the interest of patient safety, GSK would like to learn more about the experience you reported. Please contact GSK at (855) 574-7067.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1900577737942749344",
    "url": "https://x.com/GSK/status/1900577737942749344",
    "created_at": "Fri Mar 14 16:00:18 +0000 2025",
    "text": "At #SGO2025, we‚Äôre sharing data from our ongoing research and advancing conversations around how we can address barriers to care for people with gynaecologic cancers. \n\nRead more about how we‚Äôre delivering on this commitment to patients: https://t.co/YujJGB3bkE https://t.co/Z962PsdSFx",
    "likes": 9,
    "retweets": 2,
    "replies": 8,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1900517266682188281",
    "url": "https://x.com/GSK/status/1900517266682188281",
    "created_at": "Fri Mar 14 12:00:00 +0000 2025",
    "text": "While the flu is a moving target that evolves rapidly, RSV does not have the same variability. We‚Äôre committed to gaining a deeper understanding of RSV‚Äôs behaviour to improve education and prevention. \n\nLearn more üëá \n https://t.co/zhAAUK69qI",
    "likes": 7,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1900179420859523454",
    "url": "https://x.com/GSK/status/1900179420859523454",
    "created_at": "Thu Mar 13 13:37:32 +0000 2025",
    "text": "@ComedyChaCha Hi, thanks for getting in touch. In the interest of patient safety, GSK would like to learn more about the experience you reported. Please contact GSK at https://t.co/I4cIyo92ul. Thank you",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1899900176145203253",
    "url": "https://x.com/GSK/status/1899900176145203253",
    "created_at": "Wed Mar 12 19:07:55 +0000 2025",
    "text": "#News for #investors and #media:  \n\nNew data has been presented at #CROI2025 on the innovative pipeline of our specialist HIV company, @ViiVHC.  \n\nüîó Find out more: https://t.co/2noAODMpbU",
    "likes": 11,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1899067717702832227",
    "url": "https://x.com/GSK/status/1899067717702832227",
    "created_at": "Mon Mar 10 12:00:01 +0000 2025",
    "text": "The advent of long-acting options has truly been a game-changer for many people in the HIV community. \n \nIn this article, @ViiVHC's Head of R&amp;D Dr Kimberley Smith explains how and why these innovations have made such an impact: \n\nüîó https://t.co/n7j0E0imLk https://t.co/Cf1w9e5W5j",
    "likes": 5,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1898661852856356933",
    "url": "https://x.com/GSK/status/1898661852856356933",
    "created_at": "Sun Mar 09 09:07:15 +0000 2025",
    "text": "News for #investors and #media:\n\n@ViiVHC, our specialist HIV company, is presenting more than 70 abstracts at #CROI2025, reinforcing our leadership in long-acting innovation and supporting our ambition to end HIV and AIDS for good.  \n\nFind out more: https://t.co/jZ016NUvg2 https://t.co/qYliZMFdv8",
    "likes": 17,
    "retweets": 8,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1897623015447277952",
    "url": "https://x.com/GSK/status/1897623015447277952",
    "created_at": "Thu Mar 06 12:19:17 +0000 2025",
    "text": "#News for #investors and #media. \n\nAt @iRSVsociety #RSV2025, we're sharing our latest research with the global scientific community to help advance our understanding and help reduce the burden of RSV infection on our population. \n\nRead more: https://t.co/8z9eFhfDRj https://t.co/fZRno4nCyu",
    "likes": 4,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1897053975808983160",
    "url": "https://x.com/GSK/status/1897053975808983160",
    "created_at": "Tue Mar 04 22:38:08 +0000 2025",
    "text": "@krismha7 In the interest of patient safety, GSK would like to learn more about the experience you reported. Please contact GSK at (855) 574-7067.",
    "likes": 0,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1896921720415543431",
    "url": "https://x.com/GSK/status/1896921720415543431",
    "created_at": "Tue Mar 04 13:52:35 +0000 2025",
    "text": "We are harnessing the latest science and technology to redefine the future of respiratory medicine. \n\nWe‚Äôre building on decades of pioneering work to deliver more ambitious treatment goals for hundreds of millions of people with respiratory diseases. https://t.co/bEoHnJL1yR",
    "likes": 6,
    "retweets": 2,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1896458420556837225",
    "url": "https://x.com/GSK/status/1896458420556837225",
    "created_at": "Mon Mar 03 07:11:36 +0000 2025",
    "text": "#News for #investors and #media: Our ultra-long-acting pipeline biologic has been accepted for review by the US FDA for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps (#CRSwNP). \n\nLearn more: https://t.co/d0Fhb8hciu https://t.co/JVn6CBpq79",
    "likes": 10,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1895959609627615572",
    "url": "https://x.com/GSK/status/1895959609627615572",
    "created_at": "Sat Mar 01 22:09:30 +0000 2025",
    "text": "#News for #investors and #media: Our full phase III data in chronic rhinosinusitis with nasal polyps (#CRSwNP) for our ultra-long-acting pipeline biologic were published in The Lancet today and presented at #AAAAI25. Learn more: https://t.co/Vbp4q0IZqb https://t.co/ToOd3llEPn",
    "likes": 7,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1894028996091801637",
    "url": "https://x.com/GSK/status/1894028996091801637",
    "created_at": "Mon Feb 24 14:17:56 +0000 2025",
    "text": ". @IFAgeing and @MWHodin along with ambassadors from around the world join us this #ShinglesAwarenessWeek to share their experience with shingles. #OurShinglesStories https://t.co/HdO0Ew1iCX",
    "likes": 12,
    "retweets": 2,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1893923031749177541",
    "url": "https://x.com/GSK/status/1893923031749177541",
    "created_at": "Mon Feb 24 07:16:52 +0000 2025",
    "text": "We have completed our acquisition of IDRx, Inc. a Boston based, clinical-stage biotech, to accelerate innovation for patients with gastrointestinal stromal tumours.  \n\nhttps://t.co/gyK2F3M2vt https://t.co/vtoI8fr8rb",
    "likes": 9,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1892471500038406419",
    "url": "https://x.com/GSK/status/1892471500038406419",
    "created_at": "Thu Feb 20 07:09:00 +0000 2025",
    "text": "#News for #investors and #media:  \n\nToday we have announced the health authority in China has accepted for review our submission for the use of one of our biologics in chronic obstructive pulmonary disease (#COPD). \n\nLearn more here: https://t.co/Dli1xVtfJB https://t.co/260M3TOWm7",
    "likes": 8,
    "retweets": 3,
    "replies": 9,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1890587400029589698",
    "url": "https://x.com/GSK/status/1890587400029589698",
    "created_at": "Sat Feb 15 02:22:16 +0000 2025",
    "text": "The @US_FDA has approved one of our vaccines for an acute bacterial infection.  \n\nMore information for media and investors: https://t.co/FWLLcxvhlT https://t.co/WsqMknhR7D",
    "likes": 13,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1884149690733613304",
    "url": "https://x.com/GSK/status/1884149690733613304",
    "created_at": "Tue Jan 28 08:01:06 +0000 2025",
    "text": "#News for #investors and #media:\n\nSubmissions made to Chinese and Japanese health authorities for use of one of our pipeline biologics in two indications: asthma with type 2 inflammation and also CRSwNP. \n\nLearn more here: https://t.co/zkrv1ifn5S https://t.co/rZ7ts6p0kF",
    "likes": 8,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1884138121685565585",
    "url": "https://x.com/GSK/status/1884138121685565585",
    "created_at": "Tue Jan 28 07:15:08 +0000 2025",
    "text": "#News for #investors and #media: \n\nToday we have announced that the EMA has accepted the marketing authorisation application for use of one of our pipeline biologics in two indications: asthma with type 2 inflammation and also CRSwNP. Learn more here: https://t.co/oQQeYt85hI https://t.co/kJ3RNtjwR9",
    "likes": 7,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1883787030737346815",
    "url": "https://x.com/GSK/status/1883787030737346815",
    "created_at": "Mon Jan 27 08:00:01 +0000 2025",
    "text": "We‚Äôre announcing a collaboration with @UniofOxford to advance our understanding of how cancer develops, combining our expertise in the science of the immune system with Oxford‚Äôs cutting-edge research to explore the potential of cancer prevention.\n\nüîó https://t.co/7VssLTmgsO https://t.co/sBrokBjazL",
    "likes": 24,
    "retweets": 7,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1883774745587437716",
    "url": "https://x.com/GSK/status/1883774745587437716",
    "created_at": "Mon Jan 27 07:11:12 +0000 2025",
    "text": "#News for #Investors and #Media: The EMA has accepted our application for a new presentation for one of our vaccines.\n\nLearn more: https://t.co/ABDfjs01im https://t.co/F36OJw480J",
    "likes": 4,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1881238266873049558",
    "url": "https://x.com/GSK/status/1881238266873049558",
    "created_at": "Mon Jan 20 07:12:09 +0000 2025",
    "text": "#News for #Investors and #Media: The European Commission has approved an expanded indication of our immuno-oncology therapy. Learn more: https://t.co/l4zv8dYNJg https://t.co/nTG2Krwza4",
    "likes": 6,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1879559197047607670",
    "url": "https://x.com/GSK/status/1879559197047607670",
    "created_at": "Wed Jan 15 16:00:07 +0000 2025",
    "text": "Our deep understanding of the science of the immune system, use of advanced technologies and world-class scientific partnerships are enabling us to develop specialty medicines and vaccines that deliver benefit for patients and sustainable value for shareholders. \n\n#JPM2025 #JPM25 https://t.co/GPHkPMhOjG",
    "likes": 5,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1879189228069757292",
    "url": "https://x.com/GSK/status/1879189228069757292",
    "created_at": "Tue Jan 14 15:30:00 +0000 2025",
    "text": "Today at #JPM25: Hesham Abdullah, Senior Vice President, Global Head Oncology, R&amp;D, joins the #FierceJPMWeek ‚ÄòFuture of Oncology‚Äô panel to explore how advanced research and innovative treatments are reimagining patient care. \n\nFor #investors and #media: https://t.co/Rz1LdhBz8W",
    "likes": 5,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1878702548422443186",
    "url": "https://x.com/GSK/status/1878702548422443186",
    "created_at": "Mon Jan 13 07:16:06 +0000 2025",
    "text": "#News for #investors and #media: Today we announced the proposed acquisition of IDRx, Inc. aligned to our ambition to address the critical needs of patients with gastrointestinal cancers.\n \nhttps://t.co/bHc0eszwYQ #JPM2025 https://t.co/HdiRtenNSM",
    "likes": 16,
    "retweets": 5,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1877613468540375093",
    "url": "https://x.com/GSK/status/1877613468540375093",
    "created_at": "Fri Jan 10 07:08:29 +0000 2025",
    "text": "#News for #Investors and #Media: The US FDA has accepted our application for a new presentation for one of our vaccines. \n\nLearn more: https://t.co/B4M9hjmXye https://t.co/vIWZiEPH76",
    "likes": 8,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1876534851752362078",
    "url": "https://x.com/GSK/status/1876534851752362078",
    "created_at": "Tue Jan 07 07:42:27 +0000 2025",
    "text": "#News for #Investors and #Media: The FDA has granted Breakthrough Therapy Designation in a second indication for an investigational antibody-drug conjugate in our oncology pipeline. Learn more: https://t.co/MII3M7bSx8 https://t.co/lXp8ERhA14",
    "likes": 10,
    "retweets": 5,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1875104852088439076",
    "url": "https://x.com/GSK/status/1875104852088439076",
    "created_at": "Fri Jan 03 09:00:09 +0000 2025",
    "text": "Chronic rhinosinusitis with nasal polyps (#CRSwNP) exerts a significant burden on patients‚Äô physical &amp; mental health. Listen to Roy‚Äôs experience to understand why we are committed to targeting the inflammatory pathway of this condition to improve the lives of millions of people. https://t.co/XeQFuuRU2Z",
    "likes": 7,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1875077397277471073",
    "url": "https://x.com/GSK/status/1875077397277471073",
    "created_at": "Fri Jan 03 07:11:03 +0000 2025",
    "text": "#News for #investors and #media:\nToday we have announced that one of our biologics has been approved in China as a treatment option for people with chronic rhinosinusitis with nasal polyps (#CRSwNP). \n\nLearn more here: https://t.co/8z9eFhfDRj https://t.co/503xXqSkrd",
    "likes": 7,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1870094036347781223",
    "url": "https://x.com/GSK/status/1870094036347781223",
    "created_at": "Fri Dec 20 13:08:57 +0000 2024",
    "text": "@MeganDoher93752 Hello, and thank you for reaching out. If you are located in the United States, PAXIL was sold to Apotex in January 2014 and their number is 800-706-5575. However, we do not know if this product is still owned by this company. Please reach out to Apotex directly.",
    "likes": 1,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1869351908034445445",
    "url": "https://x.com/GSK/status/1869351908034445445",
    "created_at": "Wed Dec 18 12:00:00 +0000 2024",
    "text": "How can someone tell if they have a common cold, or a more serious virus like flu, COVID-19 or RSV?  \n\nRead our new Behind the Science article to find out more: https://t.co/bvD81oOnQn",
    "likes": 13,
    "retweets": 3,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1868642263321993672",
    "url": "https://x.com/GSK/status/1868642263321993672",
    "created_at": "Mon Dec 16 13:00:07 +0000 2024",
    "text": "#News for #Investors and #Media: The FDA has granted Breakthrough Therapy Designation to one of our immuno-oncology treatments. Learn more: https://t.co/SNbJuxly5R https://t.co/eHY2tHc9Vf",
    "likes": 11,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1868596961235939691",
    "url": "https://x.com/GSK/status/1868596961235939691",
    "created_at": "Mon Dec 16 10:00:07 +0000 2024",
    "text": "#News for #Investors and #Media: \n\nThe European Medicines Agency has granted Priority Medicines (PRIME) Designation for an investigational antibody-drug conjugate in our oncology pipeline. \n\nLearn more: https://t.co/KdeIbxeLDl https://t.co/cac6UGZjCW",
    "likes": 7,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1868557057168707877",
    "url": "https://x.com/GSK/status/1868557057168707877",
    "created_at": "Mon Dec 16 07:21:33 +0000 2024",
    "text": "#News for #Investors and #Media: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending an expanded indication of our immuno-oncology cancer therapy. \n\nLearn more: https://t.co/U4q0tW87aw https://t.co/3k0WeuYg1U",
    "likes": 9,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1867887256440094963",
    "url": "https://x.com/GSK/status/1867887256440094963",
    "created_at": "Sat Dec 14 11:00:00 +0000 2024",
    "text": "We‚Äôre in the middle of a global outbreak of pertussis, or ‚Äòwhooping cough‚Äô, with several countries recording higher numbers of cases than they‚Äôve seen in years. \n\nSo how did we get here? And how do we protect ourselves in the future?\nRead our new article: https://t.co/mWqIaIg3Uv",
    "likes": 5,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1866189346132365531",
    "url": "https://x.com/GSK/status/1866189346132365531",
    "created_at": "Mon Dec 09 18:33:06 +0000 2024",
    "text": "#News for #Investors and #Media: Today at #ASH24, we are excited to present positive results from our phase III clinical trial evaluating one of our #bloodcancer treatments. Learn more: https://t.co/sny0LmEXK3 https://t.co/Orl9u973rU",
    "likes": 15,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1866037602106630256",
    "url": "https://x.com/GSK/status/1866037602106630256",
    "created_at": "Mon Dec 09 08:30:08 +0000 2024",
    "text": "#News for #Investors and #Media: China‚Äôs National Medical Products Administration (NMPA) has accepted our application for one of our #bloodcancer therapies in combination with a standard of care. Learn more: https://t.co/whDDR6k4K6 https://t.co/4MZm9sHYOL",
    "likes": 10,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1866019369160962417",
    "url": "https://x.com/GSK/status/1866019369160962417",
    "created_at": "Mon Dec 09 07:17:41 +0000 2024",
    "text": "#News for #investors and #media: Today we have announced the FDA has accepted the submission for one of our biologics in chronic obstructive pulmonary disease (#COPD). \n\nLearn more here: https://t.co/v2H8kKEYFc https://t.co/LaFFGfOdCk",
    "likes": 11,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1864708814961770621",
    "url": "https://x.com/GSK/status/1864708814961770621",
    "created_at": "Thu Dec 05 16:30:00 +0000 2024",
    "text": "Advances in tech and a deeper understanding of cancer biology are shifting the ways the disease is diagnosed and treated.\n\nWe‚Äôll be sharing more about how we‚Äôre innovating to help match the right treatment with the right patient at #ASH24.\n\nüîó Learn more: https://t.co/iGjbMS1xlc",
    "likes": 7,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1864254228832661725",
    "url": "https://x.com/GSK/status/1864254228832661725",
    "created_at": "Wed Dec 04 10:23:38 +0000 2024",
    "text": "#News for #Investors and #Media: Today, the @WHO has prequalified tafenoquine and included this first single-dose medicine for P. vivax malaria in updated Guidelines for malaria, to help improve treatment for people most at risk. \n\nLearn more https://t.co/iRNWSmlQ9I https://t.co/7vzy6xmYQB",
    "likes": 18,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1863341987010580690",
    "url": "https://x.com/GSK/status/1863341987010580690",
    "created_at": "Sun Dec 01 21:58:43 +0000 2024",
    "text": "@JanineK72 In the interest of patient safety, your comment has been forwarded to the GSK safety team and you may be contacted for additional information. GSK would like to learn more about the experience you reported. Please contact GSK at (855) 574-7067",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1861668785679225265",
    "url": "https://x.com/GSK/status/1861668785679225265",
    "created_at": "Wed Nov 27 07:10:01 +0000 2024",
    "text": "#News for #Investors and #Media\n\nThe @EU_Commission has granted marketing approval for a single-vial, fully liquid presentation of one of our vaccines. \n\nüîó Learn more: https://t.co/2Vhdzggqws https://t.co/6szMCU4fuO",
    "likes": 6,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1860943385172869254",
    "url": "https://x.com/GSK/status/1860943385172869254",
    "created_at": "Mon Nov 25 07:07:32 +0000 2024",
    "text": "#News for #Investors and #Media: The US FDA has accepted our application for one of our #bloodcancer therapies in combination with standards of care. Learn more: https://t.co/wMjzR52zm1 https://t.co/k6oqbR2V1G",
    "likes": 15,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1859855985457729949",
    "url": "https://x.com/GSK/status/1859855985457729949",
    "created_at": "Fri Nov 22 07:06:36 +0000 2024",
    "text": "News for #Media and #Investors: Today we announced an expanded indication for one of our vaccines. \n\nüîó Learn more: https://t.co/1ims2gAR94 https://t.co/92wyvlnRSw",
    "likes": 18,
    "retweets": 2,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1859265448065339767",
    "url": "https://x.com/GSK/status/1859265448065339767",
    "created_at": "Wed Nov 20 16:00:00 +0000 2024",
    "text": "At GSK, we are working to prevent and change the course of respiratory diseases such as COPD and achieve more ambitious treatment goals for patients. David Brooks shares his thoughts.  \n\n#WorldCOPDDay https://t.co/imQeMqFgp1",
    "likes": 9,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1859221564022984782",
    "url": "https://x.com/GSK/status/1859221564022984782",
    "created_at": "Wed Nov 20 13:05:38 +0000 2024",
    "text": "We want those affected to know that they‚Äôre not causing a fuss by asking if more can be done to help prevent further damage to their lungs.\n\nLearn how we‚Äôre working to prevent cumulative lung damage and disease progression üëâ\nhttps://t.co/7S1OV25NuG",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1859221562320162928",
    "url": "https://x.com/GSK/status/1859221562320162928",
    "created_at": "Wed Nov 20 13:05:37 +0000 2024",
    "text": "Did you know that exacerbations in COPD can cause irreversible lung damage? \n\nExacerbations can cause damage to the lungs. Each COPD exacerbation can cause changes to the tissue which can accumulate over time.",
    "likes": 0,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1859221560298463639",
    "url": "https://x.com/GSK/status/1859221560298463639",
    "created_at": "Wed Nov 20 13:05:37 +0000 2024",
    "text": "This #WorldCOPDDay, and every other day, we‚Äôre building on over 50 years of expertise in the field of respiratory health to change the course of the disease and improve the lives of people with COPD\n\n#COPDAwareness",
    "likes": 3,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1859181653844738308",
    "url": "https://x.com/GSK/status/1859181653844738308",
    "created_at": "Wed Nov 20 10:27:02 +0000 2024",
    "text": "We‚Äôre applying our decades of expertise in respiratory medicine to deliver ambitious treatment goals for the more than 391 million people globally with COPD. Aiming to go beyond optimal symptom control, to achieve disease stability and change the course of their disease.\n\n#WorldCOPDDay",
    "likes": 8,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1858880298169118942",
    "url": "https://x.com/GSK/status/1858880298169118942",
    "created_at": "Tue Nov 19 14:29:34 +0000 2024",
    "text": "We‚Äôre proud of our commitment to improving access to medicines and vaccines, which sees us rank second as one of two leading companies in the @AtMIndex. By continuing to make progress, we will get ahead of high burden diseases in lower-income countries. #ATMI24 https://t.co/9yhqWpPQHV",
    "likes": 7,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1858771226468012347",
    "url": "https://x.com/GSK/status/1858771226468012347",
    "created_at": "Tue Nov 19 07:16:09 +0000 2024",
    "text": "#News for #Investors and #Media: Today we announced headline results from a phase III study in cholestatic pruritus of primary biliary cholangitis (PBC). \n\nLearn more: https://t.co/LQZ8qFWiE6 https://t.co/WME4Bj4g8Q",
    "likes": 12,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1857402047429021895",
    "url": "https://x.com/GSK/status/1857402047429021895",
    "created_at": "Fri Nov 15 12:35:31 +0000 2024",
    "text": "That‚Äôs a wrap on this year‚Äôs #MIHealthSummit, where we‚Äôve been discussing how we‚Äôre collaborating with partners to invest in prevention and other interventions that can transform patient care and improve health outcomes. https://t.co/Z4mIdvSc8G",
    "likes": 6,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1857076036145451426",
    "url": "https://x.com/GSK/status/1857076036145451426",
    "created_at": "Thu Nov 14 15:00:04 +0000 2024",
    "text": "We‚Äôre at @ACRheum discussing early intervention for those living with #lupus. \n\nWhen patients and‚ÄØdoctors work together to treat lupus and lupus nephritis early with a goal of‚ÄØpreserving kidney function, the risk of disease progression and organ damage can be reduced: https://t.co/ZfGIXQaD7P\n\n#ACR24",
    "likes": 7,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1857042811977191630",
    "url": "https://x.com/GSK/status/1857042811977191630",
    "created_at": "Thu Nov 14 12:48:03 +0000 2024",
    "text": "Hear from experts at #MIHealthSummit, including our own James Strenner, SVP, Head of U.S. Commercial Strategy, about how we‚Äôre getting ahead of disease together by investing in prevention.",
    "likes": 2,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1856958359267639488",
    "url": "https://x.com/GSK/status/1856958359267639488",
    "created_at": "Thu Nov 14 07:12:28 +0000 2024",
    "text": "#News for #Investors and #Media: Today we announced positive headline results from a trial evaluating our #bloodcancer treatment. We‚Äôre looking forward to sharing full results at #ASH24. Learn more: https://t.co/t4xDbyalYA https://t.co/0gZHtDNEMn",
    "likes": 9,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1856754553376707062",
    "url": "https://x.com/GSK/status/1856754553376707062",
    "created_at": "Wed Nov 13 17:42:37 +0000 2024",
    "text": "As our global population ages, and as science and technology continue to help us get ahead of disease, it‚Äôs our responsibility to reimagine healthcare ‚Äì so that we‚Äôre not just treating sickness, but also investing in keeping people well.\n\nWhich of these actions are critical for prioritising prevention in our healthcare systems?",
    "likes": 1,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1856668836566569214",
    "url": "https://x.com/GSK/status/1856668836566569214",
    "created_at": "Wed Nov 13 12:02:00 +0000 2024",
    "text": "We‚Äôre excited to convene with global health experts and policymakers at the @MilkenInstitute 2024 #MIHealthSummit, where we‚Äôll share how we‚Äôre partnering to create scalable and sustainable programs that advance preventative health solutions.\n\nLearn more about our focus on prevention: \nhttps://t.co/Mpr84tX7r3",
    "likes": 3,
    "retweets": 1,
    "replies": 4,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1856323170157859005",
    "url": "https://x.com/GSK/status/1856323170157859005",
    "created_at": "Tue Nov 12 13:08:27 +0000 2024",
    "text": "We‚Äôve launched a new initiative to uncover gaps in care associated with gynaecologic cancers and create solutions to drive progress for patients. Learn more about Your Cancer Is Our Challenge and the @HarrisPoll survey that helped uncover these insights: https://t.co/Us2ioYSbtj https://t.co/kjs68FS7Xm",
    "likes": 13,
    "retweets": 2,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1854856398661718265",
    "url": "https://x.com/GSK/status/1854856398661718265",
    "created_at": "Fri Nov 08 12:00:01 +0000 2024",
    "text": "We're using tech to revolutionise the way we understand, prevent and treat disease ‚Äì helping us reimagine what‚Äôs possible for patients.\n\nüîó Hear more from Shobie Ramakrishnan, Chief Digital and Technology Officer at GSK, on the TD Cowen Insights podcast: https://t.co/F4xhD5zmms https://t.co/pF02X7DElI",
    "likes": 5,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1854180495984107527",
    "url": "https://x.com/GSK/status/1854180495984107527",
    "created_at": "Wed Nov 06 15:14:13 +0000 2024",
    "text": "Our CEO, Emma Walmsley, spoke to @ArmstrongDrew, Executive Editor of Endpoints, at the @ftlive Global Pharma and Biotech Summit today. Their wide-ranging discussion covered crucial topics from building trust in pharma, to the importance of prevention and AI in healthcare.",
    "likes": 13,
    "retweets": 4,
    "replies": 4,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1853387943626310074",
    "url": "https://x.com/GSK/status/1853387943626310074",
    "created_at": "Mon Nov 04 10:44:54 +0000 2024",
    "text": "Discover the power of data in the fight against malaria with @malarianomoreuk's new \"Zero Malaria Experience.\" This captivating journey shows how expanding current tools like bed nets and introducing next-generation vaccines will bring us closer to a malaria-free world. https://t.co/YJRkimmmNU",
    "likes": 19,
    "retweets": 5,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1852334778718048448",
    "url": "https://x.com/GSK/status/1852334778718048448",
    "created_at": "Fri Nov 01 13:00:00 +0000 2024",
    "text": "AI analysis of ‚Äòorganoid‚Äô recreations of NHS patients‚Äô cancers could help to predict relapses and identify the most effective treatments, GSK scientists say.\n\nFind out how tech like these ‚Äòorganoids‚Äô and AI could transform lung cancer care üëá (paywall)\nhttps://t.co/co3thg7X50",
    "likes": 8,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1851236130823282933",
    "url": "https://x.com/GSK/status/1851236130823282933",
    "created_at": "Tue Oct 29 12:14:22 +0000 2024",
    "text": "#News for #investors and #media: Today we announced an agreement to acquire an investigational medicine to potentially address continued unmet need in autoimmune diseases. \nhttps://t.co/MPD4ggFS6v https://t.co/iYCtVRUijG",
    "likes": 9,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1849813213036085348",
    "url": "https://x.com/GSK/status/1849813213036085348",
    "created_at": "Fri Oct 25 14:00:12 +0000 2024",
    "text": "Early intervention and disease management is critical for patients with #lupus to reduce the risk of irreversible organ damage and/or #lupusnephritis. It‚Äôs important for doctors and patients to discuss ways to reduce this risk. \n\nWatch to learn more.  \n\n@ASNKidney #KidneyWk https://t.co/RBTLknxaTE",
    "likes": 10,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1849450779548983315",
    "url": "https://x.com/GSK/status/1849450779548983315",
    "created_at": "Thu Oct 24 14:00:01 +0000 2024",
    "text": "We‚Äôre at @ASNKidney week. As long-standing leaders in the #lupusnephritis community, we know how critical early intervention and disease management is to reducing the risk of organ damage for patients. \n\nLearn more: https://t.co/aj4GqzNPA0 \n\n#KidneyWk https://t.co/YBfbJvtvmq",
    "likes": 7,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1849332623576826000",
    "url": "https://x.com/GSK/status/1849332623576826000",
    "created_at": "Thu Oct 24 06:10:31 +0000 2024",
    "text": "News for #Investors and #Media: Today we announced new positive clinical data on one of our vaccines. \n\nLearn more: https://t.co/PeUPTbN6dD https://t.co/WR348uMosN",
    "likes": 9,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1848284768288272838",
    "url": "https://x.com/GSK/status/1848284768288272838",
    "created_at": "Mon Oct 21 08:46:42 +0000 2024",
    "text": "News for #media and #investors: \nWe announced a new collaboration with Cambridge ‚Äì the Cambridge-GSK Translational Immunology Collaboration (CG-TIC) ‚Äì to further accelerate research and development in kidney and respiratory diseases. \n\nLearn more: https://t.co/8z9eFhfDRj https://t.co/pzbetIfjb6",
    "likes": 15,
    "retweets": 5,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1848031428119818437",
    "url": "https://x.com/GSK/status/1848031428119818437",
    "created_at": "Sun Oct 20 16:00:01 +0000 2024",
    "text": "We are excited to announce a new collaboration with the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center (BMC) to advance innovative research in the field of lung diseases. https://t.co/L0YVn8ULdi",
    "likes": 15,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1847608693161852971",
    "url": "https://x.com/GSK/status/1847608693161852971",
    "created_at": "Sat Oct 19 12:00:14 +0000 2024",
    "text": "Thanks for joining us at #IDWeek2024, where we‚Äôve been sharing scientific advances from our industry-leading, prevention-focused portfolio of infectious disease vaccines and medicines.\n \nüîó Find out more: https://t.co/BydJ6qpjI2 üëà https://t.co/4KTd67t3Ya",
    "likes": 11,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1847246250476728404",
    "url": "https://x.com/GSK/status/1847246250476728404",
    "created_at": "Fri Oct 18 12:00:00 +0000 2024",
    "text": "‚ÄúThere are three things necessary to ending the HIV/AIDS epidemic‚Ä¶and prevention is key‚Äù. \n\nüîó Find out what it means to change the course of disease through prevention and earlier intervention: https://t.co/1skLZe81UZ üëà \n \n#IDWeek2024\n@ViiVHC",
    "likes": 3,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1846899064547189015",
    "url": "https://x.com/GSK/status/1846899064547189015",
    "created_at": "Thu Oct 17 13:00:25 +0000 2024",
    "text": "We are excited to be at #IDWeek2024 to present research from across our broad and growing portfolio of vaccines and medicines aimed at getting ahead of infectious diseases. \n\nüîó Learn how are we developing new ways to prevent and treat infectious diseases: https://t.co/10Z10a2eio https://t.co/36rrdhu1HX",
    "likes": 7,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1846536623149781285",
    "url": "https://x.com/GSK/status/1846536623149781285",
    "created_at": "Wed Oct 16 13:00:12 +0000 2024",
    "text": "We‚Äôre excited to join experts from across the globe at #IDWeek2024! Together with @ViiVHC, we‚Äôre pioneering new technologies to advance the prevention and treatment of infectious diseases. \n \nLearn more about our innovative research: https://t.co/Sj27i2DwL2 https://t.co/gSaMyfv1uL",
    "likes": 3,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1846433532609962323",
    "url": "https://x.com/GSK/status/1846433532609962323",
    "created_at": "Wed Oct 16 06:10:33 +0000 2024",
    "text": "#News for #Investors and #Media: Today we announced that gepotidacin has been accepted for priority review by US FDA for treatment of uncomplicated urinary tract infections in female adults and adolescents. \nLearn more: https://t.co/8z9eFhfDRj https://t.co/vNPnYVr9PE",
    "likes": 6,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1846215037142106166",
    "url": "https://x.com/GSK/status/1846215037142106166",
    "created_at": "Tue Oct 15 15:42:20 +0000 2024",
    "text": "We are proud to partner with @gaapporg to help amplify the conversation about the unmet needs of refractory chronic cough (RCC) patients on the first-ever #WorldChronicCoughDay. \n\nLearn how we are shaping the future of RCC care: https://t.co/H9IunB3tFQ",
    "likes": 7,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1845859392253550599",
    "url": "https://x.com/GSK/status/1845859392253550599",
    "created_at": "Mon Oct 14 16:09:08 +0000 2024",
    "text": "We‚Äôre aiming to support the European Network on Climate &amp; Health Education to train 10,000 medical students, across 25 leading universities in Europe, to deliver sustainable healthcare: https://t.co/sW8LSQVBD3\n\n@TheSMI https://t.co/NczhUVRd94",
    "likes": 4,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1845796698863370697",
    "url": "https://x.com/GSK/status/1845796698863370697",
    "created_at": "Mon Oct 14 12:00:00 +0000 2024",
    "text": "Are you attending #IDWeek2024? So are we! Join us as we convene with global experts, sharing the latest advancements in the prevention and treatment of infectious diseases.\n\nüîó Learn more: https://t.co/n5igGOGzVh\n\n@ViiVHC",
    "likes": 4,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1845709666786885877",
    "url": "https://x.com/GSK/status/1845709666786885877",
    "created_at": "Mon Oct 14 06:14:10 +0000 2024",
    "text": "#News for #investors and #media: Today we announced positive phase III trial results of one of our pipeline biologics for chronic rhinosinusitis with nasal polyps (#CRSwNP). \n\nLearn more here: https://t.co/96nqEEsj8H https://t.co/dFCW1HFaSl",
    "likes": 8,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1844369533600976960",
    "url": "https://x.com/GSK/status/1844369533600976960",
    "created_at": "Thu Oct 10 13:28:58 +0000 2024",
    "text": "News for #Media and #Investors: Together with @ViiVHC, we‚Äôre presenting 60 abstracts to showcase advances across our industry-leading infectious disease pipeline and portfolio at #IDWeek2024.\n\nüîó Learn more: https://t.co/Bx0oig01fe",
    "likes": 11,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1843969660447838431",
    "url": "https://x.com/GSK/status/1843969660447838431",
    "created_at": "Wed Oct 09 11:00:01 +0000 2024",
    "text": "Each year, there are around 5 million RSV infections in adults aged 60+ in high-income countries ‚Äì yet, there is still a lot to discover about this virus. \n\nWant to hear more about what scientists have learned about RSV? Read here! üëá  https://t.co/PQxPNKU9h8",
    "likes": 6,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1843644183250100393",
    "url": "https://x.com/GSK/status/1843644183250100393",
    "created_at": "Tue Oct 08 13:26:41 +0000 2024",
    "text": "We‚Äôre excited to be attending #CHEST2024 where we‚Äôre engaging with thought leaders and experts in pulmonary health. With approximately 177,000 US adults aged 65+ hospitalised due to RSV each year, it is crucial we unite our efforts to get ahead of this virus, together. https://t.co/rHLv8Z6nQ1",
    "likes": 6,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1843609503985484002",
    "url": "https://x.com/GSK/status/1843609503985484002",
    "created_at": "Tue Oct 08 11:08:53 +0000 2024",
    "text": "#News for #Investors and #Media: Today we shared data at #CHEST2024 on one of our vaccines. Learn more: https://t.co/9WOTNlPynp https://t.co/gKEkOZlc1c",
    "likes": 4,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1843247367661002982",
    "url": "https://x.com/GSK/status/1843247367661002982",
    "created_at": "Mon Oct 07 11:09:52 +0000 2024",
    "text": "News for #Media and #Investors from our specialist HIV company, @ViiVHC, on their commitment to increasing access to #HIV PrEP in low- and middle-income countries and Sub-Saharan Africa.\n\nFind out more: https://t.co/8z9eFhgbGR https://t.co/RQJeWu9QAY",
    "likes": 10,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1842505155037511920",
    "url": "https://x.com/GSK/status/1842505155037511920",
    "created_at": "Sat Oct 05 10:00:35 +0000 2024",
    "text": "Around 1 in 5 invasive meningococcal disease survivors are left with severe long-term after-effects, such as permanent physical disabilities.\n\nHear Rodolpho‚Äôs powerful story: https://t.co/qT5uZt61lT\n\n#WorldMeningitisDay https://t.co/y0Q1SwrSWc",
    "likes": 13,
    "retweets": 6,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1842322398600630630",
    "url": "https://x.com/GSK/status/1842322398600630630",
    "created_at": "Fri Oct 04 21:54:23 +0000 2024",
    "text": "@toobaffled In the interest of patient safety, your post has been forwarded to the GSK safety team and you may be contacted for additional information. GSK would like to learn more about the experience you reported. Please contact GSK at (855) 574-7067",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1842321022512488761",
    "url": "https://x.com/GSK/status/1842321022512488761",
    "created_at": "Fri Oct 04 21:48:55 +0000 2024",
    "text": "@Sue_Sue1776 @Godbless120286 @toobaffled In the interest of patient safety, your comment has been forwarded to the GSK safety team and you may be contacted for additional information. GSK would like to learn more about the experience you reported. Please contact GSK at (855) 574-7067",
    "likes": 0,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1840827497383924114",
    "url": "https://x.com/GSK/status/1840827497383924114",
    "created_at": "Mon Sep 30 18:54:10 +0000 2024",
    "text": "We‚Äôre so proud to meet all the incredible winners at this year‚Äôs #WellChild Awards.\n\nFind out how together with community partners we‚Äôre making a positive impact on the health of vulnerable and marginalised people. https://t.co/eKMrvClzXp\n\n#AheadTogether",
    "likes": 533,
    "retweets": 120,
    "replies": 11,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1840662904607035489",
    "url": "https://x.com/GSK/status/1840662904607035489",
    "created_at": "Mon Sep 30 08:00:08 +0000 2024",
    "text": "This #BloodCancerAwarenessMonth, we are excited to share a sneak peek of our upcoming ‚ÄòMapping Myelofibrosis: Our MF Journeys‚Äô video series launching soon. Watch the clip below, and subscribe to our YouTube channel for more: https://t.co/5L15KfZHEa https://t.co/9NQW0FaGiu",
    "likes": 7,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1839590856086458493",
    "url": "https://x.com/GSK/status/1839590856086458493",
    "created_at": "Fri Sep 27 09:00:12 +0000 2024",
    "text": "Join us on Monday as we come together to honour inspirational young people and healthcare professionals at the 2024 #WellChildAwards \n\nTune in to watch the ceremony streamed live https://t.co/FhflYxxanB https://t.co/diTHUngtyR",
    "likes": 14,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1838579171259285931",
    "url": "https://x.com/GSK/status/1838579171259285931",
    "created_at": "Tue Sep 24 14:00:08 +0000 2024",
    "text": "We‚Äôre at #IMS24, sharing the latest updates in our ongoing blood cancer research. Learn more here: https://t.co/OiVpzWBr2f https://t.co/CQQczHLmkK",
    "likes": 9,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1838460769647657061",
    "url": "https://x.com/GSK/status/1838460769647657061",
    "created_at": "Tue Sep 24 06:09:39 +0000 2024",
    "text": "#News for #Investors and #Media: the @EMA_News CHMP has issued a positive scientific opinion on a single-vial, fully liquid presentation of one of our vaccines. \n\nLearn more: https://t.co/a6P9v71hth https://t.co/d94im8l4KZ",
    "likes": 4,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1838126156500857020",
    "url": "https://x.com/GSK/status/1838126156500857020",
    "created_at": "Mon Sep 23 08:00:01 +0000 2024",
    "text": "By 2050, 1 death every 3 minutes could be due to antimicrobial resistance. \n\nThat's why this week, at #UNGA79, we must come together to prevent and get ahead of AMR. \n\nRead on for more about the human cost of AMR ‚Äì and how to stop it.\nhttps://t.co/o35zzDHqNA",
    "likes": 9,
    "retweets": 5,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1837129728840307106",
    "url": "https://x.com/GSK/status/1837129728840307106",
    "created_at": "Fri Sep 20 14:00:34 +0000 2024",
    "text": "At GSK, our work to advance oncology research is inspired by people like Alex. This #WorldGODay, hear more about our ongoing commitment to bring innovative treatment options to people living with #endometrialcancer: https://t.co/Jdgc4isWhc https://t.co/ziTR3ShCR4",
    "likes": 6,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1836767199958028766",
    "url": "https://x.com/GSK/status/1836767199958028766",
    "created_at": "Thu Sep 19 14:00:00 +0000 2024",
    "text": "Learn more about our commitment to advancing research for people living with ovarian cancer: https://t.co/J9KySBkWx2",
    "likes": 3,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1836737256419144190",
    "url": "https://x.com/GSK/status/1836737256419144190",
    "created_at": "Thu Sep 19 12:01:01 +0000 2024",
    "text": "Today, our Worthing manufacturing site has become the first in the UK to achieve @BSI_UK Kitemark Certification for Minimized Risk of Antimicrobial Resistance! Responsible manufacturing of antibiotics is crucial to getting ahead of AMR.  \n\nhttps://t.co/xUdlM9vyLV\n\n#UNGA79 https://t.co/S6faiGBlV9",
    "likes": 10,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1836676672399032745",
    "url": "https://x.com/GSK/status/1836676672399032745",
    "created_at": "Thu Sep 19 08:00:17 +0000 2024",
    "text": "Breaking News: We‚Äôve committed ‚Ç¨4.5m over three years to @gardp_amr to ensure equitable access to antibiotics in lower-income countries. \n\nOur funding aims to tackle the challenges that hinder critical antibiotics from reaching those in need. #PowerOf Antibiotics #UNGA79 https://t.co/YlNbNEp8jt",
    "likes": 8,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1835925090292105582",
    "url": "https://x.com/GSK/status/1835925090292105582",
    "created_at": "Tue Sep 17 06:13:46 +0000 2024",
    "text": "#News for #Investors and #Media: Japan‚Äôs MHLW has accepted our application for one of our #bloodcancer therapies in combination with standards of care. Learn more: https://t.co/zBXJ7ikXh1 https://t.co/V5d5pwWb9z",
    "likes": 10,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1835680035618885766",
    "url": "https://x.com/GSK/status/1835680035618885766",
    "created_at": "Mon Sep 16 14:00:00 +0000 2024",
    "text": "Most people with ovarian cancer are diagnosed at an advanced stage. Recognising the signs, symptoms and risk factors can help those affected seek care sooner. \n\nTest your knowledge below ‚Äì which of these is a common symptom of ovarian cancer:",
    "likes": 2,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1835660180572262865",
    "url": "https://x.com/GSK/status/1835660180572262865",
    "created_at": "Mon Sep 16 12:41:06 +0000 2024",
    "text": "@Taraghalaieny In the interest of patient safety, GSK would like to learn more about the experience you reported. Please contact GSK at https://t.co/I4cIyo92ul",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1835654083362824337",
    "url": "https://x.com/GSK/status/1835654083362824337",
    "created_at": "Mon Sep 16 12:16:52 +0000 2024",
    "text": "@IamPatihan Thanks for your message. I would love to help but due to regulations I am unable to provide medical advice. I would suggest speaking to your local doctor or healthcare professional for information.",
    "likes": 0,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1834864700158291987",
    "url": "https://x.com/GSK/status/1834864700158291987",
    "created_at": "Sat Sep 14 08:00:09 +0000 2024",
    "text": "Precision medicine technologies like biomarker testing can help doctors match patients with the cancer treatment option that is likely to be most effective for them. \n\nLearn about our #oncology research: https://t.co/I14XNH4Awh #ESMO24 https://t.co/uxi8Cffvkv",
    "likes": 10,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1834473582212043154",
    "url": "https://x.com/GSK/status/1834473582212043154",
    "created_at": "Fri Sep 13 06:05:59 +0000 2024",
    "text": "#News for #Investors and #Media: China‚Äôs National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation for one of our #bloodcancer therapies in combination with standards of care: https://t.co/6ESxwWQnvv https://t.co/myshsctXsu",
    "likes": 4,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1834260716871729521",
    "url": "https://x.com/GSK/status/1834260716871729521",
    "created_at": "Thu Sep 12 16:00:08 +0000 2024",
    "text": "Our focus on advancing innovation through #oncology research is driven by our commitment to extending and improving the lives of people with cancer. \n\nLearn about the latest updates we‚Äôll be sharing at #ESMO24: https://t.co/bkD8zIsZWG https://t.co/9ad3JaonQN",
    "likes": 5,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1834215517894144176",
    "url": "https://x.com/GSK/status/1834215517894144176",
    "created_at": "Thu Sep 12 13:00:32 +0000 2024",
    "text": "We were thrilled to have been at #ERSCongress2024, sharing more about how we‚Äôre innovating to prevent and change the course of respiratory diseases. https://t.co/InTAd5XVZi https://t.co/vboMkWeR4l",
    "likes": 2,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1834201690863530313",
    "url": "https://x.com/GSK/status/1834201690863530313",
    "created_at": "Thu Sep 12 12:05:35 +0000 2024",
    "text": "@KevinBTolbertPA Hello - We have a number of different patient assistance programs detailed here:\n https://t.co/BRasY6voHe\n If this doesn't help, I would also suggest you contact our US Response Center directly: 1-855-574-7067 / https://t.co/Mg5SdevQRl",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1834165693157113953",
    "url": "https://x.com/GSK/status/1834165693157113953",
    "created_at": "Thu Sep 12 09:42:33 +0000 2024",
    "text": "#News for #investors and #media: Today we announced positive headline data from a phase II vaccine programme.  \n \nLearn more here: https://t.co/rr8IwGiAC1 https://t.co/pNyNE5PiiF",
    "likes": 3,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1833783719699628447",
    "url": "https://x.com/GSK/status/1833783719699628447",
    "created_at": "Wed Sep 11 08:24:43 +0000 2024",
    "text": "At GSK, we‚Äôre redefining the future of respiratory care and are determined to help as many people as possible with asthma achieve clinical remission. \n\nLearn more about achieving clinical remission in asthma regardless of disease severity here: https://t.co/HZhJpMsTDP https://t.co/w6NizjowDx",
    "likes": 6,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1833515000553435384",
    "url": "https://x.com/GSK/status/1833515000553435384",
    "created_at": "Tue Sep 10 14:36:55 +0000 2024",
    "text": "In a new article, Dr David Lipson, GSK‚Äôs Vice President and Clinical Research Head, Respiratory and Immunology R&amp;D, explains why a focus on the environmental impact of respiratory care is so essential.  \n\nRead more: https://t.co/P0faRnqrC6  \n\n#ERSCongress2024",
    "likes": 9,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1833506719542231071",
    "url": "https://x.com/GSK/status/1833506719542231071",
    "created_at": "Tue Sep 10 14:04:01 +0000 2024",
    "text": "Join us at #UNGA79 as our VP of Global Health, Fiona Smith-Laittan and @Amref_Worldwide discuss how lower income countries can effectively respond to the challenge of Antimicrobial Resistance. Don't miss out on this insightful discussion hosted by @Devex. Find out more üëá",
    "likes": 6,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1833436948251238777",
    "url": "https://x.com/GSK/status/1833436948251238777",
    "created_at": "Tue Sep 10 09:26:46 +0000 2024",
    "text": "Patients are at the heart of everything we do. Hear from one refractory chronic cough patient on her experience living with the condition and how it has impacted every aspect of her life. #RefractoryChronicCough #ERSCongress2024 \n\n Read more: https://t.co/L7BJyivqLR https://t.co/dYyFfOXH5R",
    "likes": 3,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1833140846419382745",
    "url": "https://x.com/GSK/status/1833140846419382745",
    "created_at": "Mon Sep 09 13:50:10 +0000 2024",
    "text": "#News for #investors and #media: Today at #ERSCongress2024 we presented the phase III data in severe #asthma for our ultra-long-acting pipeline biologic. This was accompanied by simultaneous publication in in the #NEJM. Learn more here: https://t.co/IwxKxIRnJ3 https://t.co/27I29jyG2Z",
    "likes": 6,
    "retweets": 2,
    "replies": 4,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1833125368397537338",
    "url": "https://x.com/GSK/status/1833125368397537338",
    "created_at": "Mon Sep 09 12:48:40 +0000 2024",
    "text": "We are talking to leaders, advocates and partners at #ERSCongress2024 about how we're innovating to change the course of respiratory disease, looking beyond symptom relief to keep people safe from infections and prevent diseases from getting worse. \n\nRead more: https://t.co/8pYFo7jeGc",
    "likes": 2,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1833090478452936939",
    "url": "https://x.com/GSK/status/1833090478452936939",
    "created_at": "Mon Sep 09 10:30:01 +0000 2024",
    "text": "#RefractoryChronicCough (RCC) is a burden for both patients and the healthcare system, with a long diagnosis process, and it is poorly understood. \n\nWe‚Äôre looking forward to hearing more about RCC at #ERSCongress2024. \n\nRead more: https://t.co/Ed9YPk0H3T https://t.co/sESjs6FgZn",
    "likes": 2,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1832806604510502923",
    "url": "https://x.com/GSK/status/1832806604510502923",
    "created_at": "Sun Sep 08 15:42:01 +0000 2024",
    "text": "Exacerbations can cause damage to the lungs. Each attack can cause changes to the tissue which can accumulate over time. To find out more, here‚Äôs our latest article on preventing disease progression üëâ https://t.co/T6EGy2QGD9",
    "likes": 2,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1832796035250282683",
    "url": "https://x.com/GSK/status/1832796035250282683",
    "created_at": "Sun Sep 08 15:00:01 +0000 2024",
    "text": "Did you know that exacerbations in asthma and COPD can cause irreversible lung damage?",
    "likes": 3,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1832780932232712323",
    "url": "https://x.com/GSK/status/1832780932232712323",
    "created_at": "Sun Sep 08 14:00:00 +0000 2024",
    "text": "At GSK, we are working to prevent and change the course of respiratory diseases such as COPD and achieve more ambitious treatment goals for patients.  Hear more about this from our leaders.",
    "likes": 4,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1832773383240425574",
    "url": "https://x.com/GSK/status/1832773383240425574",
    "created_at": "Sun Sep 08 13:30:00 +0000 2024",
    "text": "With innovation comes more ambitious treatment goals. Our goal is to make clinical remission an achievable treatment outcome for people with certain types of severe asthma.  \n\nDiscover what this means for those living with the condition üëá",
    "likes": 1,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1832758285159547009",
    "url": "https://x.com/GSK/status/1832758285159547009",
    "created_at": "Sun Sep 08 12:30:00 +0000 2024",
    "text": "For decades we‚Äôve researched the impact conditions like #asthma and #COPD can have on a patient‚Äôs future.  \n\nDiscover more about how we‚Äôre working to prevent cumulative lung damage and disease progression üëâ https://t.co/kVKzYls3Dq\n\n#ERSCongress2024",
    "likes": 4,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1832398481756979633",
    "url": "https://x.com/GSK/status/1832398481756979633",
    "created_at": "Sat Sep 07 12:40:17 +0000 2024",
    "text": "We are excited to be at #ERSCongress2024 where we will be showcasing our work to redefine the future of respiratory care and improve the lives of millions. We‚Äôre building on decades of innovation and turning science into solutions with the aim to free people from the constraints of respiratory conditions like asthma and COPD. \n\nCheck out this video and learn more. https://t.co/XeIjzEjFl0",
    "likes": 10,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1832350603990692122",
    "url": "https://x.com/GSK/status/1832350603990692122",
    "created_at": "Sat Sep 07 09:30:02 +0000 2024",
    "text": "Kaivan Khavandi shares his thoughts on how we can apply our expertise to deliver the next generation standard of care and help millions of patients with respiratory conditions improve their lives in a way that has never been possible before üëâ https://t.co/mRo3q85T2Q https://t.co/N5TUBVTKUf",
    "likes": 3,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1832004021084639522",
    "url": "https://x.com/GSK/status/1832004021084639522",
    "created_at": "Fri Sep 06 10:32:50 +0000 2024",
    "text": "We believe every breath matters.\n\nThis #ERSCongress2024, see how we‚Äôre building on decades of expertise in respiratory vaccines and medicines to go beyond symptom relief to protect people from infections & prevent deterioration, exacerbations, lung damage and disease progression üëá\nhttps://t.co/M3DvtaO4OI",
    "likes": 5,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1831995824437334147",
    "url": "https://x.com/GSK/status/1831995824437334147",
    "created_at": "Fri Sep 06 10:00:16 +0000 2024",
    "text": "Climate change and air pollution negatively impact the health of patients with respiratory conditions‚Äì yet some treatments used for those same conditions contribute to greenhouse gas emissions. It‚Äôs time to break the cycle. \n\n Learn more: https://t.co/UBr3kF5tiG\n#ERSCongress2024 https://t.co/pthz1jY4Bx",
    "likes": 2,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1831964605716877542",
    "url": "https://x.com/GSK/status/1831964605716877542",
    "created_at": "Fri Sep 06 07:56:12 +0000 2024",
    "text": "#News for #investors and #media: Today we have announced positive phase III trial results of one of our biologics in chronic obstructive pulmonary disease (#COPD). Learn more here: https://t.co/LJIQfXfXuN https://t.co/lOo1mqa0Mi",
    "likes": 1,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1831708903232385335",
    "url": "https://x.com/GSK/status/1831708903232385335",
    "created_at": "Thu Sep 05 15:00:08 +0000 2024",
    "text": "This #BloodCancerAwarenessMonth ü©∏, we are grateful to those in the #bloodcancer advocacy and clinical communities who help us drive progress for those living with complex cancers, like #myelofibrosis and #multiplemyeloma https://t.co/D6pvpWOKTJ",
    "likes": 13,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1831648471331266949",
    "url": "https://x.com/GSK/status/1831648471331266949",
    "created_at": "Thu Sep 05 11:00:00 +0000 2024",
    "text": "In a GSK funded online RSV survey of 3,516 respondents in 4 countries, over 50% of adults &gt;50 years were worried about missing out on family occasions or holidays due to respiratory infections. \n\n#GlobalRSVAwarenessWeek",
    "likes": 10,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1831286108941861292",
    "url": "https://x.com/GSK/status/1831286108941861292",
    "created_at": "Wed Sep 04 11:00:06 +0000 2024",
    "text": "Did you know that older adults (60+) and those with certain underlying health conditions are at increased risk of complications due to RSV? Join us in raising awareness of the disease to help prevent RSV. \n\nLearn more about RSV: https://t.co/lFALfgyla1 üëà\n\n#GlobalRSVAwarenessWeek https://t.co/7gnGEIaGP3",
    "likes": 11,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1830849267801444665",
    "url": "https://x.com/GSK/status/1830849267801444665",
    "created_at": "Tue Sep 03 06:04:15 +0000 2024",
    "text": "#News for #investors and #media: At #ERSCongress2024 we‚Äôll be sharing our latest research across 56 abstracts including a late breaking alert session as we continue in our aim to redefine the future of respiratory medicine. Learn more here: https://t.co/G0mx6dXXYp https://t.co/VasQ7S7wJG",
    "likes": 4,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1830583959324873171",
    "url": "https://x.com/GSK/status/1830583959324873171",
    "created_at": "Mon Sep 02 12:30:01 +0000 2024",
    "text": "Respiratory syncytial virus (RSV) causes ~5 million infections in adults every year. \n\nHowever, new data shows 6 in 10 adults over 50 have never heard of the virus ‚Äì despite some being most at risk.\n\nFind out more here:\nhttps://t.co/7zfBL39lMp https://t.co/BaRuJsh1B5",
    "likes": 7,
    "retweets": 8,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1830561336461242572",
    "url": "https://x.com/GSK/status/1830561336461242572",
    "created_at": "Mon Sep 02 11:00:07 +0000 2024",
    "text": "Today, we proudly launch #GlobalRSVAwarenessWeek alongside the @COPDFoundation, @gaapporg and @IFAgeing, to raise global awareness of RSV, a virus that may affect millions annually. \n\nLearn more about the risks of RSV: https://t.co/fAQTgaWNbx üëà https://t.co/LeUlehSkA9",
    "likes": 8,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1829474143089148205",
    "url": "https://x.com/GSK/status/1829474143089148205",
    "created_at": "Fri Aug 30 11:00:00 +0000 2024",
    "text": "High-quality healthcare should be accessible to all of us, regardless of who we are or where we come from. \n\nFind out how GSK is helping to close the health equity gap here: \nhttps://t.co/fG0BalPxbd",
    "likes": 11,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1829038796052062525",
    "url": "https://x.com/GSK/status/1829038796052062525",
    "created_at": "Thu Aug 29 06:10:05 +0000 2024",
    "text": "News for #investors and #media: Today the EU Commission has approved an expanded indication for one of our vaccines. https://t.co/2qgdZ7DK8K https://t.co/CH4Ln1WaBg",
    "likes": 8,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1828749368335233093",
    "url": "https://x.com/GSK/status/1828749368335233093",
    "created_at": "Wed Aug 28 11:00:00 +0000 2024",
    "text": "Progress to achieving universal access to healthcare has slowed. \n\nHere, Thomas Breuer, our Chief Global Health Officer, explains how to speed things up again: \nhttps://t.co/chOFhk3jCI",
    "likes": 4,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1828681320806908297",
    "url": "https://x.com/GSK/status/1828681320806908297",
    "created_at": "Wed Aug 28 06:29:36 +0000 2024",
    "text": "#News for #investors and #media: Today we announced that one of our investigational medicines has been granted SENKU designation by the Japanese Ministry of Health, Labour and Welfare (MHLW). Find out more https://t.co/ldLjb4JRxF https://t.co/fKv0GEk1sX",
    "likes": 10,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1828676037082771769",
    "url": "https://x.com/GSK/status/1828676037082771769",
    "created_at": "Wed Aug 28 06:08:37 +0000 2024",
    "text": "#News for #investors and #media: Today we have announced that Japan has approved the use of one of our biologics as a treatment option for people with chronic rhinosinusitis and nasal polyps (#CRSwNP). Learn more here: https://t.co/oVfIcBZwJQ https://t.co/hKVFsa1nMF",
    "likes": 4,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1828386979613937705",
    "url": "https://x.com/GSK/status/1828386979613937705",
    "created_at": "Tue Aug 27 11:00:00 +0000 2024",
    "text": "Many groups are disproportionately affected by disease, yet still face barriers to access the healthcare they need. \n\nRead more about GSK's collaborative efforts to reduce the health equity gap here:\nhttps://t.co/WMuNYtx264",
    "likes": 3,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1828024591786139896",
    "url": "https://x.com/GSK/status/1828024591786139896",
    "created_at": "Mon Aug 26 11:00:00 +0000 2024",
    "text": "100 years ago today, we launched Ostelin, the world‚Äôs first Vitamin D supplement. \n\nStep back to 1924 with us to explore the history of our first pharmaceutical product. \n\nRead more about our heritage of innovation üëâ  https://t.co/Pd481JqIXE  \n\n#AheadTogether",
    "likes": 15,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1827662204579037456",
    "url": "https://x.com/GSK/status/1827662204579037456",
    "created_at": "Sun Aug 25 11:00:00 +0000 2024",
    "text": "Rising antimicrobial resistance and the threat of \"superbugs\" is exacerbated by global warming. \n\nFind out why - and how vaccines could help mitigate the risk of AMR - here:\nhttps://t.co/iJNdOXCLcb",
    "likes": 10,
    "retweets": 2,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1827299817317347493",
    "url": "https://x.com/GSK/status/1827299817317347493",
    "created_at": "Sat Aug 24 11:00:00 +0000 2024",
    "text": "Climate change doesn‚Äôt just affect the planet - but the health of populations, too. \n\nHere‚Äôs how ‚Äì and what we can do to reduce the risk of disease: \nhttps://t.co/RiA1bsAKgJ",
    "likes": 6,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1826937427249758617",
    "url": "https://x.com/GSK/status/1826937427249758617",
    "created_at": "Fri Aug 23 11:00:00 +0000 2024",
    "text": "‚ÄúNow I feel happier for my children and I see the better health on their faces.‚Äù\n\nVaccinating her children changed Asli‚Äôs life. \n\nWe‚Äôre supporting local innovators in Africa with @SavetheChildren to improve access to immunisation for families like Asli's\n\nhttps://t.co/h0Zwmh41sA",
    "likes": 8,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1826227753135264059",
    "url": "https://x.com/GSK/status/1826227753135264059",
    "created_at": "Wed Aug 21 12:00:00 +0000 2024",
    "text": "‚ÄúAMR is like rising sea levels. It will keep rising. It will not stop, and suddenly we‚Äôll be standing there with water around our knees.‚Äù \n\nRead more about the crisis of antimicrobial resistance and why the world urgently needs novel antibiotics: \nhttps://t.co/nFqNAjdJoX",
    "likes": 6,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1825779137975328953",
    "url": "https://x.com/GSK/status/1825779137975328953",
    "created_at": "Tue Aug 20 06:17:22 +0000 2024",
    "text": "#News for #Investors and #Media: The FDA has granted Breakthrough Therapy Designation to an investigational antibody-drug conjugate in our oncology portfolio. Learn more: https://t.co/glX5VTK9VX https://t.co/nLGuf4GaYy",
    "likes": 11,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1825507360653062238",
    "url": "https://x.com/GSK/status/1825507360653062238",
    "created_at": "Mon Aug 19 12:17:25 +0000 2024",
    "text": "@SesameSurvivor The out-of-pocket price cap will provide significant benefit to patients taking these medicines whose monthly costs currently exceed $35. The program is wide reaching and will be implemented no later than January 1, 2025. GSK will share specific details closer to implementation.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1825507232223510896",
    "url": "https://x.com/GSK/status/1825507232223510896",
    "created_at": "Mon Aug 19 12:16:55 +0000 2024",
    "text": "@SesameSurvivor GSK is taking this action as part of its longstanding commitment to improving access to respiratory medicines in the U.S. and to help asthma and COPD patients who are least able to afford the care they need.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1825507059158167675",
    "url": "https://x.com/GSK/status/1825507059158167675",
    "created_at": "Mon Aug 19 12:16:13 +0000 2024",
    "text": "@SesameSurvivor GSK announced on March 20, 2024 that it will cap out-of-pocket costs for eligible patients at no more than $35 per month for all of its asthma and chronic obstructive pulmonary disease (COPD) medicines, the most prescribed portfolio of inhalers in the U.S.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1825125490526441761",
    "url": "https://x.com/GSK/status/1825125490526441761",
    "created_at": "Sun Aug 18 11:00:00 +0000 2024",
    "text": "In 1944, we produced 80% of the UK‚Äôs penicillin, increasing the chances of survival for hundreds of WW2 soldiers. \n\nToday, we remain on a mission to develop new antibiotics to fight the rising tide of AMR:\nhttps://t.co/44m1Pxyqxm",
    "likes": 20,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1823691039804141634",
    "url": "https://x.com/GSK/status/1823691039804141634",
    "created_at": "Wed Aug 14 12:00:01 +0000 2024",
    "text": "AI and machine learning are integrated into every stage of drug development, from selecting molecules for early testing, to identifying suitable drugs for the right patient groups. \n\nLearn more here:\nhttps://t.co/Oaf8NIb4XM",
    "likes": 9,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1821848900019302563",
    "url": "https://x.com/GSK/status/1821848900019302563",
    "created_at": "Fri Aug 09 10:00:00 +0000 2024",
    "text": "Biomarkers are key, it provides information about a patient‚Äôs biological condition, indicating the most effective treatments for patients.\n\nLearn more about biomarkers here: \nhttps://t.co/mwNYr85CbT",
    "likes": 9,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1821531810297155588",
    "url": "https://x.com/GSK/status/1821531810297155588",
    "created_at": "Thu Aug 08 13:00:00 +0000 2024",
    "text": "Robots, AI and machine learning are helping to deliver medicine to patients faster. \n\nLearn more about our advanced manufacturing hubs: https://t.co/F1ge3ncbiW",
    "likes": 5,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1819104818813669788",
    "url": "https://x.com/GSK/status/1819104818813669788",
    "created_at": "Thu Aug 01 20:16:00 +0000 2024",
    "text": "#News for #Investors and #Media: The FDA has approved an expanded indication of our immuno-oncology cancer therapy in the US. \n\nLearn more: https://t.co/zPOWW9gEyS https://t.co/fnlnKp7F7R",
    "likes": 5,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1818976255024259096",
    "url": "https://x.com/GSK/status/1818976255024259096",
    "created_at": "Thu Aug 01 11:45:08 +0000 2024",
    "text": "315 million people around the world are thought to be affected by COPD - chronic obstructive pulmonary disease. Recognise the symptoms and open up to a healthcare professional today. \n\n#COPD #AheadTogether https://t.co/CtKLPcw9dH",
    "likes": 6,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1817880157085933848",
    "url": "https://x.com/GSK/status/1817880157085933848",
    "created_at": "Mon Jul 29 11:09:38 +0000 2024",
    "text": "#News for #investors and #media: Today we announced that we have entered into an agreement with Flagship Pioneering to discover future medicines and vaccines for patients.\n \nFind out more: https://t.co/fH7ct6WDKL https://t.co/5eelGphAwU",
    "likes": 23,
    "retweets": 4,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1817515350990418069",
    "url": "https://x.com/GSK/status/1817515350990418069",
    "created_at": "Sun Jul 28 11:00:02 +0000 2024",
    "text": "We‚Äôre proud to support @Hep_Alliance this #WorldHepatitisDay and are using science, technology and talent to help meet the needs of the generation of people living with chronic hepatitis B (CHB). https://t.co/3qB001TDFv",
    "likes": 11,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1816429527058317488",
    "url": "https://x.com/GSK/status/1816429527058317488",
    "created_at": "Thu Jul 25 11:05:21 +0000 2024",
    "text": "HIV remains one of the world‚Äôs biggest health epidemics, with 1.3 million new diagnoses annually. Our goal is to minimise the impact of HIV on people‚Äôs lives by treating and preventing the disease, and tackling HIV-related stigma.\n\nüîóFind out more: https://t.co/BTFu5wHsdB\n\n#AIDS2024",
    "likes": 16,
    "retweets": 7,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1816065868096209359",
    "url": "https://x.com/GSK/status/1816065868096209359",
    "created_at": "Wed Jul 24 11:00:18 +0000 2024",
    "text": "HIV remains one of the world‚Äôs biggest health threats and while great strides have been made in HIV treatment, with people living with HIV on effective treatment able to live long and full lives, stigma remains a challenge. \n\nFind out how we are committed to changing that, by minimising the impact of HIV on people‚Äôs lives through treatment, prevention and ultimately cure: https://t.co/QvTgmtyoI2 üëà\n\n#AIDS2024",
    "likes": 9,
    "retweets": 0,
    "replies": 5,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1815730420694085863",
    "url": "https://x.com/GSK/status/1815730420694085863",
    "created_at": "Tue Jul 23 12:47:21 +0000 2024",
    "text": "How many new HIV diagnoses are there every year? \n#AIDS2024",
    "likes": 2,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1815660773538177286",
    "url": "https://x.com/GSK/status/1815660773538177286",
    "created_at": "Tue Jul 23 08:10:36 +0000 2024",
    "text": "#News for #investors and #media: new data shared today at #AIDS2024 by our specialist HIV company, @ViiVHC, include updates from our pipeline that reinforce our leadership in HIV innovation and supporting the community. \n \nüîó Find out more: https://t.co/JoFkFYf4tv https://t.co/PBE3d3B7IU",
    "likes": 7,
    "retweets": 0,
    "replies": 7,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1815348567889899858",
    "url": "https://x.com/GSK/status/1815348567889899858",
    "created_at": "Mon Jul 22 11:30:00 +0000 2024",
    "text": "‚ÄúThere are three things necessary to ending the HIV/AIDS epidemic‚Ä¶and prevention is key‚Äù. \n\nFind out what it means to change the course of disease through prevention and earlier intervention üëá \n\n#AIDS2024 https://t.co/YJVNrzwTeT",
    "likes": 6,
    "retweets": 2,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1814191795363811367",
    "url": "https://x.com/GSK/status/1814191795363811367",
    "created_at": "Fri Jul 19 06:53:24 +0000 2024",
    "text": "#News for #Investors and #Media: Our marketing authorisation application for potential new indications for one of our #bloodcancer therapies, in combination with standards of care, has been accepted by the EMA. Learn more: https://t.co/rRrTPYe66b https://t.co/ddR2GCTbxd",
    "likes": 7,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1813921670182392073",
    "url": "https://x.com/GSK/status/1813921670182392073",
    "created_at": "Thu Jul 18 13:00:01 +0000 2024",
    "text": "@BloombergTV #AMR is a global health issue that threatens millions of lives every year. We‚Äôre proud to be partnering with #FlemingInitiative in our continued efforts to get ahead of AMR @FlemingCentre",
    "likes": 4,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1813921667183268310",
    "url": "https://x.com/GSK/status/1813921667183268310",
    "created_at": "Thu Jul 18 13:00:01 +0000 2024",
    "text": "Speaking with @BloombergTV, our CEO, Emma Walmsley, and Lord Darzi discuss the urgent need to tackle #antimicrobialresistance through cross-sectoral partnership, innovative treatments and vaccines, and improved public awareness.\n \nWatch the interview: https://t.co/6kUSeIe4i1",
    "likes": 9,
    "retweets": 5,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1813121464763097262",
    "url": "https://x.com/GSK/status/1813121464763097262",
    "created_at": "Tue Jul 16 08:00:18 +0000 2024",
    "text": "Together with our global health partners, we‚Äôre helping strengthen healthcare systems in lower income countries. \n\nGuided by local communities and experts, we‚Äôre contributing towards helping #ChangeTheTrajectory of high burden infectious diseases: https://t.co/n3AXQuMUzJ https://t.co/EizhtYvr9i",
    "likes": 13,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1812823675042771272",
    "url": "https://x.com/GSK/status/1812823675042771272",
    "created_at": "Mon Jul 15 12:16:59 +0000 2024",
    "text": "#News for #investors and #media: @ViiVHC, our specialist HIV company, are presenting over 20 abstracts from our innovative pipeline and portfolio of medicines at #AIDS2024.\n\nFind out more: https://t.co/8z9eFhfDRj https://t.co/SygDrRLeka",
    "likes": 9,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1811374003996479719",
    "url": "https://x.com/GSK/status/1811374003996479719",
    "created_at": "Thu Jul 11 12:16:30 +0000 2024",
    "text": "‚ÄúWomen need freedom and empowerment over what happens to them.‚Äù In partnership with @devex, @ViiVHC CEO and president of GSK Global Health, Deborah Waterhouse, discusses why a gender lens is vital if we‚Äôre to help end the HIV and TB epidemics üëâ https://t.co/00wREYQmmK https://t.co/htLSyBZ6DG",
    "likes": 7,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1811007519948517537",
    "url": "https://x.com/GSK/status/1811007519948517537",
    "created_at": "Wed Jul 10 12:00:14 +0000 2024",
    "text": "As for many people living with #myelofibrosis (MF), Andrew‚Äôs journey was not straightforward. MF can present unique symptoms for each patient, making diagnosis and treatment challenging. Read more about how he lives life to the fullest @WebMD: https://t.co/DFn0P7icnC https://t.co/BCOyaOItD9",
    "likes": 4,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1809188487033241822",
    "url": "https://x.com/GSK/status/1809188487033241822",
    "created_at": "Fri Jul 05 11:32:03 +0000 2024",
    "text": "#News for #media and #investors: Brazil and Thailand become the first malaria-endemic countries to launch new single-dose medicine to help prevent relapse of P. vivax malaria, developed in partnership with @MedsforMalaria: https://t.co/O8S8jfUBwv https://t.co/A9VHCLRIYf",
    "likes": 12,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1808387384150839521",
    "url": "https://x.com/GSK/status/1808387384150839521",
    "created_at": "Wed Jul 03 06:28:45 +0000 2024",
    "text": "#News for #investors and #media: Today we announced a new licensing agreement with CureVac. This is our latest investment in vaccine platform technologies, allowing us to match the best platform to each pathogen and help prevent illness in more people around the world. \n\nRead more: https://t.co/t5e6Q57GBK",
    "likes": 24,
    "retweets": 7,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1808093328535146821",
    "url": "https://x.com/GSK/status/1808093328535146821",
    "created_at": "Tue Jul 02 11:00:16 +0000 2024",
    "text": "Global experts encourage early intervention with evidence-based treatments to help reduce the risk of organ damage in people with lupus, including tapering the use of oral corticosteroids. \n\nLearn more at our dedicated GSK site: https://t.co/LZSoMNThTh https://t.co/iT1mKWAebr",
    "likes": 4,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1805903863729316269",
    "url": "https://x.com/GSK/status/1805903863729316269",
    "created_at": "Wed Jun 26 10:00:07 +0000 2024",
    "text": "\"Can we end epidemics?\" is a new podcast from @ViiVHC, in partnership with @ForeignPolicy. \n\nIn episode 5, GSK‚Äôs Fiona Smith-Laittan and @Amref_Worldwide‚Äôs Dr Mercy Mwangangi, discuss partnerships and health system strengthening. https://t.co/MMz9KFfC5u https://t.co/dyZdFjg0cI",
    "likes": 5,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1805518856351277161",
    "url": "https://x.com/GSK/status/1805518856351277161",
    "created_at": "Tue Jun 25 08:30:14 +0000 2024",
    "text": "Meet Zack, GSK chemist, early riser and planet protector working on #greenchemistry solutions to help make more sustainable medicines and vaccines that benefit patients and the planet. Watch his inspiring story and find out more about life at GSK #WeAreGSK #LCAW2024 #GSKcareers https://t.co/c2E1ugEzoO",
    "likes": 67,
    "retweets": 9,
    "replies": 9,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1805503695896915974",
    "url": "https://x.com/GSK/status/1805503695896915974",
    "created_at": "Tue Jun 25 07:30:00 +0000 2024",
    "text": "Did you know that #antimicrobialresistance could lead to approximately 6.9 million extra hospital days a year by 2050?\n\nLearn more about how we can get ahead of #AMR üëâ https://t.co/j68wvrzZIU",
    "likes": 4,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1805269683857199609",
    "url": "https://x.com/GSK/status/1805269683857199609",
    "created_at": "Mon Jun 24 16:00:07 +0000 2024",
    "text": "We‚Äôre highlighting the importance and evidence of early action to target drivers of irreversible organ damage in lupus, an inflammatory disease where the immune system attacks its own tissues, such as the kidneys. \n\nLearn more: https://t.co/cHtW7ffcQq https://t.co/LHA76HzwnW",
    "likes": 7,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1805215580607086718",
    "url": "https://x.com/GSK/status/1805215580607086718",
    "created_at": "Mon Jun 24 12:25:08 +0000 2024",
    "text": "It‚Äôs #LCAW2024 and we‚Äôre sharing how we‚Äôre working together with partners to develop more sustainable medicines and vaccines. It‚Äôs part of how we‚Äôre supporting healthcare systems that are better for patients and the planet. \n\n Find out more: https://t.co/6WkB508Tm8 https://t.co/PRErzirnd6",
    "likes": 3,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1805123727048192247",
    "url": "https://x.com/GSK/status/1805123727048192247",
    "created_at": "Mon Jun 24 06:20:08 +0000 2024",
    "text": "#News for #Investors and #Media: The Ministry of Health, Labour and Welfare of Japan has granted approval for our blood cancer therapy. Learn more: https://t.co/Uj2IpARFtZ https://t.co/87Z4yiIDLp",
    "likes": 5,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1805122890649456757",
    "url": "https://x.com/GSK/status/1805122890649456757",
    "created_at": "Mon Jun 24 06:16:49 +0000 2024",
    "text": "#News for #Investors and #Media: Our marketing authorisation application for a potential expanded indication for our immuno-oncology therapy has been validated by the EMA. \n\nLearn more: https://t.co/J5nm0QUPci https://t.co/R8QuSWPoiD",
    "likes": 5,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1803794382878871962",
    "url": "https://x.com/GSK/status/1803794382878871962",
    "created_at": "Thu Jun 20 14:17:48 +0000 2024",
    "text": "At the #TimesCEOSummit, our CEO, Emma Walmsley, shared how, through partnership across NHS, life sciences sector and government, there‚Äôs huge opportunity to build on UK‚Äôs strengths with a new healthcare model that moves from treating sickness to getting ahead of disease @thetimes https://t.co/d77L03Av9x",
    "likes": 7,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1803339297744916990",
    "url": "https://x.com/GSK/status/1803339297744916990",
    "created_at": "Wed Jun 19 08:09:27 +0000 2024",
    "text": "As a proud supporter of @Challenge_Works #LongitudePrize, we believe the impact of innovative technologies like @AstregoDX's PA-100 AST System could be transformative in our collective efforts to get ahead of #AMR",
    "likes": 2,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1803339295631028387",
    "url": "https://x.com/GSK/status/1803339295631028387",
    "created_at": "Wed Jun 19 08:09:27 +0000 2024",
    "text": "Congratulations to #LongitudePrize on #AMR winners @AstregoDx. Preventing the spread of #superbugs is essential in protecting global health and, alongside vaccination and good sanitation, rapid diagnostics are a key component in the prevention toolbox.\n@longitude_prize",
    "likes": 11,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1803050106544922795",
    "url": "https://x.com/GSK/status/1803050106544922795",
    "created_at": "Tue Jun 18 13:00:19 +0000 2024",
    "text": "In #endometrialcancer, early diagnoses and individualised testing could lead to better long-term outcomes for patients. Hear from Sharon about her journey with this type of #uterinecancer. https://t.co/LSkUG1U1HX",
    "likes": 6,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1801283415712333900",
    "url": "https://x.com/GSK/status/1801283415712333900",
    "created_at": "Thu Jun 13 16:00:07 +0000 2024",
    "text": "We are getting ahead of #bloodcancer at #EHA2024, as we share our research in #multiplemyeloma and #myelofibrosis. Discover more about our progress in oncology: https://t.co/uGdlRBGzyb https://t.co/SlcjXXi5u0",
    "likes": 6,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1801240262833787259",
    "url": "https://x.com/GSK/status/1801240262833787259",
    "created_at": "Thu Jun 13 13:08:38 +0000 2024",
    "text": "We're partnering with UK biotech @ochrebio through a multi-year agreement, generating new data to deepen our understanding of #liverdiseases and potentially accelerate the development of innovative therapies. Read more: https://t.co/iuKVZYTyGO",
    "likes": 14,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1801177766219448797",
    "url": "https://x.com/GSK/status/1801177766219448797",
    "created_at": "Thu Jun 13 09:00:18 +0000 2024",
    "text": "Thanks for having us #LondonTechWeek! We‚Äôve had a blast connecting with the tech community here in London and beyond. \n\nWe‚Äôre at a transformational moment in health. With science and tech, we can prevent and change the course of disease better and faster than ever before. #LTW24 https://t.co/FwuRJ5k1ys",
    "likes": 138,
    "retweets": 6,
    "replies": 7,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1800890851846975776",
    "url": "https://x.com/GSK/status/1800890851846975776",
    "created_at": "Wed Jun 12 14:00:12 +0000 2024",
    "text": "We believe tech-powered science will transform what‚Äôs possible for patients. That‚Äôs why we‚Äôre using data tech to get ahead of disease faster and better than ever before. \n\nüîó Find out what we're up to at #LondonTechWeek: https://t.co/SK68Rek1mh https://t.co/zDTDKGLMVY",
    "likes": 4,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1800845531763167724",
    "url": "https://x.com/GSK/status/1800845531763167724",
    "created_at": "Wed Jun 12 11:00:07 +0000 2024",
    "text": "We‚Äôre at this year‚Äôs @eular_org congress presenting our latest research to support the global #lupus community and emphasizing the importance of taking early action. \n#EULAR2024 https://t.co/SnbuibEGQn",
    "likes": 7,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1800090527674544453",
    "url": "https://x.com/GSK/status/1800090527674544453",
    "created_at": "Mon Jun 10 09:00:00 +0000 2024",
    "text": "By combining deep expertise in artificial intelligence (#AI) and machine learning with access to rich troves of genetic, genomic and health data, scientists are unlocking new discoveries about disease that could change the face of healthcare üëá \n#LTW24 https://t.co/yQEsZzZRNJ",
    "likes": 7,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1799713042285903902",
    "url": "https://x.com/GSK/status/1799713042285903902",
    "created_at": "Sun Jun 09 08:00:00 +0000 2024",
    "text": "Giving researchers access to rich biological data at scale is crucial to accelerating drug discovery. \n\nHere, Chris Austin, SVP, Research Technologies at GSK, explains why ‚Äì and why a diverse skillset is needed to do this well and responsibly üëá \n\n#LTW24 https://t.co/DYmcZKUyQL",
    "likes": 4,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1799411049315078492",
    "url": "https://x.com/GSK/status/1799411049315078492",
    "created_at": "Sat Jun 08 12:00:00 +0000 2024",
    "text": "RSV is one of the most common seasonal respiratory viruses ‚Äì yet until recently, its role in adult disease was not well known. Here are 3 key facts, shared by our Head of Vaccines R&amp;D &amp; Infectious Disease Research, to help increase understanding of RSV üëá\n https://t.co/PQxPNKU9h8",
    "likes": 10,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1799395953327124715",
    "url": "https://x.com/GSK/status/1799395953327124715",
    "created_at": "Sat Jun 08 11:00:01 +0000 2024",
    "text": "RSV infection is not only an illness that affects children: for some adults, getting sick with RSV can mean not being able to do what they love, shortness of breath, intense coughing or fatigue ‚Äì and even being hospitalised. Our goal is to help people enjoy life at its fullest. https://t.co/ALsex46sef",
    "likes": 8,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1799365786663821757",
    "url": "https://x.com/GSK/status/1799365786663821757",
    "created_at": "Sat Jun 08 09:00:08 +0000 2024",
    "text": "81% of people living with primary biliary cholangitis (#PBC) are also living with cholestatic pruritus, a persistent itch that may impact sleep, daily activities, and relationships. We‚Äôre committed to advancing science to change that.\n\n #EASLCongress https://t.co/eCSg2oF18U",
    "likes": 11,
    "retweets": 6,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1799199661640585290",
    "url": "https://x.com/GSK/status/1799199661640585290",
    "created_at": "Fri Jun 07 22:00:01 +0000 2024",
    "text": "News for #investors and #media: Today @US_FDA has approved an expanded indication for one of our vaccines. https://t.co/BdREW9aeei https://t.co/lO7TnfX1kW",
    "likes": 5,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1798716790203109592",
    "url": "https://x.com/GSK/status/1798716790203109592",
    "created_at": "Thu Jun 06 14:01:15 +0000 2024",
    "text": "At GSK, we‚Äôre committed to advancing cancer care through innovation. \n\nDiscover how we‚Äôre harnessing the power of biomarker testing and precision medicine to have a positive impact on patient lives: https://t.co/ZyWjNEeJtd\n\n#ASCO24 https://t.co/Bp0mLgWprf",
    "likes": 3,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1798688608582267302",
    "url": "https://x.com/GSK/status/1798688608582267302",
    "created_at": "Thu Jun 06 12:09:16 +0000 2024",
    "text": "#News for #investors and #media: Today we announced that we have acquired Elsie Biotechnologies to further enhance and advance our capabilities in the discovery and development of novel oligonucleotide therapeutics. https://t.co/GmlJcdrd62 https://t.co/ct6JJdVemE",
    "likes": 10,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1798641024463712336",
    "url": "https://x.com/GSK/status/1798641024463712336",
    "created_at": "Thu Jun 06 09:00:12 +0000 2024",
    "text": "We‚Äôre excited to be at #EASLCongress 2024 to connect with and share the stories of those living with chronic #hepatitisB. Visit us at stand I1 to get a glimpse into the challenges faced by people living with CHB üëá https://t.co/XnYqiiqkBx",
    "likes": 6,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1798339019987619993",
    "url": "https://x.com/GSK/status/1798339019987619993",
    "created_at": "Wed Jun 05 13:00:08 +0000 2024",
    "text": "This Uterine Cancer Awareness Month, we‚Äôre raising awareness of disparities in diagnosis of this often-overlooked cancer. Early detection can improve outcomes in #uterinecancer, including #endometrialcancer. Visit @IGCSociety for ways to get involved: https://t.co/a77Ry4G2hW https://t.co/qNdtjXUmNe",
    "likes": 11,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1798283531757441423",
    "url": "https://x.com/GSK/status/1798283531757441423",
    "created_at": "Wed Jun 05 09:19:39 +0000 2024",
    "text": "Want to know the leading response to our #GSKdata wall exhibit question at #ASCO24: What is the main benefit of oncology R&amp;D collaborations to get ahead of cancer?\n\nDiscover more insights from #GSKdata: https://t.co/EvdmwiA6tR https://t.co/EuhLa4Z903",
    "likes": 4,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1797971502316331506",
    "url": "https://x.com/GSK/status/1797971502316331506",
    "created_at": "Tue Jun 04 12:39:45 +0000 2024",
    "text": "As our time in Chicago comes to a close, Nina Mojas, Senior Vice President, Oncology Global Product Strategy reflects on the incredible experience we've had at #ASCO24, engaging in key discussions and sharing the latest developments from our oncology portfolio. https://t.co/F6lDuo4TXA",
    "likes": 9,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1797687472832585995",
    "url": "https://x.com/GSK/status/1797687472832585995",
    "created_at": "Mon Jun 03 17:51:07 +0000 2024",
    "text": "While cancer remains one of the world‚Äôs leading causes of death, our ultimate goal is to improve outcomes for patients with cancers in areas of high unmet need. Our Senior Vice President US Oncology, Kavya Gopal, is at #ASCO, here she shares her highlights from day 3. https://t.co/uYx1XmTtqC",
    "likes": 8,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1797644420306592101",
    "url": "https://x.com/GSK/status/1797644420306592101",
    "created_at": "Mon Jun 03 15:00:03 +0000 2024",
    "text": "DYK that 40% of #ASCO24 delegates told us that focusing on precision medicine and personalised treatment options is the most important step we can take to improve patient outcomes in cancer. \n\nDiscover more insights from #GSKdata: https://t.co/rj283fmaLZ https://t.co/SUPhiO3SBi",
    "likes": 7,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1797629050204098799",
    "url": "https://x.com/GSK/status/1797629050204098799",
    "created_at": "Mon Jun 03 13:58:58 +0000 2024",
    "text": "@DrBloodandGuts If you're having trouble paying for your medicine, you can ask your insurance company for help. We also have programs to help eligible patients afford our products. You can visit  https://t.co/jZzZfXypZU to learn more.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1797628937511530654",
    "url": "https://x.com/GSK/status/1797628937511530654",
    "created_at": "Mon Jun 03 13:58:31 +0000 2024",
    "text": "@DrBloodandGuts We care about making sure you can get your medicine. We know medicine can be expensive, so we try to make it affordable. But we don't control the price you pay at the pharmacy. Your health insurance company decides which medicines are covered by your plan and what you pay.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1797601625307000922",
    "url": "https://x.com/GSK/status/1797601625307000922",
    "created_at": "Mon Jun 03 12:09:59 +0000 2024",
    "text": "#News for #Investors and #Media: We‚Äôre pleased to share the latest research from a trial evaluating our immuno-oncology therapy at ASCO24.\n\nLearn more: https://t.co/dFSla5ff38 https://t.co/UfVBoth4su",
    "likes": 1,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1797283802391175542",
    "url": "https://x.com/GSK/status/1797283802391175542",
    "created_at": "Sun Jun 02 15:07:05 +0000 2024",
    "text": "#News for #Investors and #Media: At ASCO24, we shared late-breaking research from a phase III clinical trial evaluating one of our #bloodcancer therapies. \n\nLearn more: https://t.co/Q1NJQOzDMK https://t.co/kTQcQqiLfZ",
    "likes": 11,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1797242704872558869",
    "url": "https://x.com/GSK/status/1797242704872558869",
    "created_at": "Sun Jun 02 12:23:46 +0000 2024",
    "text": "We're at the #GSKdata wall learning what our ASCO24 conference-goers think: What scientific innovation is best placed to advance new cancer therapies to patients? \n\nSee what they think below.\n\nDiscover more insights from #GSKdata: https://t.co/U24XZhWmgx https://t.co/e67SZY56bk",
    "likes": 12,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1796988874704531673",
    "url": "https://x.com/GSK/status/1796988874704531673",
    "created_at": "Sat Jun 01 19:35:08 +0000 2024",
    "text": "We‚Äôre at #ASCO24 in Chicago, the most significant gathering of oncology professionals worldwide. Our Senior Vice President, Global Head Oncology R&amp;D, Hesham Abdullah, is here and shares his perspective from day 1.\n\nLearn more: https://t.co/5Cd9hOdjPx https://t.co/5LilvPjuvQ",
    "likes": 11,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1796573643905921367",
    "url": "https://x.com/GSK/status/1796573643905921367",
    "created_at": "Fri May 31 16:05:10 +0000 2024",
    "text": "For people living with chronic rhinosinusitis with #NasalPolyps, their symptoms don‚Äôt just take a physical toll on things like breathing, sleeping and taste. But an emotional toll too. https://t.co/WLwslbFKuv",
    "likes": 3,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1796573637161431298",
    "url": "https://x.com/GSK/status/1796573637161431298",
    "created_at": "Fri May 31 16:05:08 +0000 2024",
    "text": "We're at #EAACI2024 where we bring together deep understanding of the immune system and ongoing innovation in the field of respiratory medicine. \n\nEduardo Genofre, VP of Global Medical Affairs, shares the focus of our research: Learn more here: https://t.co/ciSiLXEbWV https://t.co/oCgcuF0VSx",
    "likes": 4,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1795856913231421446",
    "url": "https://x.com/GSK/status/1795856913231421446",
    "created_at": "Wed May 29 16:37:08 +0000 2024",
    "text": "We‚Äôre committed to getting ahead of #bloodcancer for patients living with #multiplemyeloma, like Lou. At this year‚Äôs @ASCO Annual Meeting, we‚Äôll share our latest advances in oncology research. Learn more: https://t.co/DNPuzegKNv\n\n#ASCO24 https://t.co/PSxiBmHEAb",
    "likes": 8,
    "retweets": 5,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1795476443838796091",
    "url": "https://x.com/GSK/status/1795476443838796091",
    "created_at": "Tue May 28 15:25:17 +0000 2024",
    "text": "The impact of climate change on health alongside AMR are two huge challenges hindering global health progress. Our chief global health officer @ThomasBreuer_MD reflects what we can do in the face of these challenges in our latest Behind the https://t.co/dBUIYq1tTo \n\n#WHA77",
    "likes": 6,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1795443878314610924",
    "url": "https://x.com/GSK/status/1795443878314610924",
    "created_at": "Tue May 28 13:15:52 +0000 2024",
    "text": "@Steve15966056 Thank you for reaching out. We have a number of different patient assistance programs options. Please use the link below: https://t.co/DnvTzhRcRo. If this doesn't help, I would also suggest you contact our US Response Center directly. Their number is 1-855-574-7067.",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1795424812006855014",
    "url": "https://x.com/GSK/status/1795424812006855014",
    "created_at": "Tue May 28 12:00:07 +0000 2024",
    "text": "More than 1 million people worldwide are diagnosed with a blood cancer annually. At GSK, we‚Äôre committed to advancing research for people living with #bloodcancer. This #WorldBloodCancerDay, watch to learn more about two types of blood cancer. https://t.co/AMaUyoShwt",
    "likes": 10,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1793914833827508704",
    "url": "https://x.com/GSK/status/1793914833827508704",
    "created_at": "Fri May 24 08:00:00 +0000 2024",
    "text": "Did you know that #antimicrobialresistance could result in millions of deaths every year by 2050? \n\nLearn more about how we‚Äôre forging ahead against #AMR through research and coordinated action: https://t.co/PyFCiHq4Gi",
    "likes": 7,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1793907308809933020",
    "url": "https://x.com/GSK/status/1793907308809933020",
    "created_at": "Fri May 24 07:30:06 +0000 2024",
    "text": "We‚Äôre at this year‚Äôs @ERAkidney congress, sharing the latest in our ongoing research to support the global #lupus community and encouraging people living with lupus to act early and speak with their doctors about how to slow their disease progression. #ERA24 https://t.co/ivlHSbdu1m",
    "likes": 9,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1793754413980401817",
    "url": "https://x.com/GSK/status/1793754413980401817",
    "created_at": "Thu May 23 21:22:33 +0000 2024",
    "text": "#News for #investors and #media: We‚Äôre pleased to present new data from our oncology portfolio at ASCO24, including two late-breakers. Read more: https://t.co/OfRa20NAo6 https://t.co/71XT4luSqH",
    "likes": 6,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1793636627727655402",
    "url": "https://x.com/GSK/status/1793636627727655402",
    "created_at": "Thu May 23 13:34:30 +0000 2024",
    "text": "We are thrilled to have been at #ATS2024 and our presence has further highlighted the importance of the work we are doing to prevent and change the course of respiratory diseases. \n\nhttps://t.co/7Kb5jHLoJ2 https://t.co/k2t695xNaM",
    "likes": 10,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1793552696986804500",
    "url": "https://x.com/GSK/status/1793552696986804500",
    "created_at": "Thu May 23 08:01:00 +0000 2024",
    "text": "‚ÄúWe need nature to tackle climate change and we can‚Äôt halt and reverse nature loss without a stable climate‚Äù \n\nCheck out this FT article, in partnership with GSK, and discover why healthy people need healthy ecosystems. https://t.co/xatkYfcN5C",
    "likes": 7,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1793348654771691653",
    "url": "https://x.com/GSK/status/1793348654771691653",
    "created_at": "Wed May 22 18:30:12 +0000 2024",
    "text": "As #ATS2024 comes to a close, read about why our timely implementation of evidence-based treatment plans are important in preventing deterioration in health, preventing exacerbations and disease progression.\nhttps://t.co/7httqqOiwv https://t.co/3lGMnw8GW7",
    "likes": 6,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1793321240834253070",
    "url": "https://x.com/GSK/status/1793321240834253070",
    "created_at": "Wed May 22 16:41:16 +0000 2024",
    "text": "We are proud to be a leader in the field of asthma research and of the ongoing contribution we are making to deliver next generation treatment goals and help ease the burden of asthma on millions of people with asthma. #ATS2024\n\nLearn more here: https://t.co/33XIikqvqn https://t.co/idLVDWnmR7",
    "likes": 8,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1793192542726451377",
    "url": "https://x.com/GSK/status/1793192542726451377",
    "created_at": "Wed May 22 08:09:52 +0000 2024",
    "text": "Today, our #NatureStrategy has been recognized by @BfNCoalition as part of ‚Äò#NowforNature‚Äô, which calls on businesses to act on nature and boost resilience to nature related risks.\n\nFind out more about why nature it not only fundamental for human health, but it‚Äôs also critical for long-term business success: https://t.co/T6AmqGW9yJ",
    "likes": 10,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1793182526371963182",
    "url": "https://x.com/GSK/status/1793182526371963182",
    "created_at": "Wed May 22 07:30:04 +0000 2024",
    "text": "Our CEO, Emma Walmsley, attended the @royalsociety event on #antimicrobialresistance alongside HRH Prince William, @UKAMREnvoy &amp; other leaders.\n\nThe event reinforced the need for collective action, like our #FlemingInitiative partnership, in tackling #AMR: https://t.co/hVek3gfvRG https://t.co/ted2PLmIBu",
    "likes": 13,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792942264592822596",
    "url": "https://x.com/GSK/status/1792942264592822596",
    "created_at": "Tue May 21 15:35:21 +0000 2024",
    "text": "We are proud to be a leader in the field of asthma research and of the ongoing contribution we are making to deliver next generation treatment goals and help ease the burden of asthma on millions of people with asthma. #ATS2024 \n\nLearn more here https://t.co/GewXJa6tvE https://t.co/pbR1nkmXPx",
    "likes": 4,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792942190064218602",
    "url": "https://x.com/GSK/status/1792942190064218602",
    "created_at": "Tue May 21 15:35:04 +0000 2024",
    "text": "What percentage of severe asthma patients require hospitalisation due to exacerbations every year?",
    "likes": 0,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792942184825553112",
    "url": "https://x.com/GSK/status/1792942184825553112",
    "created_at": "Tue May 21 15:35:02 +0000 2024",
    "text": "Kaivan Khavandi, Senior Vice President of Respiratory and Immunology R&amp;D is focused on research that targets the underlying cause of respiratory diseases, aiming to modify the specific biological pathways, deliver optimal symptom relief and prevent disease progression #ATS2024 https://t.co/yg7iH4Deih",
    "likes": 0,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792919600138445222",
    "url": "https://x.com/GSK/status/1792919600138445222",
    "created_at": "Tue May 21 14:05:18 +0000 2024",
    "text": "Our understanding of asthma has advanced and treatment options are helping to achieve ambitious goals. We are proud to be a leader in this field and the ongoing contribution we are making to deliver next generation treatment goals for the millions of people with asthma. https://t.co/e47ikaZSrP",
    "likes": 7,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792916450669179301",
    "url": "https://x.com/GSK/status/1792916450669179301",
    "created_at": "Tue May 21 13:52:47 +0000 2024",
    "text": "@patriotnikki3 In the interest of patient safety, your comment has been forwarded to the GSK safety team and you may be contacted for additional information. GSK would like to learn more about the experience you reported. Please contact GSK at (855) 574-7067",
    "likes": 1,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792832695946334634",
    "url": "https://x.com/GSK/status/1792832695946334634",
    "created_at": "Tue May 21 08:19:58 +0000 2024",
    "text": "This World Day for Cultural Diversity, we‚Äôre highlighting the importance of ensuring people most impacted by a particular disease are included in clinical research.\n\nWatch @Maimah's story to learn how we‚Äôre working with @tigerlilycares  to help achieve equitable health outcomes. https://t.co/QS86hqXayg",
    "likes": 6,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792800299083514218",
    "url": "https://x.com/GSK/status/1792800299083514218",
    "created_at": "Tue May 21 06:11:14 +0000 2024",
    "text": "#News for #investors and #media: Today we have announced positive results for the first phase III trials in #asthma of one of our pipeline biologics.\n\nLearn more here: https://t.co/uGDJ7nVL5r https://t.co/7CLepBdIha",
    "likes": 9,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792674079083995147",
    "url": "https://x.com/GSK/status/1792674079083995147",
    "created_at": "Mon May 20 21:49:41 +0000 2024",
    "text": "@frdmfghtrmom97 In the interest of patient safety, your comment has been forwarded to the GSK safety team and you may be contacted for additional information. GSK would like to learn more about the experience you reported. Please contact GSK at (855) 574-7067",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792673943708663898",
    "url": "https://x.com/GSK/status/1792673943708663898",
    "created_at": "Mon May 20 21:49:09 +0000 2024",
    "text": "@Jdm_over2020 In the interest of patient safety, your comment has been forwarded to the GSK safety team and you may be contacted for additional information. GSK would like to learn more about the experience you reported. Please contact GSK at (855) 574-7067",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792628906912100437",
    "url": "https://x.com/GSK/status/1792628906912100437",
    "created_at": "Mon May 20 18:50:11 +0000 2024",
    "text": "We‚Äôre aiming for people with severe asthma to achieve clinical remission, freeing them from exacerbations or the need for oral corticosteroids ‚îÄ achieving symptom control and stabilising lung function. \n\nFind out who could achieve remission ‚òü \nhttps://t.co/cfifBCdv61 https://t.co/zhjd9WRGWf",
    "likes": 7,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792596898886332676",
    "url": "https://x.com/GSK/status/1792596898886332676",
    "created_at": "Mon May 20 16:43:00 +0000 2024",
    "text": "#Asthma management is evolving. A simple blood test can identify the underlying pathology driving an individual‚Äôs asthma and help to optimise their treatment. \n\n#ATS2024 learn how biomarkers aid treatment decisions.\nhttps://t.co/Myf5CpjoLp",
    "likes": 7,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792580801579581915",
    "url": "https://x.com/GSK/status/1792580801579581915",
    "created_at": "Mon May 20 15:39:02 +0000 2024",
    "text": "#Asthma management is evolving. Dr Eduardo Genofre, VP Global Medical Affairs explains how a simple blood test can identify the underlying pathology driving an individual‚Äôs asthma and help to optimise their treatment and ease the burden. #ATS2024 https://t.co/3veDlxjPEt",
    "likes": 9,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792503285972189462",
    "url": "https://x.com/GSK/status/1792503285972189462",
    "created_at": "Mon May 20 10:31:01 +0000 2024",
    "text": "Timely intervention with the right management strategy can help to prevent exacerbations which can lead to cumulative lung damage and disease progression in #asthma and #COPD. \n\nDiscover more in our latest article: https://t.co/f9AUjVQZhT",
    "likes": 2,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792343838511554934",
    "url": "https://x.com/GSK/status/1792343838511554934",
    "created_at": "Sun May 19 23:57:25 +0000 2024",
    "text": "We are sharing our industry-leading respiratory portfolio by talking to leaders, advocates and partners about respiratory and prevention to change the course of disease #ATS2024\n\nhttps://t.co/sR2LDcW99h https://t.co/Y7ieVcS4aH",
    "likes": 6,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792194787916853281",
    "url": "https://x.com/GSK/status/1792194787916853281",
    "created_at": "Sun May 19 14:05:09 +0000 2024",
    "text": "People with #RefractoryChronicCough experience a persistent cough lasting for over 8 weeks despite treatment for an identified underlying medical condition or when one isn‚Äôt identified despite appropriate evaluation. \n\nAt #ATS2024, experts will discuss this unmet need. https://t.co/ap333iggYO",
    "likes": 7,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792174370162344160",
    "url": "https://x.com/GSK/status/1792174370162344160",
    "created_at": "Sun May 19 12:44:01 +0000 2024",
    "text": "We are excited to be at #ATS2024, where we will be showcasing our work to redefine the future of respiratory care and improve the lives of millions. \n\nFollow us for more. https://t.co/uEdVP5BGqj https://t.co/TrWLdzRDzs",
    "likes": 6,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1792155744227213647",
    "url": "https://x.com/GSK/status/1792155744227213647",
    "created_at": "Sun May 19 11:30:00 +0000 2024",
    "text": "We look beyond the visible symptoms of #asthma and #COPD. With an eye on the longer-term impact these conditions can have on a patient‚Äôs future, we aim to target the underlying drivers to prevent cumulative lung damage and disease progression. #ATS2024 \n\nhttps://t.co/0oJYO9L5eb",
    "likes": 8,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1791868610094252166",
    "url": "https://x.com/GSK/status/1791868610094252166",
    "created_at": "Sat May 18 16:29:02 +0000 2024",
    "text": "Dr Eduardo Genofre, VP Global Medical Affairs describes how our research is providing insights into the underlying drivers of #asthma including pathways that drive symptoms, exacerbations, lung damage and disease progression. #ATS2024 https://t.co/SIMzzxFL5X",
    "likes": 5,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1791550757868634578",
    "url": "https://x.com/GSK/status/1791550757868634578",
    "created_at": "Fri May 17 19:26:00 +0000 2024",
    "text": "For more than 50 years, inhalers have helped millions of people manage their asthma, but they also contribute to greenhouse gas emissions. \n\nDiscover why low carbon inhalers could help patients while reducing our environmental impact. #ATS2024 \nhttps://t.co/6dQDAD25ZG",
    "likes": 4,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1791535262020907453",
    "url": "https://x.com/GSK/status/1791535262020907453",
    "created_at": "Fri May 17 18:24:26 +0000 2024",
    "text": "One the first day of #ATS2024 Kaivan Khavandi, Senior Vice President of Respiratory and Immunology R&amp;D shares his thoughts on how we‚Äôre determined to apply our expertise to deliver ambitious treatment goals for patients and redefine the future of #respiratory medicine. https://t.co/sEOBEIo6pv",
    "likes": 7,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1791494435584270591",
    "url": "https://x.com/GSK/status/1791494435584270591",
    "created_at": "Fri May 17 15:42:12 +0000 2024",
    "text": "Today is the start of #ATS2024 &amp; we join respiratory experts from around the world to share the latest research to improve the lives and management of conditions like #asthma and #COPD. We‚Äôre ready to learn, to be inspired and help translate research to clinical care. https://t.co/n9tDdGhAbo",
    "likes": 2,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1791438518075445330",
    "url": "https://x.com/GSK/status/1791438518075445330",
    "created_at": "Fri May 17 12:00:00 +0000 2024",
    "text": "We‚Äôre looking forward to #ATS2024, where we‚Äôll be presenting real-world data on clinical remission in #SevereAsthma. \n\nIn the meantime, find out more about why we are aspiring to achieve clinical remission in severe #asthma: https://t.co/JbJ9FtRxmi",
    "likes": 3,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1791380363626807756",
    "url": "https://x.com/GSK/status/1791380363626807756",
    "created_at": "Fri May 17 08:08:55 +0000 2024",
    "text": "Our pledge will support projects to harness new technology, such as AI, to better utilise data to develop novel solutions and improve understanding of how drug-resistant infections can be tracked and prevented.\n#AMR #AntimicrobialResistance #FlemingInitiative @FlemingCentre",
    "likes": 9,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1791377747958255909",
    "url": "https://x.com/GSK/status/1791377747958255909",
    "created_at": "Fri May 17 07:58:31 +0000 2024",
    "text": "By uniting our leadership in prevention and treatment of infectious diseases with @imperialcollege and @imperialNHS‚Äôs world-class clinical and research expertise, we‚Äôre addressing the global health impact of #antimicrobialresistance, together.\n#FlemingInitiative @FlemingCentre",
    "likes": 10,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1791155484843471265",
    "url": "https://x.com/GSK/status/1791155484843471265",
    "created_at": "Thu May 16 17:15:20 +0000 2024",
    "text": "We‚Äôre excited to be partnering with the #FlemingInitiative on this innovative approach to tackling #AMR, and grateful to His Royal Highness the Prince of Wales for his ongoing support #AheadTogether #AntimicrobialResistance",
    "likes": 5,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1791134687865311263",
    "url": "https://x.com/GSK/status/1791134687865311263",
    "created_at": "Thu May 16 15:52:41 +0000 2024",
    "text": "Getting ahead of #antimicrobialresistance is critical to protecting modern medicine as we know it. But we can‚Äôt do it alone.\n\nOur CEO, Emma Walmsley, spoke with @Ara_Darzi on how we will be the founding partner of the global @FlemingCentre - tackling #AMR, together: https://t.co/JJRlYvKLRF",
    "likes": 72,
    "retweets": 8,
    "replies": 7,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1791119410565886389",
    "url": "https://x.com/GSK/status/1791119410565886389",
    "created_at": "Thu May 16 14:51:59 +0000 2024",
    "text": "Our CEO, Emma Walmsley, is at an event with @RoyalSociety today celebrating global efforts and initiatives to tackle #antimicrobialresistance, including our new partnership with #FlemingInitiative shared earlier today: https://t.co/ll9vwLcs9h https://t.co/Rxj6RkRvzP",
    "likes": 17,
    "retweets": 5,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1791092574473580804",
    "url": "https://x.com/GSK/status/1791092574473580804",
    "created_at": "Thu May 16 13:05:21 +0000 2024",
    "text": "We‚Äôre building on decades of innovation and turning science into solutions with the aim free people from the constraints of respiratory conditions like asthma and COPD. \n\nCheck out this video in the lead up to #ATS2024. https://t.co/nuNjwxiq4j",
    "likes": 9,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1790985537207042087",
    "url": "https://x.com/GSK/status/1790985537207042087",
    "created_at": "Thu May 16 06:00:01 +0000 2024",
    "text": "We‚Äôre proud that we will be the first founding partner of the global #FlemingInitiative ‚Äì an innovative and collaborative approach to tackle #antimicrobialresistance around the world.\n\nTogether we can get ahead of #AMR @FlemingCentre \n\nRead more: https://t.co/bL2Z9qUiSv https://t.co/yDKyTJb5ht",
    "likes": 50,
    "retweets": 11,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1790664086352461983",
    "url": "https://x.com/GSK/status/1790664086352461983",
    "created_at": "Wed May 15 08:42:41 +0000 2024",
    "text": "We are excited to be attending the upcoming #ATS2024 Congress. Hear from Dr. Imran Satia about the significant impact of refractory chronic cough on patients and healthcare professionals.  #RefractoryChronicCough https://t.co/bGoDCFszXL",
    "likes": 11,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1790343849899929861",
    "url": "https://x.com/GSK/status/1790343849899929861",
    "created_at": "Tue May 14 11:30:11 +0000 2024",
    "text": "At GSK respiratory innovation looks beyond short-term symptom control, to a patient‚Äôs future too. We aim to protect people from infections, prevent deterioration, exacerbations, lung damage and disease progression. #ATS2024 \n\nFind out more üëá \nhttps://t.co/yntfO2NPci https://t.co/wOiQGBZUYM",
    "likes": 11,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1788887984894365705",
    "url": "https://x.com/GSK/status/1788887984894365705",
    "created_at": "Fri May 10 11:05:06 +0000 2024",
    "text": "Nearly 5 million people worldwide have lupus. If left unmanaged, this chronic autoimmune condition can progress and lead to severe disease flares. \n\nThis #WorldLupusDay, find tips for talking with your doctor:  https://t.co/mnb7cikPlY  \n\n#MakeLupusVisible #LupusAwareness https://t.co/7vQZRlqbZM",
    "likes": 16,
    "retweets": 7,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1788196927189717441",
    "url": "https://x.com/GSK/status/1788196927189717441",
    "created_at": "Wed May 08 13:19:05 +0000 2024",
    "text": "Everyday we‚Äôre working to push the frontiers of respiratory medicine. We‚Äôre committed to deliver the next generation standard of care in asthma treat the symptoms and the underlying cause of inflammation, exacerbations and cumulative lung damage. https://t.co/fsyzMmKI3W",
    "likes": 11,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1788116655274381676",
    "url": "https://x.com/GSK/status/1788116655274381676",
    "created_at": "Wed May 08 08:00:06 +0000 2024",
    "text": "This World Ovarian Cancer Day, we are raising awareness for the tens of thousands of women diagnosed with #ovariancancer each year. Hear from Carmen about navigating her diagnosis. #WOCD2024 #NoWomanLeftBehind https://t.co/URPiegnO9C",
    "likes": 13,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1787875040941195398",
    "url": "https://x.com/GSK/status/1787875040941195398",
    "created_at": "Tue May 07 16:00:01 +0000 2024",
    "text": "Our CEO Emma Walmsley has been at #MIGlobal sharing how we‚Äôre using science and tech to prevent and change the course of disease ‚Äì and why we‚Äôre partnering with @MilkenInsitute to help health systems invest in prevention and earlier intervention: https://t.co/AeVF8mXZm1 https://t.co/8ewjfhPewV",
    "likes": 10,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1787825526083563965",
    "url": "https://x.com/GSK/status/1787825526083563965",
    "created_at": "Tue May 07 12:43:16 +0000 2024",
    "text": "For more than 50 years, inhalers have helped millions of people manage their asthma, but they also contribute to greenhouse gas emissions. \n\nDiscover why low carbon inhalers could help patients while reducing our environmental impact. #WorldAsthmaDay \n\nhttps://t.co/44PTUJTvmO",
    "likes": 8,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1787792055738957857",
    "url": "https://x.com/GSK/status/1787792055738957857",
    "created_at": "Tue May 07 10:30:16 +0000 2024",
    "text": "Globally, how many people have asthma?",
    "likes": 1,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1787792053398556688",
    "url": "https://x.com/GSK/status/1787792053398556688",
    "created_at": "Tue May 07 10:30:15 +0000 2024",
    "text": "#WorldAsthmaDay is a day when we ask, ‚Äòcan more be achieved for people with #asthma?‚Äô  \n\nJoelle had life-threatening asthma attacks before being diagnosed with a specific type of #SevereAsthma. Check out her story: https://t.co/xBqIz4urre. https://t.co/jlpgAseCke",
    "likes": 7,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1787784484705771932",
    "url": "https://x.com/GSK/status/1787784484705771932",
    "created_at": "Tue May 07 10:00:11 +0000 2024",
    "text": "On #WorldAsthmaDay we say thank you to the patients in our clinical trials or share their experiences, the experts and patient organisations who partner with us and GSK employees who are working tirelessly to deliver the next generation of #asthma care. https://t.co/BrvHp0HBvr",
    "likes": 10,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1787535326950375755",
    "url": "https://x.com/GSK/status/1787535326950375755",
    "created_at": "Mon May 06 17:30:07 +0000 2024",
    "text": "From vaccines to help protect all stages of life to working to change the course of diseases like asthma and hepatitis B, we‚Äôre innovating to get ahead of disease, together. Read more üëâ https://t.co/jlA3ZXybrq https://t.co/nsV9rDn5Vk",
    "likes": 6,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1787519940217516053",
    "url": "https://x.com/GSK/status/1787519940217516053",
    "created_at": "Mon May 06 16:28:58 +0000 2024",
    "text": "We‚Äôre pleased to be the founding partner of Project Prevent, a new initiative from @MilkenInstitute bringing together cross-sector experts to accelerate investment in, and access and uptake of, preventative healthcare. #MIGlobal\nFind out more: \nhttps://t.co/AeVF8mXZm1 https://t.co/4HARydqPEl",
    "likes": 7,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1786395359406694806",
    "url": "https://x.com/GSK/status/1786395359406694806",
    "created_at": "Fri May 03 14:00:17 +0000 2024",
    "text": "Get to know our #TargetTheFuture grant recipient: @CancerSupportHQ! Learn more about how their programme is connecting #multiplemyeloma patients and caregivers with vital resources: https://t.co/lSTUEpgARy #AheadTogether https://t.co/Dkpb46sxSN",
    "likes": 4,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1786332330480562670",
    "url": "https://x.com/GSK/status/1786332330480562670",
    "created_at": "Fri May 03 09:49:50 +0000 2024",
    "text": "Do you have #asthma or nasal polyps? \nYou are the experts on these conditions and your voice is important. We‚Äôre delighted to have partnered with @gaapporg on this survey to help improve understanding of these conditions. \nComplete the survey here by 12 May https://t.co/lZb35p575t",
    "likes": 8,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1785278037883273458",
    "url": "https://x.com/GSK/status/1785278037883273458",
    "created_at": "Tue Apr 30 12:00:27 +0000 2024",
    "text": "As people‚Äôs immune systems weaken with age, the burden of vaccine-preventable diseases rises. That‚Äôs what motivates us to work towards making adult immunisation the standard of care across the globe. #WIW2024 https://t.co/SnVQ2UjZOE https://t.co/cfZgIwLnBH",
    "likes": 6,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1785232990320095597",
    "url": "https://x.com/GSK/status/1785232990320095597",
    "created_at": "Tue Apr 30 09:01:27 +0000 2024",
    "text": "Did you know there are an estimated 82 million new gonorrhoea cases globally each year? \n \nGo Behind the Science to learn more about disease prevention üëá  https://t.co/FIoXmWnPwl",
    "likes": 7,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1784832571785851061",
    "url": "https://x.com/GSK/status/1784832571785851061",
    "created_at": "Mon Apr 29 06:30:20 +0000 2024",
    "text": "Nine projects have been funded through #ProjectAfricaGRADIENT, a collaboration between GSK, @Novartis and @MRCza. Among them, Dr. Tekete and Dr. Ou√©draogo are leading two important studies, looking at the impact of genetic diversity on malaria treatment #ZeroMalaria https://t.co/URDQyViiex",
    "likes": 9,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1784175686548140033",
    "url": "https://x.com/GSK/status/1784175686548140033",
    "created_at": "Sat Apr 27 11:00:06 +0000 2024",
    "text": "Discover how we are leading the fight against #infectiousdiseases. Our ground-breaking research and development efforts are aimed at protecting communities worldwide. Learn more üëá https://t.co/SjIxprkoZm",
    "likes": 18,
    "retweets": 5,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1783495864985563305",
    "url": "https://x.com/GSK/status/1783495864985563305",
    "created_at": "Thu Apr 25 13:58:44 +0000 2024",
    "text": "#Vaccination plays a crucial role in adult health and productivity. A recent report from @OHENews highlights the investment case for #adultvaccination, demonstrating its broader societal returns beyond individual health benefits.",
    "likes": 8,
    "retweets": 2,
    "replies": 4,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1783481093842247863",
    "url": "https://x.com/GSK/status/1783481093842247863",
    "created_at": "Thu Apr 25 13:00:02 +0000 2024",
    "text": "Today, Liberia introduces RTS,S into its routine immunisation programme. To support this, our partner @lastmilehealth is supporting the training of community health workers on delivering malaria vaccines as part of routine vaccination protocols in Liberia #WorldMalariaDay https://t.co/342LVI8QGW",
    "likes": 9,
    "retweets": 3,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1783405625797410980",
    "url": "https://x.com/GSK/status/1783405625797410980",
    "created_at": "Thu Apr 25 08:00:09 +0000 2024",
    "text": "Our ¬£1bn investment in global health R&amp;D over 10 yrs will help get ahead of #malaria in lower income countries. From the world‚Äôs 1st malaria vaccine to novel antimalarials we support the global elimination of malaria by helping improve prevention and treatment. #WorldMalariaDay https://t.co/nqHTxTafWK",
    "likes": 11,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1783400305285124382",
    "url": "https://x.com/GSK/status/1783400305285124382",
    "created_at": "Thu Apr 25 07:39:01 +0000 2024",
    "text": "Investing in adult vaccination programmes plays a crucial role in protecting lives, healthcare systems and economies. The new report from @OHENews evidences the Socio-Economic Value of Adult Immunisation Programmes. Check it out üëá",
    "likes": 6,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1783043236908412940",
    "url": "https://x.com/GSK/status/1783043236908412940",
    "created_at": "Wed Apr 24 08:00:09 +0000 2024",
    "text": "For the past two years, 100% of our Phase III clinical trials have had diversity plans to reflect the people most impacted by a particular disease. Find out more: https://t.co/T2mQcXCxkt https://t.co/jFAlL77XsF",
    "likes": 6,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1783032770421219400",
    "url": "https://x.com/GSK/status/1783032770421219400",
    "created_at": "Wed Apr 24 07:18:34 +0000 2024",
    "text": "#News for #Investors and #Media: Our application for a potential expanded indication for our immuno-oncology therapy has been accepted by the @US_FDA with Priority Review status. Learn more here: https://t.co/xo7A1fPjCF https://t.co/UKkFWkDMyx",
    "likes": 5,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1782673262159298733",
    "url": "https://x.com/GSK/status/1782673262159298733",
    "created_at": "Tue Apr 23 07:30:00 +0000 2024",
    "text": "Today @savechildrenuk is launching a new 'Immunisation Accelerator' to find innovations that address the barriers that exist for children receiving vaccinations. Here's Save the Children‚Äôs Dr Tewodros Gebremichael to explain more üëá https://t.co/SRFKTWiMnI",
    "likes": 12,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1781238841359179956",
    "url": "https://x.com/GSK/status/1781238841359179956",
    "created_at": "Fri Apr 19 08:30:08 +0000 2024",
    "text": "Margaret‚Äôs family has been deeply affected #malaria, but thanks to the support of Gaudenciah, a community health promoter trained by @Amref_Worldwide through our partnership, she is now able to access the healthcare she needs. #WorldMalariaDay https://t.co/OKc7emljUd https://t.co/7h92vYY6TH",
    "likes": 11,
    "retweets": 5,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1780478992992129251",
    "url": "https://x.com/GSK/status/1780478992992129251",
    "created_at": "Wed Apr 17 06:10:46 +0000 2024",
    "text": "#News for #investors and #media: Today we have announced phase III data in uncomplicated urogenital gonorrhoea (GC). \nFind out more https://t.co/T9LSem2cgA https://t.co/HjGrXpMWG0",
    "likes": 7,
    "retweets": 3,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1780477947570258065",
    "url": "https://x.com/GSK/status/1780477947570258065",
    "created_at": "Wed Apr 17 06:06:37 +0000 2024",
    "text": "For #investors and #media: Today we announced new positive long-term follow-up trial data in shingles. \nFind out more: https://t.co/INbDJ2S673 https://t.co/TSOcDu46d4",
    "likes": 9,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1780118041847537971",
    "url": "https://x.com/GSK/status/1780118041847537971",
    "created_at": "Tue Apr 16 06:16:28 +0000 2024",
    "text": "#News for #Media and #Investors: Today, we announced that the Biologics License Application for our vaccine candidate has been accepted by the @US_FDA.  \n  \nFind out more: https://t.co/FITFOnmOfE https://t.co/9TSsCPgROV",
    "likes": 19,
    "retweets": 6,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1778754940963377526",
    "url": "https://x.com/GSK/status/1778754940963377526",
    "created_at": "Fri Apr 12 12:00:00 +0000 2024",
    "text": "Closing the health equity gap is better for everyone, not just those who face barriers to accessing high quality healthcare. \n\nThis is how companies like GSK are working with partners to find solutions: \nhttps://t.co/0UZZ6jQ7bV",
    "likes": 6,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1778030166796591505",
    "url": "https://x.com/GSK/status/1778030166796591505",
    "created_at": "Wed Apr 10 12:00:00 +0000 2024",
    "text": "All patients deserve access to high quality healthcare, yet the needs of many go unmet due to preventable factors.\n\nThis is why closing the health equity gap not only benefits those facing barriers to access, but society as a whole: https://t.co/Hoo7EdaTbJ",
    "likes": 11,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1775825642136695073",
    "url": "https://x.com/GSK/status/1775825642136695073",
    "created_at": "Thu Apr 04 10:00:00 +0000 2024",
    "text": "‚ÄúA disease that was once almost uniformly fatal is now a disease that can be controlled with treatment‚Äù ‚Äì getting ahead of HIV is one way we‚Äôre innovating to help prevent and change the course of disease. \n\nFind out more üëá\n\n@ViiVHC  https://t.co/gS6lNkolVD",
    "likes": 14,
    "retweets": 5,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1775441611612176596",
    "url": "https://x.com/GSK/status/1775441611612176596",
    "created_at": "Wed Apr 03 08:34:00 +0000 2024",
    "text": "So far, 75 health systems around the world have committed to lowering their carbon footprint. \n\nRead the latest FT article, in partnership with GSK, to discover how low carbon inhalers could be key to reducing their emissions. https://t.co/6vXG6AiMQ5",
    "likes": 15,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1774028801984414075",
    "url": "https://x.com/GSK/status/1774028801984414075",
    "created_at": "Sat Mar 30 11:00:00 +0000 2024",
    "text": "Biomarker testing is helping doctors find precision treatments for patients that could dramatically improve health outcomes for everything from cancer to respiratory disease: https://t.co/x39THuprQx",
    "likes": 10,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1773726866001494275",
    "url": "https://x.com/GSK/status/1773726866001494275",
    "created_at": "Fri Mar 29 15:00:13 +0000 2024",
    "text": "Meet Lou ‚Äì a patient with #multiplemyeloma who shares what life can be like for those living with this blood cancer. This #MyelomaActionMonth we are inspired to keep driving progress for patients like Lou. Get to know her story here: https://t.co/wR6n5Hy75G https://t.co/xeh6usKwcO",
    "likes": 10,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1773666414810763693",
    "url": "https://x.com/GSK/status/1773666414810763693",
    "created_at": "Fri Mar 29 11:00:01 +0000 2024",
    "text": "Modern medicine has revolutionised the way we live, but the challenges to our health are evolving. We believe prevention is the best medicine ‚Äì for patients, societies and our economy. \n\nThis is why: https://t.co/dSmD1JuSvX",
    "likes": 12,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1773364473387954270",
    "url": "https://x.com/GSK/status/1773364473387954270",
    "created_at": "Thu Mar 28 15:00:12 +0000 2024",
    "text": "Our Mapping myelofibrosis podcast allows us to sit down with myelofibrosis experts, to learn more and discuss how we can collectively work together to close the gaps in complex #bloodcancers. \nWatch it here: https://t.co/NyUT0VHdQQ\n#MappingMF https://t.co/o12CicEg0V",
    "likes": 5,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1772639681089360143",
    "url": "https://x.com/GSK/status/1772639681089360143",
    "created_at": "Tue Mar 26 15:00:08 +0000 2024",
    "text": "Frustrated by lack of awareness of #myelofibrosis, Thomas educated himself and identified a care team to better navigate his cancer journey. His story sheds light on challenges people with complex #bloodcancers face.\n\nRead more in @ReutersPlus: https://t.co/ABjSY4m4Ti https://t.co/ByQLzUzXHt",
    "likes": 3,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1772264820873605143",
    "url": "https://x.com/GSK/status/1772264820873605143",
    "created_at": "Mon Mar 25 14:10:35 +0000 2024",
    "text": "@MedicallyGaslit In the interest of patient safety, GSK would like to learn more about the experience you reported. Please contact GSK at https://t.co/I4cIyo92ul",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1771801656620949748",
    "url": "https://x.com/GSK/status/1771801656620949748",
    "created_at": "Sun Mar 24 07:30:08 +0000 2024",
    "text": "On #WorldTBDay, we stand with the global TB community, reaffirming our commitment to help #ChangeTheTrajectory of this disease in lower income countries by investing in innovative partnerships and working with communities at the heart of the epidemic. #YesWeCanEndTB https://t.co/U4ALUK1VLa",
    "likes": 16,
    "retweets": 5,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1771287063830163562",
    "url": "https://x.com/GSK/status/1771287063830163562",
    "created_at": "Fri Mar 22 21:25:19 +0000 2024",
    "text": "@GabiPie1 In the interest of patient safety, your comment has been forwarded to the GSK safety team and you may be contacted for additional information. GSK would like to learn more about the experience you reported. Please contact GSK at (855) 574-7067",
    "likes": 0,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1771156278884159815",
    "url": "https://x.com/GSK/status/1771156278884159815",
    "created_at": "Fri Mar 22 12:45:38 +0000 2024",
    "text": "@catsscareme2021 In the interest of patient safety, your comment has been forwarded to the GSK safety team and you may be contacted for additional information. GSK would like to learn more about the experience you reported. Please contact GSK at (855) 574-7067",
    "likes": 38,
    "retweets": 4,
    "replies": 45,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1771094048754778567",
    "url": "https://x.com/GSK/status/1771094048754778567",
    "created_at": "Fri Mar 22 08:38:21 +0000 2024",
    "text": "TB is a complex disease, making it challenging to prevent and treat. As drug-resistant strains continue to emerge, its vital we work with partners to find new and innovative ways to get ahead of TB and contribute to ending the epidemic.\n\n#YesWeCanEndTB #WorldTBDay https://t.co/yrfYjQ20O4",
    "likes": 14,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1770827738292621416",
    "url": "https://x.com/GSK/status/1770827738292621416",
    "created_at": "Thu Mar 21 15:00:07 +0000 2024",
    "text": "Patients are at the centre of everything we do. In episode 2 of our Mapping myelofibrosis podcast, we sat down with Kapila Viges, CEO of @MPN_RF  to better understand the unmet needs in research &amp; care for the #myelofibrosis community. Watch here: https://t.co/3xJvv6u3FE https://t.co/DEywIgMGQK",
    "likes": 5,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1770752266154193294",
    "url": "https://x.com/GSK/status/1770752266154193294",
    "created_at": "Thu Mar 21 10:00:13 +0000 2024",
    "text": "As #WorldTBDay approaches, we‚Äôre delighted to share a new episode of TB Voices featuring Pamella. Her story highlights the importance of understanding TB and advocating for yourself to get the right diagnosis and treatment. https://t.co/q6TxxjkQtE #YesWeCanEndTB https://t.co/toNLENQS62",
    "likes": 3,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1770737432658395308",
    "url": "https://x.com/GSK/status/1770737432658395308",
    "created_at": "Thu Mar 21 09:01:17 +0000 2024",
    "text": "Dr. Veron Ramsuran from @UKZN shares his groundbreaking work as part of #ProjectAfricaGRADIENT. \n\nBy studying human genes and their response to TB drugs among African populations, he's on a mission to find better ways to diagnose and treat TB patients. https://t.co/QudcTNxXOj",
    "likes": 8,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1770087844364661055",
    "url": "https://x.com/GSK/status/1770087844364661055",
    "created_at": "Tue Mar 19 14:00:03 +0000 2024",
    "text": "At GSK, we‚Äôre committed to innovating to get ahead of pneumococcal disease ‚Äì together with the experts, doctors and scientists we‚Äôre connecting with at #ISPPD this week ü§ù https://t.co/H14bkHtA44",
    "likes": 11,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1770075152774041863",
    "url": "https://x.com/GSK/status/1770075152774041863",
    "created_at": "Tue Mar 19 13:09:37 +0000 2024",
    "text": "We‚Äôve dedicated over 20 yrs to developing an essential TB candidate vaccine, so we‚Äôre delighted that it‚Äôs moved into a Phase 3 trial with our partners, @GatesMRI. M72 is the 1st potential new #TB vaccine candidate in over 100 yrs that so far meets @WHO‚Äôs target product profile. https://t.co/eirgjtgoWS",
    "likes": 19,
    "retweets": 8,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1769725539651047619",
    "url": "https://x.com/GSK/status/1769725539651047619",
    "created_at": "Mon Mar 18 14:00:23 +0000 2024",
    "text": "When Betty‚Äôs daughter, Rebecca, became unwell, her determination to help her get the right diagnosis of TB was unwavering. With the support of community nurse Daisy, they've been working together to ensure Rebecca's recovery. #WorldTBDay #YesWeCanEndTB https://t.co/vnw72dmPQa",
    "likes": 12,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1768979464984084964",
    "url": "https://x.com/GSK/status/1768979464984084964",
    "created_at": "Sat Mar 16 12:35:45 +0000 2024",
    "text": "#News for #investors and #media: \nTogether with the clinical community, we‚Äôve been advancing #gynaecologic cancer research. We‚Äôre pleased to share our latest findings at the 2024 #SGOmtg. \n\nLearn more: https://t.co/PBjb68bQyT https://t.co/X1JHdXwXFj",
    "likes": 17,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1768619436100006226",
    "url": "https://x.com/GSK/status/1768619436100006226",
    "created_at": "Fri Mar 15 12:45:07 +0000 2024",
    "text": "We‚Äôre excited to be at #ISPPD in Cape Town from March 17-20 to engage with the global pneumonia and pneumococcal community. \n\nLearn how we want to innovate in this area - and continue to advance science against these diseases together üëá  https://t.co/QSB1Mgufpr",
    "likes": 8,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1768228900562170105",
    "url": "https://x.com/GSK/status/1768228900562170105",
    "created_at": "Thu Mar 14 10:53:16 +0000 2024",
    "text": "What an incredible and inspiring day meeting @ghettokidstfug from Uganda. We were privileged to hear their stories and share with them how our science and innovation are making a difference in the fight against malaria. #ZeroMalaria",
    "likes": 12,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1767928611896524995",
    "url": "https://x.com/GSK/status/1767928611896524995",
    "created_at": "Wed Mar 13 15:00:02 +0000 2024",
    "text": "This #MyelomaActionMonth, @IMFmyeloma is empowering the #multiplemyeloma community to take actions that support patients. Follow along as we raise awareness by highlighting perspectives from patients and advocates this month. https://t.co/ecVm7GVs4N",
    "likes": 13,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1767838301099073875",
    "url": "https://x.com/GSK/status/1767838301099073875",
    "created_at": "Wed Mar 13 09:01:10 +0000 2024",
    "text": "Through #ProjectAfricaGRADIENT, an initiative we support with @Novartis and @MRCza, scientists are studying genetic variation amongst African populations. Carene Ndong Sima from @StellenboschUni is looking at understanding how people‚Äôs genes affect their responses to TB drugs. https://t.co/NHHLw51LgV",
    "likes": 10,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1766479058806726792",
    "url": "https://x.com/GSK/status/1766479058806726792",
    "created_at": "Sat Mar 09 15:00:01 +0000 2024",
    "text": "Colorectal cancer can be hard to diagnose because symptoms often don‚Äôt present during its early stages‚Äîthat‚Äôs why regular screenings are so important to help increase early detection. \n\nThis #ColorectalCancerAwarenessMonth, get informed about testing: https://t.co/wtXTTxCZgy https://t.co/7oDDrurGpK",
    "likes": 11,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1766027354583769448",
    "url": "https://x.com/GSK/status/1766027354583769448",
    "created_at": "Fri Mar 08 09:05:07 +0000 2024",
    "text": "This International Women‚Äôs Day, we‚Äôre celebrating GSK people who #InspireInclusion by making a positive impact on women‚Äôs health and helping to forge a more inclusive world for women. Find out more üëá \n\n#IWD2024 https://t.co/UM5eFjzyQ3",
    "likes": 11,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1765709006415249834",
    "url": "https://x.com/GSK/status/1765709006415249834",
    "created_at": "Thu Mar 07 12:00:07 +0000 2024",
    "text": "HIV remains one of the world‚Äôs biggest health threats and while great strides have been made in HIV treatment, stigma remains a challenge. \n\nWe are committed to changing that, by minimising the impact of HIV on people‚Äôs lives through treatment, prevention and ultimately cure. https://t.co/Nk6Bi5LFPd",
    "likes": 12,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1765641680525344957",
    "url": "https://x.com/GSK/status/1765641680525344957",
    "created_at": "Thu Mar 07 07:32:35 +0000 2024",
    "text": "#News for #Investors and #Media:  \nToday we announced positive headline results from a phase III clinical trial evaluating one of our #bloodcancer therapies. \nLearn more: https://t.co/uI2g5469TJ https://t.co/9WL739WMfw",
    "likes": 7,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1765409372165771771",
    "url": "https://x.com/GSK/status/1765409372165771771",
    "created_at": "Wed Mar 06 16:09:28 +0000 2024",
    "text": "News for #investors and #media: Today @ViiVHC, our specialist HIV company, have announced an update on the LATITUDE study evaluating adherence challenges faced by people living with #HIV. \n\nFind out more: https://t.co/yBTkF6MpYw https://t.co/0xmSUs3X2D",
    "likes": 7,
    "retweets": 1,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1765332044144369731",
    "url": "https://x.com/GSK/status/1765332044144369731",
    "created_at": "Wed Mar 06 11:02:12 +0000 2024",
    "text": "With the support of @Novartis and @MRCza, we‚Äôre proud to contribute to #ProjectAfricaGRADIENT which funds research on genetic diversity in Africa. One project, led by Professor Collen Masimirembwa from @WitsUniversity, is looking at certain patients‚Äô reactions to TB drugs üî¨ https://t.co/4bRlFAM949",
    "likes": 4,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1764972192167551173",
    "url": "https://x.com/GSK/status/1764972192167551173",
    "created_at": "Tue Mar 05 11:12:16 +0000 2024",
    "text": "A new app could help in the quest to develop new HIV treatments designed with quality of life in mind. Long-acting medicines, for example, give patients the option of doing away with daily routines that are challenging for some. Read more in our article üëá\nhttps://t.co/ysu5hf0EuZ",
    "likes": 5,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1764726285568295096",
    "url": "https://x.com/GSK/status/1764726285568295096",
    "created_at": "Mon Mar 04 18:55:08 +0000 2024",
    "text": "News for #investors and #media: Phase I findings presented today at #CROI2024 by our specialist HIV company, @ViiVHC, set the stage for the next generation of medicines.\n\nFind out more: https://t.co/8z9eFhfDRj https://t.co/XuFaZXBrok",
    "likes": 8,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1764637481066979405",
    "url": "https://x.com/GSK/status/1764637481066979405",
    "created_at": "Mon Mar 04 13:02:15 +0000 2024",
    "text": "To positively impact the health of 2.5 billion people, we need exceptional talent. Cynthia's story highlights how diverse teams offer unique insights, helping us to better understand the needs of diverse patients: https://t.co/Rg5FOgyeRa https://t.co/dNaN2Czca1",
    "likes": 10,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1763897095117758600",
    "url": "https://x.com/GSK/status/1763897095117758600",
    "created_at": "Sat Mar 02 12:00:13 +0000 2024",
    "text": "Thank you for joining us this #ShinglesAwarenessWeek! We hope you discovered more about shingles pain and the impact it can have on people‚Äôs lives.\n\n(@IFAgeing @ILCUK @EFIC_org &amp; GCOA @MWhodin) https://t.co/k1gj1zXYT4",
    "likes": 10,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1763588035331883331",
    "url": "https://x.com/GSK/status/1763588035331883331",
    "created_at": "Fri Mar 01 15:32:08 +0000 2024",
    "text": "#Investors and #Media \nIn our 2023 #GSKAnnualReport, CEO Emma Walmsley, reflects on our progress. With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide. https://t.co/YZWVkfqUQe",
    "likes": 17,
    "retweets": 4,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1763544481796677740",
    "url": "https://x.com/GSK/status/1763544481796677740",
    "created_at": "Fri Mar 01 12:39:04 +0000 2024",
    "text": "#Investors and #Media\nWe‚Äôve published our 2023 #GSKAnnualReport and\n#ESG Performance Report. Learn how we are uniting science, technology and talent to get ahead of disease together for health impact, shareholder returns and thriving people\n\nMore: https://t.co/rfCh2jmbKC https://t.co/DZo8V3ot1y",
    "likes": 4,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1763498240798847459",
    "url": "https://x.com/GSK/status/1763498240798847459",
    "created_at": "Fri Mar 01 09:35:19 +0000 2024",
    "text": "The most common symptom of shingles is a painful rash that can have serious, long-lasting complications affecting people‚Äôs life &amp; well-being. Up to 1 in 3 adults over 50 will develop shingles in their lifetime.\n\n#ShinglesAwarenessWeek\n\n(@IFAgeing @ILCUK @EFIC_org &amp; GCOA @MWhodin) https://t.co/Ro1qgCVwZj",
    "likes": 4,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1763220216144609351",
    "url": "https://x.com/GSK/status/1763220216144609351",
    "created_at": "Thu Feb 29 15:10:33 +0000 2024",
    "text": "Do you know what a biologic medicine is or their role in the treatment of a range of conditions such as #EGPA, #HES, #asthma or #lupus? \n\nThis #rarediseaseday learn more about the role of biologics in immune-mediated conditions.  \n\nhttps://t.co/5gPenqotsh https://t.co/m4UTtKaFbm",
    "likes": 3,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1763220127544152323",
    "url": "https://x.com/GSK/status/1763220127544152323",
    "created_at": "Thu Feb 29 15:10:12 +0000 2024",
    "text": "Today is #rarediseaseday. From the rare to the more common, we‚Äôre striving to improve outcomes for people with a range of immune-mediated diseases. \n\nRead more about how biologic therapies are advancing our care ambitions for people with rare conditions. \n\nhttps://t.co/5gPenqotsh https://t.co/ycwTGkiVxv",
    "likes": 6,
    "retweets": 5,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1763196230295826648",
    "url": "https://x.com/GSK/status/1763196230295826648",
    "created_at": "Thu Feb 29 13:35:14 +0000 2024",
    "text": "#Investors and #Media\nWe‚Äôre publishing our Annual Report tomorrow. At GSK we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade. #GSKAnnualReport. https://t.co/XUvVKHW34p",
    "likes": 11,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1763134583791321498",
    "url": "https://x.com/GSK/status/1763134583791321498",
    "created_at": "Thu Feb 29 09:30:16 +0000 2024",
    "text": "The study of immunology has advanced the management of immune-mediated diseases from more common conditions like #asthma &amp; lupus to rare conditions like EGPA or HES.\n\nThis #rarediseaseday learn about how biologics are advancing treatment in this field. https://t.co/Dx2H7OXyRI https://t.co/PEXhZs1yhE",
    "likes": 12,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1762856389691441540",
    "url": "https://x.com/GSK/status/1762856389691441540",
    "created_at": "Wed Feb 28 15:04:50 +0000 2024",
    "text": "News for #Investors and #Media: @ViiVHC, our specialist HIV company, are presenting 64 abstracts from our innovative pipeline and portfolio of medicines at #CROI2024 \n\nFind out more: https://t.co/u0hpLmRX9K https://t.co/WLuQRtb2TW",
    "likes": 4,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1762813652149719346",
    "url": "https://x.com/GSK/status/1762813652149719346",
    "created_at": "Wed Feb 28 12:15:00 +0000 2024",
    "text": "Antibiotics were one of the most significant medical discoveries of the 20th century. \n\nGo Behind the Science to learn more about the need for antibiotics: https://t.co/Ay70DbewTc",
    "likes": 12,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1762761583300579355",
    "url": "https://x.com/GSK/status/1762761583300579355",
    "created_at": "Wed Feb 28 08:48:06 +0000 2024",
    "text": "We‚Äôre proud to have @ViiVHC, our specialist HIV company, presenting at #CROI2024",
    "likes": 7,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1762499709594116334",
    "url": "https://x.com/GSK/status/1762499709594116334",
    "created_at": "Tue Feb 27 15:27:31 +0000 2024",
    "text": "We think about HIV every day so people like Warren won't have to.\n\nRead about our work in HIV: https://t.co/JPZeXChLo8 üî¨\n\n@ViiVHC https://t.co/28dZ4p7zre",
    "likes": 8,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1762439989764194382",
    "url": "https://x.com/GSK/status/1762439989764194382",
    "created_at": "Tue Feb 27 11:30:12 +0000 2024",
    "text": "Shingles is a painful disease which may lead to long-lasting complications that can affect people‚Äôs quality of life. Hear about Lionel‚Äôs experience first-hand üëá \n\n#ShinglesAwarenessWeek \n\n(@IFAgeing @ILCUK @EFIC_org &amp; GCOA @MWhodin) https://t.co/EDWlTxQFXN",
    "likes": 15,
    "retweets": 4,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1762095101122117950",
    "url": "https://x.com/GSK/status/1762095101122117950",
    "created_at": "Mon Feb 26 12:39:44 +0000 2024",
    "text": "Welcome to Shingles Awareness Week üéâ \n\nShingles is a painful disease with potentially long-lasting complications. \n\nTune in and learn more about Shingles with Lionel, @IFAgeing, @ILCUK, @EFIC_org and GCOAüëá \n\nhttps://t.co/6eOgApyRD1 https://t.co/10nb6cjuiA",
    "likes": 11,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1762077584899133889",
    "url": "https://x.com/GSK/status/1762077584899133889",
    "created_at": "Mon Feb 26 11:30:08 +0000 2024",
    "text": "Hear Prof Ian Pavord, Professor of Respiratory Medicine at the University of Oxford, discussing the possibility of achieving clinical remission in certain types of #asthma üëá \n\n Learn more https://t.co/bIcDHSfNO8 \n\n#AAAAI24 #Respiratory https://t.co/npSLY9PNLf",
    "likes": 9,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1762011706815897712",
    "url": "https://x.com/GSK/status/1762011706815897712",
    "created_at": "Mon Feb 26 07:08:22 +0000 2024",
    "text": "#News for #investors and #media: Today we have announced positive headline results from our phase III clinical trial evaluating our antibiotic in development. Find out more here. https://t.co/FqBcFfwrGF https://t.co/GvQRigRzXq",
    "likes": 16,
    "retweets": 4,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1760991878701302175",
    "url": "https://x.com/GSK/status/1760991878701302175",
    "created_at": "Fri Feb 23 11:35:56 +0000 2024",
    "text": "Research into the timely use of #Biologic medicine could change how immune-mediated conditions like severe #asthma or #EGPA are being treated.  \n\nDiscover moreüëâ https://t.co/NEqTigSp38 \n\n#AAAAI24",
    "likes": 8,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1758067221580877903",
    "url": "https://x.com/GSK/status/1758067221580877903",
    "created_at": "Thu Feb 15 09:54:23 +0000 2024",
    "text": "#News for #investors and #media: We have completed the acquisition of Aiolos Bio. We look forward to building on our expertise in respiratory medicines.  \n\nhttps://t.co/vktKb01rq6 https://t.co/9SuWtDUVcw",
    "likes": 20,
    "retweets": 2,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1757080362608390443",
    "url": "https://x.com/GSK/status/1757080362608390443",
    "created_at": "Mon Feb 12 16:32:58 +0000 2024",
    "text": "Let's empower the most vulnerable populations worldwide, to reduce the global burden of disease associated with RSV. üí™üåç @ReSViNET",
    "likes": 5,
    "retweets": 0,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1757079623597199697",
    "url": "https://x.com/GSK/status/1757079623597199697",
    "created_at": "Mon Feb 12 16:30:01 +0000 2024",
    "text": "We're excited to be at @ReSViNET this week, raising awareness about RSV and connecting with a global community dedicated to protecting at-risk individuals from RSV infection. https://t.co/7y84dZZ9hO",
    "likes": 11,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1756940330484523088",
    "url": "https://x.com/GSK/status/1756940330484523088",
    "created_at": "Mon Feb 12 07:16:31 +0000 2024",
    "text": "#News for #Investors and #Media: Today we announced that the @US_FDA has granted Fast Track designation for our investigational medicine. Learn more: https://t.co/y30IBOPKpW https://t.co/ia02doJoUs",
    "likes": 11,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1755972756275859836",
    "url": "https://x.com/GSK/status/1755972756275859836",
    "created_at": "Fri Feb 09 15:11:44 +0000 2024",
    "text": "We‚Äôll be at @ReSViNET in Mumbai from February 13-16 sharing knowledge as well as the latest results of our research.\n\nRead this article below to find out more about RSV: https://t.co/shzFH0xuDo https://t.co/7N8gOCrmlK",
    "likes": 10,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1755509274954879022",
    "url": "https://x.com/GSK/status/1755509274954879022",
    "created_at": "Thu Feb 08 08:30:01 +0000 2024",
    "text": "Do you have a game-changing data-driven idea to protect the power of antibiotics, focussing on low- and middle-income countries? The #TrinityChallenge is welcoming applications. \n\nSubmit your solution by 29 February: https://t.co/woSa1r41vB https://t.co/fvLvBielUl",
    "likes": 12,
    "retweets": 4,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1754632545486946448",
    "url": "https://x.com/GSK/status/1754632545486946448",
    "created_at": "Mon Feb 05 22:26:12 +0000 2024",
    "text": "#News for #Investors and #Media: Tomorrow at the #ASCOPlenarySeries, we look forward to presenting positive results from our phase III clinical trial evaluating our blood cancer therapy. Learn more: https://t.co/D2PG38OBsa https://t.co/cHXUJRkzZO",
    "likes": 12,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1754157922043519056",
    "url": "https://x.com/GSK/status/1754157922043519056",
    "created_at": "Sun Feb 04 15:00:13 +0000 2024",
    "text": "On #WorldCancerDay, we‚Äôre inspired by the strength of the patient community. Today and every day, we strive to provide treatment options that can help patients get ahead of their disease. \n#CloseTheCareGap https://t.co/RBMAxoSQEG",
    "likes": 15,
    "retweets": 5,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1753508640365920334",
    "url": "https://x.com/GSK/status/1753508640365920334",
    "created_at": "Fri Feb 02 20:00:13 +0000 2024",
    "text": "Cancer is the second leading cause of death worldwide. As #WorldCancerDay approaches, our focus remains on driving research and innovation to bring novel treatment options to people living with cancer so we can #CloseTheCareGap. https://t.co/ru8vLkdrut",
    "likes": 12,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1753372690709098645",
    "url": "https://x.com/GSK/status/1753372690709098645",
    "created_at": "Fri Feb 02 11:00:00 +0000 2024",
    "text": "‚ÄúWith knowledge comes empowerment.‚Äù\n\nOur Head of Vaccines R&amp;D Phil Dormitzer shares three key facts scientists have learned about RSV - and explains why they could help us protect those most at risk. \n\nRead his article here: https://t.co/NoqvUj5xXj",
    "likes": 12,
    "retweets": 5,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1752250338768298366",
    "url": "https://x.com/GSK/status/1752250338768298366",
    "created_at": "Tue Jan 30 08:40:10 +0000 2024",
    "text": "On #WorldNTDDay, we stand united with @WHO and the global NTD community to eliminate and control NTDs. Our targeted R&amp;D and medicine donations are making strides in eliminating lymphatic filariasis and treating soil-transmitted helminths. #BeatNTDs https://t.co/c5eZNgIEn9",
    "likes": 4,
    "retweets": 3,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1751876494551330991",
    "url": "https://x.com/GSK/status/1751876494551330991",
    "created_at": "Mon Jan 29 07:54:39 +0000 2024",
    "text": "#News for #Investors and #Media: Today the European Commission granted authorisation for our blood cancer therapy. \n\nLearn more: https://t.co/SKc9AgLkGx https://t.co/jcfh3ruSGW",
    "likes": 18,
    "retweets": 3,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1749452256733499768",
    "url": "https://x.com/GSK/status/1749452256733499768",
    "created_at": "Mon Jan 22 15:21:35 +0000 2024",
    "text": "Congratulations, Cameroon!\n\nIt‚Äôs a proud day for us at GSK, seeing the official launch of our groundbreaking malaria vaccine ‚Äì the world's first ‚Äì as a routine vaccination in malaria endemic countries.",
    "likes": 25,
    "retweets": 6,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1749370597019124039",
    "url": "https://x.com/GSK/status/1749370597019124039",
    "created_at": "Mon Jan 22 09:57:06 +0000 2024",
    "text": "Breaking news! Cameroon is the first country outside of the WHO-coordinated pilot to roll out our groundbreaking malaria vaccine, Mosquirix. After 35 years of hard work, we're incredibly proud of our team for developing this vaccine and making it accessible to those who need it. https://t.co/To9iBKZt5W",
    "likes": 20,
    "retweets": 12,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1748380522403762310",
    "url": "https://x.com/GSK/status/1748380522403762310",
    "created_at": "Fri Jan 19 16:22:54 +0000 2024",
    "text": "Disruptions to immunisation services between 2019 and 2021 resulted in 67 million under 18s missing out on vaccines.\n\nThis continues to have serious consequences ‚Äì including recent outbreaks of preventable disease.\nRead our article to find out more:\n\nhttps://t.co/W5lbUxDEnt",
    "likes": 4,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1748299146396627362",
    "url": "https://x.com/GSK/status/1748299146396627362",
    "created_at": "Fri Jan 19 10:59:32 +0000 2024",
    "text": "Do you know how many under 18s missed out on one or more vaccinations between 2019 and 2021?",
    "likes": 2,
    "retweets": 5,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1747289081686454283",
    "url": "https://x.com/GSK/status/1747289081686454283",
    "created_at": "Tue Jan 16 16:05:54 +0000 2024",
    "text": "@quite8797 In the interest of patient safety, GSK would like to learn more about the experience you reported. Please contact GSK at https://t.co/I4cIyo92ul",
    "likes": 0,
    "retweets": 0,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1747242377801011311",
    "url": "https://x.com/GSK/status/1747242377801011311",
    "created_at": "Tue Jan 16 13:00:19 +0000 2024",
    "text": "We're delighted to see so many more @TNFD_ official Early Adopters commit to disclose their nature-related information. \n \nBy protecting nature, we're building business resilience and ensuring a stable supply of vital raw materials for medicines and vaccines. https://t.co/gtCOyj3drW",
    "likes": 4,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1745369960547864829",
    "url": "https://x.com/GSK/status/1745369960547864829",
    "created_at": "Thu Jan 11 09:00:00 +0000 2024",
    "text": "We believe prevention is the best medicine ‚Äì for patients, societies, and our economy. \nHere‚Äôs why: https://t.co/AG3h1uOqye \n#AheadTogether #JPM24 #JPM2024",
    "likes": 18,
    "retweets": 3,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1744981248794136813",
    "url": "https://x.com/GSK/status/1744981248794136813",
    "created_at": "Wed Jan 10 07:15:24 +0000 2024",
    "text": "#News for #Investors and #Media: Today we announced positive news that our medicine has been approved in China for the treatment of severe asthma with an eosinophilic phenotype in certain patients. Learn more üëâ https://t.co/L7XOSedVYG https://t.co/8fXQezv5yS",
    "likes": 22,
    "retweets": 4,
    "replies": 3,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1744645329239126287",
    "url": "https://x.com/GSK/status/1744645329239126287",
    "created_at": "Tue Jan 09 09:00:35 +0000 2024",
    "text": "We believe prevention is the best medicine. It‚Äôs why we‚Äôve built one of the broadest vaccine portfolios in the world to help protect all stages of life. #AheadTogether #JPM24 #JPM2024 https://t.co/36XhiZ3dLa",
    "likes": 10,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1744630054728962556",
    "url": "https://x.com/GSK/status/1744630054728962556",
    "created_at": "Tue Jan 09 07:59:53 +0000 2024",
    "text": "#News for #investors and #media: Today we announced that we have entered into an agreement to acquire Aiolos Bio to build on our expertise in respiratory medicines\n\nLink: https://t.co/uCzisGwGSI https://t.co/7wAQjwfHQQ",
    "likes": 16,
    "retweets": 5,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1742923845491978514",
    "url": "https://x.com/GSK/status/1742923845491978514",
    "created_at": "Thu Jan 04 15:00:01 +0000 2024",
    "text": "We‚Äôre looking forward to meeting investors &amp; industry colleagues at next week‚Äôs JP Morgan Healthcare Conference in San Francisco and sharing more about our focus on prevention to get ahead of disease. #JPM2024 #AheadTogether #JPM24 \nhttps://t.co/cpvai18Uo7 https://t.co/ShKPsOUSnA",
    "likes": 9,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1742122098602995724",
    "url": "https://x.com/GSK/status/1742122098602995724",
    "created_at": "Tue Jan 02 09:54:10 +0000 2024",
    "text": "Only around 3% of total health spending is dedicated to #prevention across wealthy countries, resulting in people living with diseases that could have been prevented or managed sooner.\n\nRead our article for more on why we believe prevention is the best medicine üëá\n\nhttps://t.co/OA27zWX3o7",
    "likes": 4,
    "retweets": 1,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1741051506424508671",
    "url": "https://x.com/GSK/status/1741051506424508671",
    "created_at": "Sat Dec 30 11:00:00 +0000 2023",
    "text": "A patient-centred approach is key to transforming #respiratory care and relieving struggling services. Read our article to find out how our scientists are helping to make that a reality üëá \nhttps://t.co/66XSZfiDtM",
    "likes": 7,
    "retweets": 2,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1740689115601842655",
    "url": "https://x.com/GSK/status/1740689115601842655",
    "created_at": "Fri Dec 29 11:00:00 +0000 2023",
    "text": "Investing in adult vaccine programs is not only beneficial for individuals but also for society as a whole. CEO of the Global Coalition on Aging, @MWHodin, calls for collective action to make adult immunisation the new standard of care üëá #GCOA \nhttps://t.co/64RqYRD61x",
    "likes": 11,
    "retweets": 2,
    "replies": 0,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1740326729749578139",
    "url": "https://x.com/GSK/status/1740326729749578139",
    "created_at": "Thu Dec 28 11:00:00 +0000 2023",
    "text": "The ‚Äòtripledemic‚Äô will hit older people hard this winter ‚Äì but there are things we can all do to reduce the impact. Read our article to find out more üëá\nhttps://t.co/JAujZwAZwB",
    "likes": 9,
    "retweets": 2,
    "replies": 2,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1739964341569376579",
    "url": "https://x.com/GSK/status/1739964341569376579",
    "created_at": "Wed Dec 27 11:00:00 +0000 2023",
    "text": "By responsibly harnessing #AI, we can transform healthcare and deliver better outcomes for patients. Below, our AI experts discuss how we can embrace this powerful technology to accelerate delivery of new medicines and vaccines üëá  https://t.co/JhatVoAjjr",
    "likes": 9,
    "retweets": 1,
    "replies": 1,
    "author": "GSK"
  },
  {
    "username": "GSK",
    "tweet_id": "1739601951828885535",
    "url": "https://x.com/GSK/status/1739601951828885535",
    "created_at": "Tue Dec 26 11:00:00 +0000 2023",
    "text": "Achieving clinical remission for severe asthma patients could significantly improve their quality of life and minimise the risk of attacks. Read our article about the solutions we're developing to get there üëá https://t.co/TWek8fi2xV",
    "likes": 9,
    "retweets": 0,
    "replies": 1,
    "author": "GSK"
  }
]